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CHAPTER I
GENERAL INTRODUCTION
-Background fatigue studies at the University M edical Centre Nijmegen 
In the early 1980’s chronic unexplained fatigue (myalgic encephalomyelitis) was 
studied almost exclusively from a medical perspective. Numerous studies were 
conducted to find viral and immunological causes for the condition [1]. Some years 
later the possible psychological determinants and consequences of unexplained fatigue 
received increasing attention [2-6]. In 1990 the Nijmegen Fatigue Research Group 
(NFRG) started as a close collaboration between the departments of General Internal 
Medicine, Virology and Medical Psychology of the University Medical Centre 
Nijmegen (UMCN). Already from the start, the NFRG and its research methods paid 
attention to both somatic and psychological determinants and consequences of chronic 
fatigue. At that time, such a multidisciplinary approach to chronic fatigue was 
relatively new.
The NFRG studied CFS from a biopsychosocial perspective on illness and disease. In 
contrast to traditional medical models, the biopsychosocial model views an illness or 
disease not exclusively from a somatic perspective, but pays equally attention to 
possible psychological and social determinants and consequences [7-9]. According to 
this model, a complaint constitutes not only physical sensations but also cognitive, 
emotional, behavioural and social aspects. Since reliable and validated instruments to 
quantify fatigue severity and to assess psychological and social aspects of fatigue were 
still scarce, one of the first goals of the NFRG was the development of a 
multidimensional assessment method which also could be used to assess the relation 
between complaint severity and immunological parameters.
In the initial NFRG studies, the following nine relatively independent dimensions of 
experienced fatigue were identified: subjective experience of fatigue, psychological 
well-being, physical activity, functional disability, social functioning and support, 
neuropsychological functioning, sleep problems, attributions concerning the possible 
cause of fatigue, and sense of control over symptoms (self-efficacy expectations) [10]. 
In subsequent studies, questionnaires, standardised sleep- and complaint-diaries, 
neuropsychological tests and a motion-sensing device (actometer) were used to assess 
these nine dimensions. The measurement method was tested and validated in cross­
sectional and prospective studies pertaining to CFS patients as well as to patients with 
multiple sclerosis [11-13]. The method proved also reliable to identify severely fatigued 
patients in other patient samples [14-15].
In line with the focus of the UMC Nijmegen on evidence-based practice, one of the 
major goals of the NFRG was to develop a theoretically based and empirically tested 
model for perpetuating factors in CFS. A model that could serve as guideline for 
subsequent fatigue studies and the development and testing of specific intervention 
strategies for CFS.
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-The development o f  a model offatigue
Many CFS studies do not distinguish between factors that initiate CFS and factors that 
perpetuate fatigue. Our group has approached the CFS problem by separating these two 
kinds of factors. Already early psychological and psychiatric CFS studies hypothesized 
that behavioral and psychological factors might contribute to the persistence of 
symptoms in CFS. It was for example suggested that initial fatigue complaints would 
cause avoidance of physical activity and that prolonged inactivity would lead to 
deconditioning, hence causing a vicious circle [2,16]. The first natural course CFS study 
of the NFRG indeed found that psychological factors predicted the persistence of 
fatigue over a one-and-a-half year period. More fatigue at baseline, a long illness 
duration, strong somatic causal attributions, and low self-efficacy, predicted more 
fatigue severity at follow-up [17]. These findings, and the inability to demonstrate 
somatic markers for the illness, resulted in the development of a model for persistence 
of fatigue in CFS [13]. In this model it was assumed that the onset o f fatigue might 
have been caused by a somatic or psychological event, but that irrespective of the cause 
both cognitive and behavioral factors were responsible for the persistence of fatigue. 
The model for fatigue that fitted the data of the CFS sample is depicted in Figure 1. 
Predictors for persistence of fatigue were low self-efficacy, low physical activity and a 
strong focus on bodily symptoms. A stronger conviction that the complaints had a 
physical cause resulted in  more activity reduction. Reduced activity and stronger focus 
on bodily symptoms contributed both to more impairment in daily life.
Figure 1. Model o f perpetuating factors in CFS (Vercoulen, 1998)
The CFS model was subsequently tested with data of a sample of MS patients. The data 
of this sample did not fit the model very well, which indicated that in MS the relations 
between fatigue, disability, activity and psychological factors were different from CFS. 
In tradition of evidence-based practice, the CFS model served as initial guideline to 
develop and test specific intervention strategies for CFS [18]. It also offered a 
framework to study and further detail experienced fatigue and its relation to cognitions, 
emotions, behaviours and social context, both in CFS and other medical conditions.
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-Building further on previous findings: possible research questions and goals 
Since both the initial findings and the model of perpetuating factors in CFS were based 
on data of ambulant patients who visited our specialised research centre, one could 
question whether these patients represented the CFS population in general and whether 
the empirically verified relations would apply to other CFS samples. One could not 
exclude the possibility that the research participants represented a relatively mildly 
impaired subgroup of CFS patients. The findings of our previous studies pertained to 
CFS patients who had a relatively long illness duration and showed very little 
spontaneous recovery over time. Thus, it might be possible that patients with a 
relatively short illness duration would have a better prognosis or that different 
psychological factors would predict persistence of fatigue. In summary, the results of 
our previous studies needed to be verified in other CFS populations.
Physical activity had an important place in the model of CFS and the relation between 
physical activity and experienced fatigue could also be of importance to other fatigued 
patient groups. However, the CFS model described only the long-term relationship 
between activity reduction and persistence of fatigue. By choice, the model was only 
based on self-report measures, while subsequent assessment showed that actual 
physical activity, as measured by an actometer, was only marginally related to self­
ratings of activity and not to fatigue severity. It was also demonstrated that physical 
activity levels in CFS showed a large variation between patients, making 
deconditioning as a key feature of CFS somewhat unlikely [19]. Finally, a physical 
exercise study that compared twenty CFS patients with twenty matched controls failed 
to demonstrate significant differences in physical fitness [20]. It seemed therefore 
paramount to assess the activity-fatigue association in more detail and find ways to 
classify different physical activity patterns in CFS.
Although the first CFS studies of the NFRG confirmed that concentration and memory 
problems belonged to one of the frequent and major symptoms of CFS, concentration 
problems were no part of the CFS model [10,13]. Several other neuropsychological 
studies had reported cognitive slowing in CFS and had hypothesised about possible 
cerebral mechanisms underlying CFS [21]. A previous study showed that although 
almost three-quarters of the patients mentioned serious memory and concentration 
problems, less than 30% showed some form of impairment in neuropsychological 
functioning. Similar to the physical activity findings, there was no relation between 
neuropsychological impairment found on standardised tests and self-reported memory 
and concentration problems [22]. Also consistently with the physical activity results, 
neuropsychological impairment test scores showed no relation with fatigue severity 
while the self reported measures of neuropsychological problems did. The fact that test 
performance was associated to actual physical activity and that self reported 
concentration problems correlated both with fatigue severity and focussing on bodily 
symptoms, which were all dimensions in  our model, warranted further exploration of 
the role of neuropsychological functioning in CFS.
The development of assessment instruments and the development of the CFS model 
provided an excellent reference to investigate the occurrence of fatigue and to compare 
biopsychosocial aspects of fatigue in other medical conditions. The NFRG made a start 
by applying the multidimensional assessment method to patients with multiple sclerosis
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and by testing the CFS model with data of MS patients [12,13]. Although initial 
findings indicated that psychological factors were also associated with fatigue in  MS, 
no relation between fatigue severity and the degree of neurological disability was 
found. However, relations between MS specific disease characteristics and the 
experience of fatigue were not included, and the data pertained to a sample of relatively 
mildly disabled patients, which might have obscured a possible impairment-fatigue 
relation. Compared to multiple sclerosis, fatigue had received little systematic attention 
in  other neurological conditions. In order to test whether the experience of severe and 
disabling fatigue was specific to MS, investigations in other chronic neurological 
conditions were needed.
OUTLINE OF THIS THESIS
In the first three studies of this dissertation we addressed the questions whether our 
previous results o f CFS patients were applicable in general and specific subgroups. In 
the firs t  study (Chapter 2) it was tested whether research participants might differ from 
CFS patients in general. Demographics, fatigue severity, disability status and illness 
cognitions of patients who participated in  or previous research were compared to a 
large sample of members of the Dutch ME association.
Our previous natural course study showed very little spontaneous recovery among 
patients with a mean illness duration over five years and the goal of the second study 
(Chapter 3) was to test whether the rate of spontaneous recovery was higher in patients 
with a relatively short illness duration. Since in  a relatively early phase of the illness 
other psychosocial factors might be important for the persistence of fatigue, it was also 
assessed which factors predicted self-rated improvement and fatigue severity at follow- 
up.
Since most UMCN research participants were ambulant patients there was little 
knowledge about patients who were not able to visit the research centre. The objectives 
of the third study (Chapter 4) were to describe demographics, illness characteristics 
and natural course of a group of homebound CFS patients, and to test whether these 
patients differed from the CFS patients who had visited our research centre.
The studies described in the next four chapters addressed physical activity and 
neuropsychological performance in CFS. The focus of the fourth study (Chapter 5) was 
to describe intra-individual physical activity patterns. We asked the question whether 
measurements of daily activity levels, activity peaks, rest periods and day-to-day 
fluctuations in activity, would help to identify subgroups of CFS patients. It was tested 
whether CFS patients showed activity characteristics different from controls and how 
the various activity patterns were distributed among patients and controls. The next 
study (Chapter 6) assessed whether the daily activity and fatigue patterns, and their 
interrelations, were characteristic for the strongly experienced exertion related daily 
fatigue in CFS.
Concentration problems had no place in our CFS model but many studies have 
described abnormal neuropsychological findings and implied possible cerebral 
dysfunctions. However, none of these studies addressed the possible influence of 
illness behaviour during neuropsychological testing of CFS patients, and none of these
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studies have controlled for such behaviour. The sixth study (Chapter 7) assessed 
whether CFS patients would display more illness behaviour during neuropsychological 
testing than patients with multiple sclerosis. The next study (Chapter 8) investigated 
whether attention processes that might be characteristic for the illness could affect 
mental slowing in CFS. The influence of body consciousness and high symptom report 
upon a reaction time task was investigated to test this possibility.
Although previous studies o f our group already compared CFS patients to patients with 
multiple sclerosis, these studies did not include disease parameters specific to MS. 
Multiple sclerosis is characterised by cerebral and spinal demyelinisation and 
associated cerebral atrophy. The eighth study (Chapter 9) assessed whether the degree 
o f demyelinisation in  specific brain areas, or the degree of brain atrophy, were related 
to the experience of fatigue in patients with multiple sclerosis.
A provisional model for fatigue in MS was derived from the CFS model and therefore 
did not include depression [10]. Similar to CFS, sense of control over symptoms turned 
out to be an important psychological predictor for fatigue, while neurological disability 
was only related to physical activity. However, this model was tested on patients with 
relatively mild disability, which might have obscured a possible association between 
fatigue and neurological disability. Study nine (Chapter 10) investigated 86 MS 
patients with more serious neurological disability than the MS patients of the model 
study in order to test whether differences in fatigue and depression were directly related 
to the degree of neurological disability. Subsequently it was investigated whether 
helplessness, a psychological construct closely related to self-efficacy, could act as 
mediator between personality and disease characteristics on one hand, and fatigue and 
depression on the other.
Fatigue in  multiple sclerosis has received considerable research attention and is even 
considered as a MS specific symptom. It is therefore somewhat surprising that fatigue 
and its relation to levels of physical impairment and depression have hardly been 
studied in  other neurological populations. The objectives of the tenth and eleventh 
study (Chapters 11 & 12) were to assess whether the experience of severe fatigue 
might also be characteristic o f stroke victims and patients with neuromuscular disease, 
and to investigate how the experience of fatigue in these conditions was related to 
disability and depression ratings. Myotonic dystrophy is a progressive disabling 
neurological condition that besides muscle weakness can present itself clinically in 
daytime sleepiness and reduced motivation. Since it might be hard to distinguish 
sleepiness, low motivation and experienced fatigue in  these patients, the last study 
(Chapter 13) was specifically aimed to assess those interrelations and investigate 
whether serious fatigue and daytime sleepiness might be the same phenomena. In 
Chapter 14 the relations between the findings of these studies are discussed together 
with clinical implications and possible directions for future research.
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CHAPTER II
RESULTS OF A LARGE SURVEY AMONG MEMBERS 
OF THE DUTCH ME-ASSOCIATION °
ABSTRACT
The present study describes demographics, complaint and illness 
characteristics of a sample of approximately 2000 members of the 
Dutch ME Foundation. About 75% of the respondents reported 
severe fatigue and major functional limitations on standardized 
tests. The survey revealed that the illness had a high impact on 
work participation and medical consumption. Most of the 
respondents indicated that they often experienced too little 
understanding for their complaints from their environment, and a 
significant proportion (37%) that it was unlikely that CFS could 
be cured. In agreement with previous studies, the majority of 
respondents thought that their complaints were caused by physical 
disturbance. A comparison of 270 patients referred to a CFS clinic 
and prepared to participate in  a scientific investigation showed, 
that besides the relatively long illness duration of the members of 
the ME foundation, members of the ME foundation had less 
positive cognitions concerning their illness. There was however, 
no indication that patients participating in CFS research were 
characterised by relatively mild complaints and disability.
°S van der Werf, J Prins, T Jansen, J van der Meer, G Bleijenberg 
A comparison between participants in CFS research and members of the Dutch 
ME-association: results of a large survey of complaints, disability status
and illness cognitions. 
This chapter is a translation of a manuscript that was published in 
Gedragstherapie 2002, 35(2):147-155
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INTRODUCTION
Both, in  the Netherlands and internationally, the research and treatment of patients with 
chronic fatigue syndrome usually finds place in specialised CFS centres. One can ask 
oneself the question if  these specialised centres attract a certain type of CFS patient. 
Especially, since research has shown that among other things, the work status and 
illness beliefs o f patients can affect not only their course of complaints, but also their 
request for help and subsequent intervention [1,2]. For a wider implementation of 
treatment centres, it is very important to investigate whether the CFS patients who have 
participated in research reflect the more general patient population. At the University 
Medical Centre in Nijmegen (UMCN) demographic data and illness characteristics of 
more than 1200 CFS patients have been collected but similar data lack for an equally 
large sample of the general CFS population. It is for this reason that the Nijmegen 
Fatigue Research Group decided to take part in a survey about medical care that the 
Dutch ME association distributed among its members. The approximately eight 
thousand members of the Dutch ME association form a large group from the nation­
wide estimated 27,000 diagnosed CFS patients known to family doctors in the 
Netherlands [3]. The most important goal o f this study was to get a good picture of a 
large random sample of CFS patients and, where possible, compare them to patients 
who participated in research at the UMCN. In addition to describing the demographic 
and illness characteristics of this group, it was tested how many of the survey 
respondents met the operational criteria for severe chronic fatigue and disability that 
were used to include patients for UMCN related research. Furthermore, who diagnosed 
CFS, what consequences the disease had on work and medical consumption and what 
beliefs respondents held regarding CFS were all looked into.
METHOD
-Survey
The questions in the survey could be divided into the following categories:
1) Demographic characteristics.
2) The severity, duration, and onset of the complaints.
3) The individual who made the diagnosis.
4) Consequences on work and medical consumption.
5) The patient’s beliefs regarding (a) self-efficacy; (b) cause of the complaint;
(c) possibilities for recovery; (d) reactions from their social environment.
Fatigue severity was measured with the shortened fatigue questionnaire (Verkorte 
Vermoeidheid Vragenlijst: VVV), which consisted of four items that could be 
answered on 7-point Likert scale (score range 4-28). A cut off value of twenty points 
was used to identify severe fatigue [4]. Physical disability was assessed with the 
RAND-36-Physical Function Scale (0=completely disabled and 100=not disabled). In 
the research literature, a score of <=65 on this scale is considered a significant physical 
impairment.
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-Procedure
In November 1998, a survey was enclosed in the ME association’s newsletter and sent 
to an estimated 7000 of its members. Enclosed instructions explained the purpose of 
the survey, that it was anonymous and intended for ME/CFS patients. We used the term 
ME since many patients still refer to their condition as ME and not CFS. Only the 
surveys from patients whose length of complaints and the severity of the fatigue and 
disability could be determined were used in this study. Where possible, a comparison 
was made with a group of 270 CFS patients who participated in a randomised trial 
studying the effect of cognitive behaviour therapy. Detailed characteristics of this 
group have been described in a previous study [2]. Group differences between variables 
were tested two-sided with a significance level of 0.01
RESULTS
-Response rate to the survey
In total, 2610 (37%) of the 7000 questionnaires were returned and 1955 (28%) of them 
had complete data regarding complaint duration, fatigue severity (VVV) and functional 
impairment (RAND-36-physical functioning).
-How many respondents fulfilled the operational criteria fo r  profound fatigue and 
functional disability?
The average scores on the VVV and RAND-36-physical functions tests were 23.9 
(SD=4.6) and 44.6 (SD=22.1) respectively. Both scores were well within the range of 
severe fatigue and profound disability. The mean VVV-score was lower than that of the 
UMCN CFS group (table 1).
Table 1. Demographic and illness characteristics o f survey respondents and UMCN research 
participants
Survey
Respondents
Research
participants
Significance
testing
Percentage females 85 79 X2 = 6.3*
Mean age in years ( SD) 41.0 (11.8) 36.7 (10.1) t = 5.7*
Mean illness duration in years (SD) 9.8 (7.8) 5.6 (5.6) t = 8.5*
Percentage of patients with a gradual onset of 59 60 x2 = 0.1
the illness
Mean VVV-score (SD) 23.9 (4.7) 26.1 (2.0) t = 7.6*
Mean rand-36-physical function score (SD) 44.6 (22.1) N/A
Percentage of patients reporting to be severely 85 91 X2 = 16.6*
or very severely impaired.
*p < 0.01.
In total, 75% of the respondents fulfilled the criteria of a minimal complaint duration of 
six months and being severely fatigued (VVV>=20) and disabled (RAND-36-physical
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function<=65). The respondents were also asked who had confirmed their diagnosis of 
CFS/ME. Bearing this in mind, more than one of the following choices could be made: 
solely a self-diagnosis, confirmations from (a) a family doctor, (b) a medical specialist, 
or (c) an alternative doctor/therapist. Nine percent of these cases were solely self­
diagnoses while in  another 29% of the respondents the self-diagnosis was combined 
with a diagnosis o f an alternative doctor/therapist. In 38% and 50% of the respondents, 
a general practitioner or specialist made the diagnosis respectively.
-Demographic and illness characteristics
Both the respondent group and the UMCN CFS group consisted of more than three- 
quarters females. The mean age of the respondents was higher and they had also a 
significantly longer complaint duration (Table 1). Ninety-one percent of the 
respondents had an age between 20 and 60 years, which is comparable with the age 
selection of the UMCN CFS group. These observed differences in age and complaint 
duration remained significant even when tests were restricted to the group of 
respondents between 20 and 60 years old. Five percent of the respondents were older 
than sixty years and four percent of the respondents were younger than twenty years.
-Consequences o f  the disease on work and medical consumption 
A large proportion (79%) of the respondents was employed before the complaints 
began and worked an average of 34 hours a week. The complaints led to a considerable 
reduction in work hours. The respondents indicated that they worked an average of 
26.8 hours less and many (63%) of them received unemployment or disability benefits 
as a result o f their illness. More than half (52%) of the respondents were declared 
completely unfit for work.
One out o f ten respondents was busy with or was considering taking legal action with 
regards to unemployment or disability benefits, while 17% of the respondents had dealt 
with similar situations in their past.
The majority of the respondents (85%) stated that an alternative doctor or therapist 
treated them. More than half (54%) of the respondents were in  contact with a 
psychologist, psychiatrist or social worker as a result of their complaints. It also 
appeared that in  the six months prior to the questionnaire many respondents sought 
advice from a general practitioner (47%), medical specialist (30%) or an alternative 
doctor/therapist. Furthermore, the questionnaire revealed that 45% of the respondents 
had medicine prescribed to them by family doctor or specialist. According to the 
respondents, they spend an average of 100 Euros a month on extra costs as a result of 
their disease, which is not reimbursed by any authority.
-Illness cognitions
Table 2 indicates how respondents think about the possible causes of their complaints. 
More than 95% of the respondents checked at least one of the four physical 
explanations for their complaints, while also 45% of them checked at least one of the 
psychosocial explanations. The reactions of the respondents and the UMCN CFS group 
to the seven other illness beliefs showed also differences (Table 3). Respondents could 
indicate on a 4-point scale (agree completely, agree, disagree, disagree completely)
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how much they agreed with the different statements. The respondents believed more 
strongly that: (1) ME patients are forced to do things very slowly; (2) it is important 
that the social environment of a ME patient sees how little he or she is capable of; (3) 
ME can not be cured; (4) a ME patient is not capable of physical exertion; (5) ME 
patients must show how serious their complaints are. In contrast, the UMCN research 
group believed more strongly than the survey respondents that a ME patient can (learn 
to) influence their own complaints. The survey respondents and the UMCN CFS group 
did not differ significantly regarding their opinion concerning ‘not being taken 
seriously by their social environment’.
Table 2. Respondents' beliefs about the possible causes o f their complaints
Percentage of the respondents who think that their complaints are caused by : %
The immune system 80
A virus 57
Tension or stress 40
Environmental factors 31
Too busy life-style 28
Physical dysfunction 27
Too much worrying 11
The work-situation 8
The home-situation 6
Table 3. Illness beliefs and self-efficacy o f survey respondents and UMCN research
participants
Percentage of patients that partially or totally agreed with the 
following statements:
Survey
Respondents
UMCN
CFS
X2Test
When you have ME, you are forced to do things very slowly. 76 58 38.9*
It is important that the social environment of a 
ME -patient sees how little he or see is capable of.
83 72 20.8*
ME cannot be cured. 37 19 32.7*
A ME-patients is often not taken seriously by their social 
environment.
76 73 1.2
A ME-patient is not capable of physical exertion 49 28 38.5*
ME-patients have to show how serious their complaints are. 73 52 48.8*
ME-patients can (learn to) influence their complaints. 74 82 6.8*
* p < 0.01
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DISCUSSION
To a large extent the results of the questionnaire among the members of the Dutch ME- 
association resemble previously published national and international research data on 
CFS. More than three-quarters of the CFS patients was female. The complaints were 
mostly ascribed to a somatic origin and the percentage of patients who were completely 
unable to work is high [5-7]. Three quarters of the respondents to this questionnaire 
fulfilled the criteria for severe fatigue and serious disability. Thus, concerning the 
severity of the complaints and disability, the respondents were rather similar to the 
patients who took part in the research in the UMCN. The average fatigue scores of the 
respondents were even somewhat lower than the UMCN CFS group. Also, relatively 
less respondents reported experiencing severe or very severe functional impairment in 
their daily lives compared to the UMC CFS group. Consequently, these data do not 
correspond with the ideas of some of the CFS patients, that CFS patients, participating 
in  research or treatment, are less fatigued and less disabled.
Almost one tenth of the respondents stated that they had diagnosed themselves. 
Because a family doctor or specialist did not confirm their diagnosis, there is a chance 
that a part of this group suffers from another disease that perhaps rules out the 
diagnosis of CFS. There is also a possibility that some of the group of respondents with 
less severe complaints and impairment were in partly or complete remission of CFS.
In comparison to persons with other medical chronic conditions, it seems that more 
CFS patients visit a doctor/therapist practising alternative medicine/therapy. Figures of 
the National Central Office of Statistics from 1999 showed that one in ten people with 
poor health made at least one visit a year to an alternative doctor/therapist. In this study 
more than half o f the respondents made at least one visit to an alternative doctor or 
therapist within the six months prior to this questionnaire. The present study did, 
however, not include any questions for further explanations of this finding.
Almost one tenth of the respondents was considering or involved in  a legal procedure 
concerning unemployment or disability benefits. The data of our intervention study 
suggested that these legal procedures could stand in  the way of a successful treatment 
with cognitive behaviour therapy.
The respondents were on average older and had considerably longer complaint 
durations than the patients from the UMCN CFS group. Studies indicate that the longer 
the complaint duration is, the less chance there is of spontaneous recovery [1,7]. Also in 
comparison to the UMCN CFS group, the respondents were characterised by impeding 
cognitions. For example, a considerable proportion of the respondents was convinced 
that a ME patient is forced to do things very slowly; a belief that possibly coincides 
with avoiding activity in daily life. The process of avoiding activity has found to be an 
important persisting factor for fatigue [8]. In addition, respondents were less positive 
about the chances of recovery. The idea that a ME patient is not capable of physical 
exertion was nearly twice as often present in  respondents compared to research 
patients.
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Whether this sort o f highly frequent, impeding cognitions are a result of the long 
complaint duration or whether these illness cognitions make the complaints persist is, 
considering the methodological design of this study, difficult to answer.
This questionnaire involved a part (28%) of the total members of the Dutch ME 
association, while these members were only a part of the total amount of the estimated 
27,000 CFS patients in the Netherlands. Taking into consideration this fact and the lack 
of data from the non-respondents, one must be careful about generalising the results to 
CFS population in general. Nevertheless, the acquired information gives a good picture 
of a large group of Dutch CFS patients especially since the data show similarities with 
various other studies concerning CFS patients. In spite of the above-mentioned 
restrictions, this was the largest survey among CFS patients in the Netherlands to date. 
In turned out that both fatigue severity and disability levels o f CFS patients 
participating in scientific research at the UMCN are not lower compared to CFS 
patients in general. It does however seem that in the UMCN group, more patients had 
positive beliefs concerning CFS and the treatment possibilities thereof.
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CHAPTER III
THE NATURAL COURSE OF CHRONIC FATIGUE SYNDROME PATIENTS 
WITH A RELATIVELY SHORT ILLNESS DURATION0
ABSTRACT
The objective of this study was to describe the course of fatigue of 
CFS patients with a relatively short duration of complaints and to 
test which psychosocial factors predict spontaneous improvement 
one year later. Seventy-nine patients with a complaint duration of 
less than two years were tested at baseline and at one-year follow- 
up. During this time period, no systematic intervention took place. 
Self-reported improvement and fatigue severity were the main 
outcome measures. In total 46% (95CI=35-58%) of the patients 
with a short illness duration reported to be improved. This was a 
significantly (%2 =20.3, p<0.001) higher percentage compared to 
the 20% (95CI=15-26%) self-reported improvement in a 
previously published natural course study among 246 CFS 
patients with a longer illness duration. Persistence of complaints 
after 1-year follow-up was associated with high baseline levels of 
experienced concentration problems, less strong psychosocial 
causal explanations for the complaints, and higher levels of the 
experienced lack of social support. Baseline fatigue severity 
predicted fatigue severity at follow up. The results showed that 
CFS patients with a relatively short duration of complaints had a 
more favourable outcome compared to patients with a long illness 
duration. The data also indicated that complete recovery only 
occurred among patients with a complaint duration of less than 
fifteen months. This finding has important implications, since it 
suggests that after such a time period spontaneous recovery hardly 
occurs.
° S van der Werf, B de Vree, M Albers, J van der Meer, G Bleijenberg. 
Natural course and predicting self reported improvement in patients with chronic 
fatigue syndrome with a relatively short illness duration. Journal o f 
Psychosomatic Research, 2002,53:749-753.
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INTRODUCTION
Chronic Fatigue Syndrome (CFS) is characterised by severe disabling fatigue of 
definite onset, lasting longer than 6 months and for which no somatic cause can be 
found [1]. Follow-up studies in patients with CFS showed that only small proportions 
of these patients, varying between 0% and 8%, recovered spontaneously [2-6]. The 
means of the illness duration in  these studies ranged between 3 to 9 years, while the 
follow-up periods varied between 1 and 3 years. These differences make direct 
comparisons between these studies difficult. Nevertheless, the reported number of 
patients becoming symptom-free indicated that prognosis in CFS is rather poor. 
Follow-up data o f patients who suffered prolonged fatigue (>1 month) but did not fulfil 
the criteria of a 6-month illness duration, showed that approximately half of the 
patients reported full recovery of their symptoms at follow-up [7,8]. These discrepancies 
between recovery rates in CFS patients and recovery rates in studies concerning 
patients suffering prolonged fatigue do suggest a reversed relation between complaint 
duration and spontaneous recovery of symptoms. Some prospective studies have indeed 
found that illness duration in CFS was a predictor o f persistence of fatigue [2,9]. 
Therefore, there is a need for investigating prognosis in CFS patients with a relatively 
short duration of complaints.
In a previous study of natural course in CFS patients with a median duration of 
complaints of 5 years, 20% of the CFS patients reported improvement (including 3% 
recovery) in complaints after a 1 Vi year followup period [2]. In this study, the 
persistence of fatigue was not only predicted by long illness duration, high level of 
baseline fatigue and functional disability, but also by the lack of perceived control over 
symptoms (low self-efficacy expectations) and strong physical attributions. The 
importance of physical attributions was confirmed by the cohort study of Wilson et al., 
but illness duration, premorbid psychiatric diagnosis and cell mediated immune 
function, did not predict outcome [4]. Another prospective study reported long illness 
duration and low internal locus of control to be significant predictors for persisting 
fatigue [9]. Based on their data, the authors suggested that interventions should enhance 
perceived control. Bombardier & Buchwald surveyed large groups (>400) of persons 
with chronic fatigue or chronic fatigue syndrome and found that prognostic indicators 
differed for both groups. However, the presence of dysthymia at baseline predicted 
poorer outcome in both groups [3].
An uncontrolled intervention study found that CFS patients with a shorter illness 
duration had a lower incidence of psychiatric disorder [10]. The authors of this study 
also reported that the effectiveness of counselling was greater among patients with 
relatively short illness duration. The average complaint duration in  their sample was 21 
months, and after counselling 80% of their patients reported improvement at follow-up. 
In summary, most o f the described studies suggested a possible relation between illness 
duration and spontaneous recovery, while psychosocial factors were consistently found 
to predict outcome. In spite of this, most of the data were limited to patients with 
relatively long illness duration. Consequently, this follow-up study was aimed at 
assessing improvement rates among patients with a recent diagnosis of CFS (maximum 
illness duration of 2 years) and to compare them with the findings in our previous
CFS patients with a short illness duration 25
natural course study. Furthermore it was tested whether similar or other psychosocial 
factors as found in our previous natural course study predicted outcome. Based on the 
literature we expected higher improvement and recovery rates among patients with a 
relatively recent diagnosis of CFS.
METHOD
-Subjects
This study was carried out at the University Medical Centre Nijmegen in the 
Netherlands and was approved by the medical ethical committee. Informed consent 
was obtained prior to the start of the study. All patients with a major complaint of 
fatigue referred to the outpatient clinic of the department of internal medicine were 
assessed by means of detailed history, physical examination, and computer assessment 
of questionnaires. Patients were eligible for the study if they met the US Centres for 
Disease Control and Prevention criteria for CFS or idiopathic fatigue [1]. The patients 
had also to fulfil operational criteria for severe fatigue and severe functional 
impairment. These criteria were defined as a score of 35 or more on the subscale 
fatigue severity of the Checklist Individual Strength (CIS-fatigue) and a sum score of 
700 or more on eight subscales of the Sickness Impact Profile (SIP8). Additional 
inclusion criteria were that the age of a patient ranged between 18 and 65 years and a 
symptom duration of less than 2 years. Consecutive patients fulfilling the inclusion 
criteria of this study were approached. In this study no record was kept about the 
number of participants who refused to participate.
In total, 79 CFS-patients with a relatively short duration of complaints (mean 1.4 years, 
min. 6 months and max. 24 months) completed baseline assessment. Sixty-six (85%) of 
the 79 patients were female. The mean age of this sample was 34.8 years (range: 16-57 
years). Educational level was rated with a 7-point educational scoring system 
applicable to the situation in the Netherlands (1=only primary school, 7= university 
degree). The mean educational score of this sample was 4.4, approximating 11 years of 
education. Seventy-five percent of the total sample worked (paid job) before the illness 
started while 29% of the sample indicated that they had worked (paid job) in the month 
preceding assessment. Seventy-eight of the 79 patients participated at follow-up, 1 year 
later.
-Comparison group
Improvement ratings were compared with a previous natural-course study in which the 
same measurement method was used. The improvement ratings of this comparison 
group (n=199, 77% female) pertained to patients fulfilling similar operational inclusion 
criteria for fatigue severity and disability as used in the current study. The mean illness 
duration of this sample was 8.8 years and 51 patients had an illness duration of 2 years 
or less.
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Measures
-Self-reported change
At follow-up, patients were asked to evaluate their present situation in comparison with 
the situation at initial assessment. Patients could choose out of the following four 
categories: (1) recovered, (2) complaints improved, (3) similar complaints, (4) worse.
-Fatigue severity at follow-up
Fatigue severity at follow-up was measured with the subscale CIS-fatigue severity of 
the CIS. The CIS-fatigue severity subscale has eight items rated on a 7-point scale. 
Scores can range between 8 (non-fatigued) and 56 (extremely fatigued) and scores of 
35 or higher are indicative of severe fatigue [11,12].
-Predictor variables
1. Functional impairment: total score of the eight subscales of the SIP8 [13].
2. Psychological distress: psychological distress was rated by the sum score of the 
depression (SCL90-DEP) and anxiety (SCL90-ANX) scales of the Symptom 
Checklist 90 (SCL90) [14].
3. Dissatisfaction with the extent of social support: A subscale of the Social Support 
List was used to rate the perceived discrepancy in actual support and wanted 
support (SSL-D) [15].
4. Physical activity: the Physical Activity Rating Scale (PARS) served as measure of 
physical activity levels. Patients were asked to rate the frequency of 10 different 
activities over the last 2-week period on a 5-point scale. These 10 ratings were then 
averaged into a total activity score that could vary between 0 (low physical activity 
level) and 5 (high physical activity level) [16].
5. Self-efficacy: sense of control over symptoms was measured with 5 questions (SE-
5) that had been used in our previous studies. The score could range between 5 and 
25. Higher score indicating higher levels of self-efficacy concerning fatigue [2,11].
6. Causal attributions: Beliefs regarding the physical and psychosocial causes of 
fatigue complaints were measured with the Causal Attributions List (CAL). The 
CAL consists of two subscales and patients could indicate on each of the two 4- 
item subscales how strongly they agreed (scale 1 to 5) with possible causes of their 
complaints. High scores on these two scales indicate stronger physical or stronger 
psychosocial attributions [2,11].
7. Concentration problems: the CIS subscale concentration (CIS-CON) served as a 
measure of experienced concentration problems [2,17].
8. Sleeping problems: The SCL-90 subscale sleeping problems (SCL-SLP) served as 
a measure of sleeping problems e.g. items like cannot sleep, frequently wake up at 
night.
9. Focusing on bodily symptoms: the SCL90 somatisation subscale (SCL90-SOM) 
was used to represent this dimension.
10. Fatigue severity: baseline CIS-fatigue score.
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-Statistics
Improvement ratings between the two patient samples were compared with c 2 statistics 
and 95% confidence intervals (95CI) were provided. The sample was divided in a 
group of patient who reported to be recovered or improved and a group of patients who 
reported no change or worsening of symptoms at follow-up. To compare these two 
samples with respect to their baseline psychosocial dimensional scores and mean 
illness duration, t-tests were used. Additionally, the combination of baseline 
psychosocial dimensions that could best predict self-reported improvement and fatigue 
severity at follow-up was tested. Testing was carried out two-sided with an alpha set at 
0.05 and, in case variables showed a non-normal (-1<skewness<1) distribution, 
appropriate (log) transformations were applied.
RESULTS
-Self- reported improvement
At follow-up, 6 (8%) patients indicated that they had no complaints anymore, 30 (38%) 
patients reported that they had less complaints, 29 patients reported that their 
complaints remained similar, and 13 (17%) patients indicated that their complaints had 
become worse. Thus, 46% (95CI=35%-58%) of the patients reported to be improved or 
recovered which was a significantly (c2 =21.2, p<0.001) higher percentage compared 
to the 19% (95CI=13%-25%) improvement in the comparison group of 199 patients 
with a higher mean illness duration. Post hoc analysis within the comparison group also 
revealed a significant (c2 =15.8, p<0.001) difference in improvement rates between 
patients with a short and longer illness duration. In total, 36% percent ( 95CI=24-52%) 
of the 51patients with a short illness duration (<=2 years) reported either full recovery 
(n=4) or improvement (n=15), while 12% (95CI=7-19%) of the patients with an illness 
duration of more than 2 years reported either full recovery (n=1) or improvement 
(n=17). Fisher exact testing showed that full recovery was significantly (p<0.05) more 
likely in the group with short illness duration (8%, 95CI=2-19%) compared to the 
subgroup with a long illness duration (<1%, 95CI=0-3% ).
-Relation between self-reported improvement and baseline fatigue severity measures 
In Table 1, baseline psychosocial dimensional scores of the group recovered and 
improved patients (improved group) were compared to the group of patients who 
reported no change or worsening of symptoms (non-improved group) at follow-up. The 
improved group reported significantly less concentration problems at baseline and 
reported significantly more psychosocial causal attributions. The differences on both 
baseline fatigue severity (p=0.05) and dissatisfaction with the extent of social support 
(p=0.05) approached significance. Improved patients tended to report less baseline 
fatigue and less baseline dissatisfaction with social support.
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- Self- reported improvement
Stepwise multiple regression analysis entering all the dimensional scores and disease 
duration at baseline resulted in a significant model (R2 adj. 0.18, F= 6.2, df (3,73), 
p<0.01) with three significant predictors. Self reported improvement was predicted by 
lower levels of experienced concentration problems (a= -0.33, p<0.01), stronger 
psychosocial attributions concerning the cause of the complaints (beta = -0.29, p<0.01), 
and less dissatisfaction with amount of social support (a= -0.24, p=0.03).
-Fatigue severity at follow- up
A similar stepwise multiple regression analysis with fatigue severity at follow-up as 
dependent variable resulted in a significant model (R2 adj. 0.11, F= 10.2, df (1,73) 
p<0.01). Fatigue severity at baseline was the single significant predictor for fatigue 
severity at follow-up (a=0.35, p<0.01), while experienced concentration problems did 
approach significance as a predictor (a=0.21, p=0.05).
Table 1. Self-reported change at follow-up and the with baseline measures
Baseline measurements Recovered No change Univariate analysis
and improved or worsened t-value, df, signif.
(n=36) (n=42)
Mean (SD) Mean (SD)
Fatigue severity (CIS-fatigue) 48.6 (6.8) 51.0 (5.7) t= 1.96, df(75), p=0.05
Functional impairment 1593 (576) 1801 (599) t= -1.56, df(76), ns
(SIP8-total)
Psychological distress 39.3 (9.3) 4 5 .3 (16.3) t= -1.87, df(76), ns
(SCL anxiety+depression)
Physical Causal attributions 14.1 (3.01) 14.6(2.8) t= -0.74, df(76), ns
(CAL)
Psychosocial Causal 9.0 (1.8) 8.1 (2.1) t= 2.05, df(76), p<0.05
attributions (CAL)
Self-efficacy (SE-5) 15.9 (3.5) 15.0 (3.1) t= 1.20, df(76), ns
Physical Activity ratings 44.2 (11.2) 4 4 .2 (9.4) t= -0.00, df(75) ns
(PARS)
Concentration problems 26.3 (5.9) 2 8.4 (7.0) t= 2.32, df(76), p<0.05
(CIS-con)
Sleep problems (SCL-SLP) 7.4 (3.2) 8.3 (3.8) t= 1.07, df(76), ns
Focussing on bodily symptoms 27.6 (6.2) 3 0.1 (9.2) t= -1.60, df(76), ns
(SCL-SOM)
Dissatisfaction with the extent 40.4 (6.2) 44.5 (11.2) t= -1.98, df(76), p=0.05
of social support (SSL-D)
Baseline illness duration in 16.3 (4.7) 1 6.6 (5.3) t= -0.30, df(76), ns
months
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DISCUSSION
This study specifically targeted CFS patients with a relatively short illness duration. 
The findings suggested that a shorter illness duration was associated with higher rates 
of spontaneous improvement and recovery. Since no details were available concerning 
non-participants, there is some uncertainty whether the investigated sample might have 
been biased towards a more favourable illness course. Nevertheless, a post hoc analysis 
among equally fatigued and disabled patients of a previous natural course study 
provided further support for our finding that improvement and full recovery were more 
likely among patients with a short illness duration.
Spontaneous recovery, however, was still rare, and all of the recovered patients in the 
present sample had an illness duration of less than 1 V year. The finding that many 
(36%) patients with a short illness duration reported at least improvement could imply 
higher success rates for early interventions in CFS, since it might be easier to treat 
patients who experienced a positive change in their complaints.
The regression analyses showed that more baseline concentration problems predicted 
persistence or worsening of symptoms at follow-up and a similar trend was observed 
for the prediction of fatigue severity. A previous neuropsychological study of our group 
indicated that the experience of concentration problems in CFS was not related to 
actual performance on neuropsychological tests. It was suggested that experienced 
concentration problems might reflect higher levels of distress or a stronger focus on 
bodily symptoms [17].
Although physical causal attributions have been found to predict the course of fatigue 
in CFS, the extent of physical causal attributions did not predict complaint persistence 
in this group [2,14]. However, when the patients favoured more strongly a psychosocial 
explanation for their complaints, the prognosis was better. Perhaps that most CFS 
patients suppose a physical cause for their complaints, but that some of these patients 
not rule out that, besides a physical cause, additional factors could play a role in their 
symptoms. It is also possible that patients with a relatively short illness are more open 
to different causal explanations, but that the need for a single more conclusive physical 
causal explanation strengthens when the complaints persist and no medical answers can 
be given over a prolonged period of time.
Baseline dissatisfaction with the extent of social support turned out to be another 
significant predictor. This finding could indicate that early in the course of the illness, 
reactions of friends, relatives, and co-workers play a crucial role. Negative reactions or 
little understanding could provoke psychological distress, which in turn could promote 
the persistence of symptoms. Since this study showed that spontaneous improvement or 
recovery occurred more frequently in a relatively early phase of the illness, it would be 
interesting to see whether the self-rated improvement in these patients continued to 
complete recovery or whether relapse occurred in the relatively few recovered patients.
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CHAPTER IV
HOMEBOUND CHRONIC FATIGUE SYNDROME PATIENTS°
ABSTRACT
Homebound Chronic Fatigue Syndrome (CFS) patients are often 
not able to visit the research centres and they might be 
underrepresented in CFS studies. The goal of this study was to 
describe the illness characteristics and natural course of 
homebound CFS patients. Eighteen homebound and 32 ambulant 
CFS patients, matched on gender, age and illness duration, were 
compared with respect to activity levels, fatigue severity, 
functional limitations psychological distress, and illness 
cognitions. In the homebound group, the measurements were 
repeated one year later. Homebound patients had a longer illness 
duration, were physically less active, reported more daily fatigue 
and more physical limitations, but they did not differ with respect 
to psychological distress and sense of control over symptoms. At 
follow-up, symptom severity and physical activity levels had 
hardly changed. The long illness duration and the persistent low 
physical activity levels might be risk factors for physical 
deconditioning and this could have important implications for 
choosing intervention strategies. In order to find predictors for 
becoming homebound it is necessary to assess activity patterns in 
a relatively early stage of CFS and test their possible relation with 
indices of physical deconditioning.
° S van der W erf, J Prins, E K lein-Rouweler, M Alberts, J van der Meer,
G Bleijenberg.
Homebound Chronic Fatigue Syndrome patients.
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INTRODUCTION
Chronic Fatigue Syndrome (CFS) studies often pertain to patients who are able and 
willing to visit the research centres. Since homebound patients may have difficulties 
visiting the research centres it is possible that these patients are systematically missed 
in CFS research and treatment studies. Homebound patients are most likely physically 
inactive and early CFS related research has already suggested that this might have 
important clinical implications [1,2]. A previously developed model for persistence of 
fatigue in CFS showed that a low sense of control over symptoms (self-efficacy) was 
an independent predictor for persistence of fatigue, while being stronger convinced of a 
physical cause of the illness (somatic causal attributions) contributed to more 
avoidance behaviour and subsequent lower activity levels [3]. Both, lower activity 
levels and a stronger focus on bodily symptoms cause higher levels of experienced 
fatigue and disability. According to this model, one could hypothesise that homebound 
patients might be characterised by stronger physical causal attributions, more fatigue 
and disability.
A recent study showed that baseline physical activity patterns were a significant 
predictor for success of cognitive behaviour therapy in CFS [4]. This finding suggested 
that the pervasively passive CFS patients who visited our research centre might need 
another type of cognitive behaviour therapy (more activation) than the physically more 
active patients. However, both the model and therapy findings pertained to ambulant 
patients who visited our research centre. It is not known how the model variables 
compare to homebound patients or whether the fact of being homebound might cause 
more psychological distress. Therefore, the aims of this study are to describe 
demographics, illness characteristics, and natural course of a group of homebound CFS 
patients, and to compare these findings with that of ambulant CFS patients, who are 
matched with respect to gender, age and illness duration.
METHOD
-Subjects
A contact person of the Dutch ME association was asked to find members who were 
willing to participate in CFS-related research but who were incapable to visit the 
research centres because of severe functional limitations. Subsequently, this contact 
person did send these patients an information letter and a short form on which patients 
could provide biographical background information and indicate whether they did want 
to participate in the proposed study. The researchers received 29 of these forms (28 
females/ 1 male). Three patients indicated that they were not willing or capable to 
participate because they disagreed with the purpose of the study (1), or judged the 
home-visits as physically too demanding (2). Another five patients were excluded: two 
patients did not fulfil the age criteria (18-60) of this study, one patient questioned his 
homebound status, another patient reported that fatigue was not the main complaint, 
and one patient lived too far away from the research centre to be visited by the 
researcher. The 20 remaining patients were visited at home. During the initial home
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visit one participant was identified as an anorexia nervosa patient. Another patient died 
between baseline and follow-up assessment; the exact cause remained unknown to the 
researchers. Subsequently, the baseline data of the homebound group pertained to 
eighteen patients.
As a comparison group baseline data were used of 270 ambulant CFS patients who had 
volunteered to participate in a randomised controlled study with three arms: cognitive 
behaviour therapy, support groups and natural course [4]. All of these patients had a 
diagnosis of CFS according to the Centres of Disease Control (CDC) criteria and 
fulfilled operational criteria concerning fatigue severity and functional impairment [5]. 
Out of this sample as many patients were selected who matched the homebound group 
in gender, age, and illness duration, resulting in 32 matched patients.
-Procedure
The interview and tests were administered during two sessions at the patients’ home. 
During the two-week interval between these sessions patients carried the actometer and 
filled out self-observation lists and a sleep diary. Demographics of the bed-ridden 
group were compared to baseline data of the large (n=270) comparison group of 
ambulant CFS patients. Subsequently, comparisons were made between the 
homebound CFS patients and matched non-homebound CFS-patients. The homebound 
patients were also approached twelve months later to collect follow-up data concerning 
complaint severity, disability and activity levels.
-Sociodemographics
Data concerning age, sex, education marital status, duration of complaints, previous 
and present employment-status were collected. Educational level was determined with 
a Dutch standardized scoring system ranging from ‘no formal education’ (1) to 
‘university degree’ (7) [4].
-Fatigue severity
A subscale of the checklist individual strength (CIS-fatigue) was used to rate fatigue 
severity. In this questionnaire the patient was asked about fatigue in the two weeks 
preceding the assessment. The subscale contains eight items; each scored on a seven- 
point Likert scale (range 8-56) [6]. In addition, the patients rated the intensity of their 
daily fatigue on a daily self-observation list during a two-week period.
Fatigue severity was rated four times a day on a scale of 0 (no fatigue) to 4 (severely 
fatigued). The daily fatigue score could range between 0 and 16, and the twelve daily 
fatigue scores were averaged into one Daily Observed Fatigue (DOF) score [4].
Table 1. Participant characteristics
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Homebound Matched* ambulant Total ambulant
group (n=18) group (n=32) group (n=270 )
Age Mean (SD) 42.2 (8.0) 42.0 (8.7) 37.3 (10.1)
% Female 100 100 79
Education Mean (SD) 4.6 (1.6) 4.3 (1.5) 4.2 (1.6)
Illness duration in years 12.5 12.2 5.6
(range) (4-32) (3-28) (0.5-32)
% married 39 75# 70
% divorced 33 16 6
% paid job 0 18 31
*Patients were matched on gender, age and illness duration. #significant (p<0.05) differences between scores 
of the matched ambulant sample and the homebound sample.
-Physical activity levels and sleep-patterns
Physical activity levels were also measured with the daily self-observation list and 
concurrently with a motion-sensing device (actometer). Similar to the daily-observed 
fatigue score (DOF), a daily-observed activity score (DOA) was calculated. The DOA 
score could also range between 0 and 16, higher scores indicating more self-reported 
activity [4]. The actometer had to be worn continuously around the ankle during the 2- 
week self-observation period. A mean physical activity score (actoscore) for the total 
registration period was computed and expressed as the mean number of accelerations 
per 5-minute interval. Furthermore, the activity pattern of each patient was typified by 
comparison of the 12 individual daily activity scores with the reference score of CFS 
patients. Three categories were defined: pervasively passive (92% or more below the 
reference score); pervasively active (92% or more above the reference score); 
moderately active (defined as being neither pervasively passive nor pervasively active
[7]. Each day throughout the self-observation period, patients also had to rate their 
number of hours sleep at night and their number of hours sleep during the day. These 
daily scores were averaged over the 12-day self-observation period (mean hours sleep 
at night) and (mean hours daytime sleep) [3].
-Functional impairment
Self-rated impairment was measured with a single item (how impaired are you in daily 
life?) and could be answered on a 4-point scale (not at all - little - severe - very severe). 
In addition seven subscales of the Sickness Impact Scale (SIP) were used to rate both 
physical and psychosocial disability. Total functional impairment (SIP7-total) score 
was computed by addition of the weights of the individual items of seven SIP 
subscales. The subscales: mobility (SIP mobility), ambulation (SIP ambulation) and 
home-management (SIP-home), represented the physical dimensions (SIP physical), 
while the subscales: social interactions (SIP-social) and recreation/pastimes (SIP- 
recreation), represented the psychosocial dimension (SIP-psychosocial). The remaining
Homebound CFS patients 35
two subscales were alertness behaviour (SIP-alertness) and sleep problems (SIP-sleep)
[8]. In addition, an interviewer used the Karnofsky rating index to rate functional 
impairment. The Karnofsky performance status scale is a descriptive, ordinal scale 
whereby an independent clinical psychologist rates the patient’s functional status at 
ten-point intervals from 0 to 100. Lower ratings on this scale indicate higher 
impairment [9].
-Psychological distress
The eight subscales of the Symptom Checklist (SCL90) were used to assess different 
areas of psychological problems. The SCL90-total score can range between 90 and 450 
and can be considered as a general measure of psychological distress [10]. The Beck 
Depression Inventory for Primary Care (BDI-PC) served as a measure of depressive 
symptoms and was used instead of the standard BDI to prevent bias by somatic 
symptoms [11]. In both the homebound and the comparison group the same 
psychologist used the Structured Clinical Interview Diagnosis for DSM-III-R patient 
version to assess current (within the last month) depression and anxiety disorder and 
lifetime depression.
-Illness cognitions and avoidance coping
Similar to previous studies, sense of control in relation to CFS was measured with the 
self-efficacy scale, consisting of five questions. Four items were scored on a five-point 
Likert scale and one item on a 4-point Likert scale. The total score ranges from 5 to 24, 
a higher score reflecting more sense of control [4]. Somatic attributions with respect to 
the cause of CFS related symptoms were measured by the causal attribution list 
consisting of five questions scored on a 4-point Likert scale. The total score could 
range between 5 and 20, a higher score indicating stronger somatic attributions. 
Psychosocial attributions with respect to the cause of CFS related symptoms were also 
rated on five 4-point scale questions [4]. Avoidance behaviour was measured with four 
questions regarding the avoidance of physical activity as a way of coping with 
complaints. These four items were scored on a 4-point scale and added into one total 
score [12].
-Focusing on bodily symptoms
The somatisation subscale of the SCL90 was used to quantify psychosomatic symptom 
report and served as measure of focusing on bodily symptoms [3]. The subscale 
consists of twelve items scored on a 5-point Likert scale. The score can range from 0­
60 [10].
-Statistics
In order to test differences between the two groups, independent sample t-tests were 
carried out. Categorical variables were analysed by means of %2 tests. Two-sided tests 
were conducted with a significance level of 0.05. In order to retain power with these 
relatively small sample sizes, and the explorative nature of this study, no adjustments 
were made for multiple comparisons.
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RESULTS
-Demographics
Participant characteristics are shown in Table 1. The homebound group was 
significantly (t=2.0,df=287, p<0.05) older and had a significantly (t=5.0, df=287, 
p<0.01) longer illness duration than the total CFS group. All patients of the homebound 
sample and 216 (79%) patients of the total ambulant sample were female (c2=4.4, df=1, 
p<0.05). Subsequently, the comparison group was matched on gender, age and 
complaint duration. The mean level of education did not differ significantly (t=0.66, 
df=48, p=0.51) between the homebound and matched ambulant sample. Compared to 
the matched ambulant sample, a significantly (%2=4.9, df=1, p<0.05) smaller proportion 
of the homebound group was married. Although more homebound patients than 
matched ambulant patients reported to be divorced, the difference did not reach 
significance (%2=1.2, df=1, p=0.27). None of the homebound and 5 (16%) of the 
matched ambulant patients had a paid job (%2=3.1, df=1, p=0.08).
-Physical activity levels
Homebound patients had significantly lower actoscores and all homebound patients 
were classified as pervasively passive, compared to 36% of the matched CFS patients 
and 24% of the total ambulant CFS group. Homebound patients did, however, report to 
be more active on the daily-observed activity (DOA) score. No significant groups 
differences were found between the mean hour’s sleep at night and the mean hours 
sleep in the daytime (Table 2).
-Fatigue severity
Table 2 shows that homebound and matched CFS patients had comparable CIS-fatigue 
severity scores. Homebound patients experienced significantly higher levels of daily 
fatigue.
-Functional impairment
All homebound patients (100%) reported ‘very severe’ impairment in daily life on the 
general impairment item, whereas of the non-homebound patients 15% experienced 
‘very severe’ impairment, 76% ‘severe impairment’, and 9% ‘minor’ impairment (c2 
=35.9, df=3, p<0.01). Table 3 depicts the various SIP ratings and the Karnofsky score. 
Homebound patients reported significantly more physical limitations compared to the 
matched ambulant CFS patients as well as compared to the total ambulant CFS sample. 
The significantly lower Karnofsky rating of the homebound group confirmed these 
findings. In contrast, homebound patients rated their psychosocial limitations less 
severe compared to both other samples.
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Table 2. Comparing fatigue and activity ratings between the homebound and matched 
ambulant CFS patients
Homebound Matched ambulant Total ambulant Significance testing
group(n=18) group (n=32) group(n=270) Homebound/matched
Mean (SD) Mean (SD) Mean (SD)
CIS-fatigue 53.6 (3.5) 52.8 (2.9) 52.1 (3.9) t= -0.86, df=48, p=0.39
DOF (0-16)* 13.2 (2.1) 7.4 (1.9) 8.0 (2.2) t= -9.58, df=46, p<0.01
Actoscore 27.1 (13.8) 61.3 (18.4) 66.2 (21.9) t= 6.86, df=48, p<0.01
% pervasively 100 36 24 X2 =14.6, df=1, p<0.01
passives
DOA (0-16)# 3.7(0.9) 2.8 (0.5) 2.9 (0.8) t= -4.56, df=46, p<0.01
CIS-activity§ 15.8 (3.7) 17.0 (4.4) 17.6 (3.9) t= 0.97, df=48, p=0.33
Mean hours 7.4 (2.9) 8.2 (1.6) 8.3 (2.1) t= 1.15, df=48, p=0.26
sleep at night
Mean hours 1.7 (1.7) 1.5 (1.4) 1.7 (1.8) t= -0.34, df=48, p=0.73
daytime sleep
*Daily Observed Fatigue: higher scores indicate more experienced fatigue. 
#Daily Observed Activity: higher scores indicate more self-reported activity. 
§Higher scores indicate less activity.
-Psychological distress
There were no significant differences between the homebound and matched samples on 
the BDI-PC depression ratings and the SCL90-total score. Four (24%) homebound 
patients and five (16%) matched ambulant patients had an anxiety disorder (c2=0.06, 
df=1, p=0.80). Five homebound patients (29%) and one (3%) matched ambulant patient 
fulfilled the DSM-III criteria of a current major depression (c2=7.1, df=1, p<0.01), 
while 65% (n=11) of the homebound and 53% percent (n=17) of the matched ambulant 
patients had a lifetime diagnosis of a major depressive episode (%2=0.61, df=1, p=0.44). 
In the total CFS sample 6% had a current depression and 28% fulfilled the criteria for a 
lifetime depression.
-Illness cognitions and avoidance coping
Homebound patients had stronger somatic causal attributions than matched ambulant 
patients but both groups did not differ with respect to the strength of psychosocial 
causal attributions and their self-efficacy scores. There was a trend (p=0.07) that 
homebound patients reported more avoidance coping.
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Table 3. Comparisons o f functional impairment between the homebound and matched 
ambulant CFS samples
Homebound Matched Total Significance testing
group(n=18) ambulant ambulant Homebound/
Mean scores (SD) group(n=32) group(n=270) Matched
Karnofsky 49 (10) 71 (9) 71 (9) t= 8.17, df=47, p<0.01
SIP7-total 1761 (664) 1662 (525) 1646 (563) t= -0.82, df=48, p=0.45
SIP-physical 888 (296) 495 (214) 509 (240) t= -5.53, df=48, p<0.01
SIP-social 443 (216) 605 (228) 562 (228) t= 2.55, df=48, p<0.05
SIP-ambulation 248 (153) 125 (73) 134 (87) t= -3.98, df=48, p<0.01
SIP-mobility 329 (110) 148 (122) 165 (115) t= -5.23, df=48, p<0.01
SIP-homemaking 311 (130) 222 (94) 211 (109) t= -2.82, df=48, p<0.01
SIP-recreation/pastimes 149 (89) 212 (84) 187 (71) t= 2.51, df=48, p<0.05
SIP-social interactions 293 (188) 392 (203) 374 (205) t= 1.75, df=48, p=0.09
SIP-sleeping problems 172 ± 89 180 ± 75 179 (93) t= 0.32, df=48, p=0.74
SIP-alertness behaviour 2 8 7 ± 215 382 ± 211 397 (193 ) t= 1.51, df=48, p=0.13
Table 4. Psychological distress, illness cognitions and coping
Homebound Matched Total ambulant Significance testing
group ambulant group group Homebound/matched
Mean (SD) Mean (SD) Mean (SD)
BDI-PC 3.0 (4.1) 3.5 (3.5) 3.1 (2.7) t= 0.44, df=46, p=0.66
SCL90-total 159 (34) 170 (44) 168 (39) t= 0.97, df=49, p=0.30
Self-efficacy 13.6 (3.4) 14.2 (2.6) 14.7 (3.4) t= 0.78, df=49, p=0.42
Somatic attributions 16.1 (2.9) 14.6 (2.1) 13.8 (2.6) t= -2.07,df=49, p<0.05
Psychosocial 9.4 (3.2) 9.9 (2.5) 9.3 (2.5) t= 0.55, df=49, p=0.55
attributions
Avoidance coping 11.8 (2.5) 10.3 (3.4) 10.3 (2.5) t= -1.86, df=49, p=0.07
-Focusing on bodily symptoms
The homebound sample had significantly higher SCL90-somatisation scores compared 
to the matched ambulant sample (homebound patients: mean=34.1, SD=7.9) and 
matched ambulant patients (mean=29.1, SD= 8.3, t=-2.08, df=287, p<0.05). The mean 
SCL90-somatisation score for the total CFS sample was 30.2, SD= 7.2.
-Follow-up measures homebound group
In total 15 of the 18 homebound patients agreed to participate in the follow-up 
measurements. Three of the 18 patients indicated that they experienced the baseline 
measurements as too exhausting, and they decided not to participate at follow-up. Valid 
actometer data were available for twelve of the fifteen patients. None of the CIS and 
SIP measures at follow-up differed significantly from baseline (Table 5). All 12 
patients who carried the actometer were again classified as pervasively passive.
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Table 5. Follow-up data o f the homebound sample
Homebound baseline Homebound follow-up Paired T-test
Mean (SD) Mean (SD)
CIS fatigue* 53.3 (3.8) 50.9 (5.8) t= 1.18, df=14, p=0.24
CIS concentration 22.4 (7.1) 21.3 (7.9) t= 0.75, df=14, p=0.42
CIS-activity 16.1 (3.5) 15.5 (4.4) t= 0.29, df=14, p=0.74
SIP7-total* 1761 (663) 1741 (604) t= 0.12, df=14, p=0.91
SIP-physical 909 (289) 879 (330) t= 0.30, df=14, p=0.78
SIP-psychosocial 432 (219) 441 (227) t=-0.17, df=14, p=0.87
Actoscore# 25.2 (11.8) 24.3 (14.0) t= 0.20, df=11, p=0.84
*n=15, # n=12
DISCUSSION
As far as we know this is the first study that investigated homebound CFS patients by 
visiting them at home. The mean age and mean illness duration of these patients 
exceeded that of a large non-matched sample of CFS patients who visited our research 
centre. Subsequent matching for age and illness duration showed that fewer 
homebound patients were married or had a paid job. As such, the homebound sample 
seemed to represent a demographically different group.
The matching procedure showed that homebound patients were physically far less 
active, reported more daily fatigue and more physical disability, believed stronger in a 
physical cause for their complaints, and seemed to be more focused on bodily 
symptoms. Although homebound patients had more often a current diagnosis of 
depression, their self reported psychological distress and self-efficacy were comparable 
to the matched ambulant patients while homebound patients reported less psychosocial 
disability. However, the limited sample size of the homebound group and the fact that 
non-institutionalised homebound patients were visited, warrant some caution by 
generalising the interpretation of the results and might have biased the results towards 
less invalidated homebound patients. Furthermore, the control group was chosen out of 
CFS patients who participated in an intervention study and could therefore be 
confounded by patients who were more open to a psychological explanation of their 
complaints.
The homebound and matched ambulant samples did not differ with respect to their 
mean number of hours sleep at night and their mean number of hours sleep in the 
daytime, making an excessive sleep-demand during the day an unlikely cause for the 
low levels of daytime physical activity. Interestingly, the self-observation data of 
activity showed a disparity with the actometer data. Despite the fact that all homebound 
patients were identified as pervasively passive, they rated their daily activity higher 
compared to the matched ambulant CFS group. It is possible that the persistent low 
physical activity levels biased the self-perception of activity, which is a subjective and 
relative measure. Perhaps that these homebound patients, in contrast to more active
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patients, were more inclined to judge non-physical activities, like reading, telephoning, 
watching television or using the computer, as a physical exertion.
Although the homebound sample had comparable fatigue severity ratings (CIS-fatigue) 
as the more active ambulant sample, their mean daily-observed fatigue score was 
significantly higher. The CIS-fatigue score involves an overall rating and in CFS 
samples easily reaches the extreme end of its scale. In contrast, the DOF score involves 
four ratings per day for a prolonged period of time, and therefore allows for more 
variation and reduces the chance of extreme scoring. The model of persistence of 
fatigue and the fact that the time-period of diary paralleled the observation period of 
the actometer, suggest a relation between the low activity levels and high daily fatigue 
scores of the homebound patients. However, a previous study showed that baseline 
daily fatigue scores were not related to activity type in ambulant patients and the 
design of current study makes it not possible to test the causal direction of such a 
relationship. Taking into account the persistence of low activity levels at follow-up, 
one cannot dismiss the possibility that homebound patients are more prone to physical 
deconditioning and that this in itself maintains or aggravates complaints.
Despite comparable distress ratings, the homebound patients did report less 
psychosocial limitations. It is possible that the physical disability of homebound 
patients diminishes or restricts social interactions and that they are therefore less taxed 
by social demands (e.g. work or housekeeping). Perhaps that the homebound patients 
need a close network of support of family and friends in order to be able to live outside 
a care centre.
According to the SCID interview, more homebound patients fulfilled the criteria of a 
current major depressive episode. However, their self-reported levels of distress did not 
differ from the matched ambulant patients. One possible explanation for this apparent 
disparity could be that one of the major DSM criteria for depression is ‘a markedly 
diminished interest or pleasure in all, or almost all, activities most of the day, nearly 
every day’. The low activity levels or the strong physical limitations could prevent 
them from carrying out pleasurable activities and as such make them fulfil this 
criterion. As such, identifying depressive mood in homebound patients deserves more 
careful control for illness related confounders like extreme low physical activity levels. 
Compared to the total CFS sample, both the homebound and matched ambulant groups 
were characterised by higher prevalence of a lifetime depressive episode. Post-hoc 
analyses revealed that this finding also remained significant when possible age 
differences were taken into account. These findings might suggest that CFS patients 
with a history of depressive episodes are more prone to persistence of symptoms.
The follow-up measurements indicated persistence of both complaints and low activity 
levels. This finding contrasts with the regression to the mean effect described in the 
natural course condition of the intervention study [4]. In that study, the CIS and SIP7- 
total scores were significantly lower at follow-up (8 and 14 months) compared to 
baseline. The absence of such an effect in the homebound sample seems indicative for 
very little variation in complaint severity over time. A long illness duration, little 
complaint variability over time and persistent low physical activity levels might be risk 
factors for physical deconditioning, which in turn can have important implications for 
choosing treatment strategies.
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CHAPTER V
IDENTIFYING PHYSICAL ACTIVITY PATTERNS IN CHRONIC FATIGUE 
SYNDROME USING ACTIGRAPHIC ASSESSMENT0
ABSTRACT
Changes in physical activity are thought to play an important role 
in maintaining symptoms in Chronic Fatigue Syndrome (CFS). 
The aim of this study was to describe intra-individual physical 
activity patterns in more detail and to identify pervasively passive 
patients. With help of a movement-sensing device, physical 
activity levels were registered continuously over a twelve-day 
period in 277 CFS patients. Within this registration period, the ten 
largest activity peaks were computed. The intensity and duration 
of these activity peaks and their subsequent rest periods were 
described and compared to those of 47 healthy controls. In 
addition, the twelve daily activity scores were used to identify 
those patients who were characterised by persistent low levels of 
physical activity. The CFS sample had less intense and shorter 
activity peaks, while the average rest periods that followed these 
peaks lasted longer. Approximately one fourth of the CFS sample 
differed distinctly from the control group and was labelled as 
pervasively passive. The measurements and classification of 
actual physical activity levels were found to reduce heterogeneity 
in the CFS population and therefore could provide the opportunity 
to optimise behavioural intervention protocols for CFS.
° S van der W erf, J Prins, J Vercoulen, J van der Meer, G Bleijenberg 
Identifying physical activity patterns in chronic fatigue syndrome using actigraphic
assessment.
Journal of Psychosomatic Research 2000:49:373-379
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INTRODUCTION
Patients with Chronic Fatigue Syndrome (CFS) often describe themselves as being 
profoundly less physically active and unable to reach similar physical activity levels as 
compared to before the onset of their illness. Many CFS patients report that even minor 
physical exertion results in a significant increase in fatigue- and CFS-related 
symptoms. There is evidence that many CFS patients cope with their illness by resting 
or avoiding physical activity [1-3]. In cognitive behaviour models of CFS it has been 
hypothesised that pervasive avoidance of physical activity decreases the tolerance for 
physical exertion and as such can perpetuate the CFS-related symptoms [4]. Clinical 
observations and especially patients’ self-reports suggest, that the lifestyles of some 
other CFS patients are characterised by very active periods, followed by abnormally 
long periods of inactivity. Some authors have suggested that in CFS the periods of rest 
are interrupted by short periods of marked activity during which patients perform at 
“normal” levels [5]. These short periods of high physical activity may have detrimental 
effects and cause fatigue among patients with a low overall physical activity level. 
However, until now no empirical data are available to test this assumption.
Since changes in physical activity patterns are supposed to play an important role in 
maintaining symptoms and subsequently many therapeutic interventions have 
emphasised on activity regulation, it is crucial to identify abnormal activity patterns in 
a valid and reliable way. In earlier studies of our research group, actual motor activity 
has been recorded with an ankle-worn motion-sensing device (actometer) in 
conjunction with self-report measures of physical activity [6,7]. The data of these 
studies suggest that self-report measures of activity reflect the patients’ view about 
their physical activity and may have been biased by cognitions concerning illness and 
disability. In clinical practice, it has been observed that part of the CFS patients are 
characterised by profound physical inactivity, while other patients are far more active 
but nevertheless judge themselves as rather inactive. Both, research results and clinical 
impressions, indicate that it is important to test whether patients’ self-report concerning 
long-term inactivity after exertion, large day-to-day fluctuations in activity, and 
pervasive inactivity, can be substantiated by a behavioural measure of activity.
In this study, physical activity was measured with an actometer over twelve 
consecutive days in both healthy controls and CFS patients. The general activity scores 
that were used in previous studies provided little information about intra-individual 
differences and might have obscured large fluctuations in daily activity scores. 
Therefore, parameters were developed to describe changes in physical activity in more 
detail. Specific attention was paid to periods of high activity and subsequent rest 
periods. Furthermore, it was tested whether the CFS sample was characterised by many 
large day-to-day fluctuations in physical activity. The actometer measurements were 
also used to subtype activity patterns in CFS in order to identify pervasively passive 
patients. Previous studies found that part of the CFS patients had elevated depression 
scores.
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Since physical inactivity could be a symptom of depression, one might hypothesise 
that, in particular, pervasively passive patients would be characterised by increased 
levels of psychological distress. Therefore, it was tested whether levels of fatigue, 
psychological distress, and functional impairment were elevated in pervasively passive 
CFS patients, as compared to more physically active CFS patients.
METHOD
-Subjects
All patients with a major complaint of fatigue, referred to the outpatient clinics of 
internal medicine of the University Medical Centre Nijmegen and the University 
Hospital Maastricht between October 1996 and December 1998 were assessed by 
means of detailed history, physical examination and questionnaires. Patients had to 
fulfil the CDC criteria for CFS [8]. Additional criteria were being aged between 18 and 
60 years, not previously or currently being engagement in CFS research, not being 
pregnant or engaged in pregnancy-stimulating techniques and living within 1 /  hour 
travelling time of the participating centres. A total of 99 of the 476 patients who 
fulfilled the criteria of CFS did not meet the additional operational criteria. The 
remaining patients were asked whether they wanted to participate in a randomised 
controlled study to assess the effects of cognitive behavioural therapy upon fatigue and 
functional disability. Ninety-nine patients refused participation and one patient was 
excluded because of pregnancy at pre-test. The baseline data of the remaining 277 CFS 
patients were analysed in this study. Furthermore, actometer and self-report data of 47 
healthy subjects were collected. Most of these healthy subjects were neighbourhood 
controls in other chronic fatigue studies.
-Measurements
The actometer (©Actilog V3.0) that was used is a motion-sensing device that can 
register and quantify human physical activity [6]. The actometer is small and light 
(55x25x15mm, 26gr) and has to be worn at the ankle. The small size makes the 
actometer suitable for long-term continuous registrations. The actometer has a piezo­
electric sensor that is sensitive in three directions. Accelerations of the sensor larger 
than a pre-defined threshold are considered as activity and are stored into an internal 
memory. Each second the micro controller reads and resets the counter of the 
actometer. The integration counter is set at five minutes providing every five minutes 
an activity score that is stored in the internal memory of the actometer. At the end of 
the registration period data are fed into an external computer.
In this study the actometer was worn day and night during at least a fourteen-day 
period. In order to retain twelve complete registration days, the first and last 
registration days were omitted for the analyses. Subjects were asked to remove the 
actometer only in certain situations (swimming, bathing) and to write in a daily 
complaint diary whether there were any other lengthy periods that they removed the 
actometer. When the actometer had failed more than two days, patients were asked to
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carry the actometer for an additional two weeks. In the final statistical analyses, 
maximally one invalid registration day was allowed. This missing value was replaced 
by the mean value of the remaining eleven registrations days. Various parameters were 
calculated with specially developed software that also graphically displayed the levels 
of activity (Figure 1). The software distinguished rest (night) and wake (day) periods, 
resulting in a day length score. All other parameters that were developed pertain to 
these daily active (wake) periods.
-Definition o f  general physical activity
For the total registration period twelve Daily Physical Activity scores were calculated. 
Subjects who were missing more than one valid registration day were omitted from 
further analyses. In case of one missing day, that day was substituted with the mean 
value of the remaining 11 registration days. A general physical activity score reflected 
the mean physical activity level over the total 12-day time period and was expressed in 
the mean number of accelerations per 5-minute period.
-Definition o f  parameters o f  high activity and subsequent rest periods 
In order to distinguish between relatively high (peak) and low (valley) activity periods 
the average general physical activity score of the control group (the table 2, mean score 
=91) was designated as cut-off. The succeeding (5-minute) time periods above this cut­
off were labelled as peaks and the succeeding 5-minute time periods below this cut-off 
as valleys. The program identified the 10 largest activity peaks by calculating the total 
energy of each peak (duration peak * D number of accelerations in each succeeding 5- 
minute period). Subsequently, both the average peak duration and average peak 
amplitude of these 10 largest peaks were calculated.
Specific attention was paid to what happened after each of these 10 activity peaks. Rest 
periods were defined as the amount of time (after a large peak) that the actometer score 
stayed below the preset value of 91. The average duration of these 10 rest periods was 
calculated for each subject (rest duration after peak). Both peak and rest duration were 
expressed in minutes by multiplying the number of succeeding registration intervals by 
five. The number of accelerations occurring in a 5-minute interval expressed the 
intensity of activity (peak amplitude).
Furthermore, the average intensity of activity during the 1-hour period following each 
peak was computed. Theoretically, another peak could occur during this time period. 
Subsequently, the average peak amplitude during the 10 largest peaks was compared 
with the average actometer amplitude during the 1-hour periods following these peaks. 
This comparison made it possible to calculate the relative decrease in activity after 
peak performance, which could be expressed as a percentage of reduction in activity: % 
activity reduction after peak.
-Definition o f  large day-to-day fluctuations
Both absolute and relative fluctuation scores were computed to detect fluctuations in 
activity over subsequent days. A major day-to-day fluctuation was counted as the 
individuals’ daily physical activity score showed a 22-point difference with the 
subsequent day. The absolute difference of 22 points that was used equals the standard
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deviation of the mean general physical activity score of the total CFS sample (Table 1). 
The number of absolute large day-to-day fluctuations in a 12-day period could range 
from 0 to 11. Relative large fluctuations were defined as day-to-day differences of 
more than 33%; the total score was the number of relative large day-to-day fluctuations 
and could also range from 0-11 points.
-Definition ofpervasively passive CFS patients
The individuals’ activity patterns were based on the 12 individual daily physical 
activity scores. Since our purpose was to make a classification within the CFS sample, 
the mean general physical activity score of the total CFS sample served as reference 
value (table 1, mean=66). For each subject the 12 daily physical activity scores were 
compared to this reference value. When a daily physical activity score fell below this 
value, that day was labelled as relatively inactive. A daily physical activity score equal 
or above this value was labelled as relatively active.
Taking in account the possibility of unforeseen external circumstances affecting 
activity levels, it was decided that pervasively passive patients had to be less active 
compared to other CFS patients for at least ninety percent of the total observation 
period. Subsequently, pervasively passive patients were defined as those subjects 
whose average daily physical activity scores stayed below the reference score in at least 
eleven of the 12 assessment days. Patients scoring at least 11 days above the preset 
value were defined as pervasively active, while the remaining patients were labelled as 
moderately active. For comparison, activity profiles of healthy controls were calculated 
by using the same procedure and the same CFS reference value.
-Self-reported fatigue, activity, depressive symptoms and functional disability 
Parallel to the 12-day actometer registration period, patients and controls were asked to 
rate their fatigue and activity levels four times a day on a 5-point (0-4) scale. These 
daily ratings were averaged into experienced daily fatigue and reported daily activity 
scores (range 0-16). Depressive symptoms were rated with the Beck Depression 
Inventory (BDI-tot) [9]. Seven subscales of the Sickness Impact Profile (SIP) were used 
to assess functional disability in the following areas: home management, mobility, 
alertness behaviour, sleep/rest, ambulation, social interactions and recreation and 
pastimes [10]. These seven subscale-scores were added to provide a total score of 
general disability.
-Statistics
Testing differences between CFS and controls on nominal variables was done by %2 
test, and continuity correction was applied. The t test or ANOVA were used to make 
group comparisons between other variables. To control for the gender differences in 
both samples, gender was introduced as fixed factor in the analysis. We tested two­
sided and the alpha was set at 0.05.
For the behavioural measures, a multivariate analysis of variance was carried out with 
general physical activity, peak duration, peak amplitude, rest duration after peak, and 
percentage activity reduction after a peak, as dependent variables and group and gender 
as factors. Similar multivariate analyses were carried out for the relative and absolute
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large day-to-day fluctuation scores, and for the experienced daily fatigue and reported 
daily activity score. Four one-way ANOVA’s were used to assess whether pervasively 
passive, moderately activity, and pervasively active CFS patients differed with respect 
to their experienced daily fatigue, reported daily activity, depressive symptoms, and 
general disability scores. In case of an overall significance, the Bonferroni correction 
was applied to compare the three individual groups.
RESULTS
The group characteristics of the CFS patients and healthy controls are displayed in 
Table 1. The CFS sample had significantly more females but the groups were 
comparable concerning their mean age. Tables 2 and 3 show that the general physical 
activity was significantly higher for the controls and that in both groups, males had 
higher general activity scores compared to females.
Table 1. Group demographics
CFS total Controls P-value
(n=277) (n=47)
Females/Males (% females) 218/59 (79%) 23/24 (49%) X2 =14.2, p=0.00*
Age in years (range) 37.5 (18-60) 40.1 (19-63) t= 1.5, p=0.14#
*X2 test, # t-test
-Peaks and subsequent rest periods
Tables 2 and 3 illustrate that the average peak amplitude of healthy controls was 
higher, and men (across groups) had higher peaks compared to women. The peak 
duration was also longer for healthy controls, while in both the control and CFS group 
men had longer peaks than females. The rest duration after peak was longer for CFS 
patients and no gender differences were found. The percent activity reduction after a 
peak was larger for CFS patients, no gender differences were found.
-large day-to-day fluctuations
There were no significant group, gender or interaction effects for the number of 
absolute or relative large day-to-day fluctuations (Tables 2 and 3)
-Pervasively passive CFS patients
In total, 64 CFS patients (24%) were being classified as pervasively passive. None of 
the healthy controls met this qualification (0% controls vs. 24% CFS, ^ 2=14.2, 
p<0.001). In both the control and CFS group, the majority of subjects was classified as 
moderately active (58% controls vs. 60% CFS, %2=0.07, p<0.87), while proportion-ally 
more controls got the qualification pervasively active (42% controls vs. 15% CFS,
C2=18.1, p<0.001).
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Pervasively active patient
Pervasively passive patient
Figure 1. Two 12- day actigraphs o f a pervasively active and a pervasively passive patient
-Experienced daily fatigue and reported daily activity
Multivariate analysis showed significant group and gender effects, but no interaction 
effect. CFS patients reported more experienced daily fatigue and less reported daily 
activity compared to controls. Men reported less experienced daily fatigue compared to 
women (Tables 2 and 3).
-Activity patterns and the relation with experienced daily fatigue, reported daily 
activity, depressive symptoms and general disability
One-way analyses of variance revealed a significant effect for reported daily activity. 
(table 4) Post-hoc testing revealed that pervasively passive CFS patients reported less 
daily activity compared to moderately and pervasively active CFS patients. Moderately 
active patients had significantly lower reported daily activity scores compared to the 
pervasively active patients. Pervasively passive CFS patients had higher general 
disability scores compared to moderately active and pervasively active CFS patients. 
Levels of daily experienced fatigue and psychological distress were equal for the three 
types of activity patterns (Table 4).
50 Chapter V
Table 2. Means, standard deviations and proportions o f activity parameters and types o f 
activity patterns
Mean (SD)
CFS
females
(n=218)
CFS
Males
(n=59)
CFS
Total
Control 
females 
(n =23)
Control
Males
(n=24)
Control
Total
General physical 
activity*
65 (22) 70 (22) 66 (22) 84 (16) 97 (30) 91 (25)
Peak amplitude* 177 (27) 182 (30) 178 (28) 179 (20) 198 (27) 189 (25)
Peak duration in 
minutes#
102 (40) 124 (55) 107 (44) 141 (40) 157 (51) 150 (46)
Duration rest period 
after peak#
92 (51) 87 (43) 91 (50) 53 (22) 70 (58) 62 (45)
% activity reduction 
after peak
59 (15) 57 (15) 59 (15) 44 (16) 47 (19) 46 (17)
No. of relative large
day-to-day
fluctuations
4.0 (2.2) 3.6 (2.1) 3.9 (2.2) 3.3 (1.8) 3.3 (1.9) 3.3 (1.8)
No. of absolute 
large day-to-day 
fluctuations
3.4 (2.0) 3.7(2.1) 3.5 (2.0) 3.8 (1.6) 4.1 (2.0) 3.9 (1.8)
Experienced daily 
fatigue
8.1 (2.2) 7.7 (2.0) 8.0 (2.1) 2.4 (1.8) 1.0 (0.8) 1.7(1.6)
Reported daily 
activity
4.7 (1.7) 4.4 (1.5) 4.6 (1.7) 6.0 (2.5) 6.2 (2.4) 6.1 (2.4)
% pervasively 
passives
26% 17% 24% 0% 0% 0%
% moderately 
active
58% 69% 60% 56% 58% 59%
% pervasively 
active
16% 14% 15% 44% 42% 41%
*activity levels expressed in number of accelerations per 5 minute period, #peak and rest durations expressed
in minutes
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Table 3. Results o f the statistical analyses
Dependent measures F DF P Dependent measures F DF P
General physical activity No. relative large day-
Group* to-day fluctuations
Gender 39.7 3,320 0.00 Group 2.0 3,308 0.16
Group x Gender 6.1 3,320 0.01 Gender 0.1 3,308 0.70
0.9 3,320 0.35 Group x Gender 0.3 3,308 0.56
Peak amplitude No. of absolute large
Group 3.9 3,320 0.05 day-to-day
Gender 7.3 3,320 0.01 fluctuations 1.3 1,308 0.25
Group x Gender 2.4 3,320 0.13 Group
Gender
Group x Gender
0.7
0.1
1.308
1.308
0.39
0.94
Peak duration Experienced daily
Group 25.8 3,320 0.00 fatigue
Gender 7.3 3,320 0.01 Group 346. 1,311 0.00
Group x Gender 0.2 3,320 0.68 Gender
Group x Gender
1
6.8
2.6
1.311
1.311
0.39
0.94
Duration rest period after Reported daily
peak activity
Group 12.2 3,320 0.00 Group 24.8 1,308 0.00
Gender 0.7 3,320 0.42 Gender 1.8 1,308 0.68
Group x Gender 2.0 3,320 0.16 Group x Gender 0.1 1,308 0.84
% activity reduction after
peak
Group 25.3 3,320 0.00
Gender 0.1 3,320 0.72
Group x Gender 1.0 3,320 0.32
*Group: CFS/Controls
TableA^_Therelationb^:we^iactivity£atterns_andse^-reportm^aSU^^—^
Pervasively Moderately Pervasively *F-value 
passive active active P-value
Experienced Daily 
Fatigue 
Reported daily 
Activity 
Psychological 
Symptoms (BDI­
tot)
General Disability 
(SIP7-total)
8.3 (2.3) 7.9 (2.1) 7.8 (1.8) F(2,261)=1.0, p=0.37
4.0 (1.4) 4.7 (1.6) 5.6 (1.7) F(2,236)=11.3, p<0.01
13.4 (6.3) 13.2 (6.4) 12.9 (5.7) F(2,266)=0.1, p=0.93
1967 (630) 1743 (580) 1793 (690) F(2,266)=3.2, p=0.04
*One-way analyses of variance with type of activity patterns as independent factor
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DISCUSSION
Previous studies showed that CFS patients were as a group less physically active 
compared to healthy controls. Nevertheless, quite large variations in actometer scores 
suggested considerable individual differences. Earlier studies also indicated that self­
report measures of physical activity and actual measurement of activity were not highly 
correlated. Furthermore, our clinical observations strengthened our belief that by 
merely comparing overall levels of physical activity important information about the 
individual’s physical activity patterns would be lost.
To our knowledge this study is the first attempt to distinguish and describe physical 
activity patterns in a large CFS sample by means of prolonged measurement of actual 
physical activity. The mean general physical activity score indicated that over a 
prolonged period of time, CFS patients not only reported to be less active but also were 
physically less active compared to healthy controls. Overall, men were more physically 
active compared to females. However, inspection of the average scores indicated that 
this was especially true for the control group. The relatively small control group could 
have reduced the statistical power to detect a significant interaction effect (group x 
gender).
The average peak amplitude of the ten largest peaks was smaller for the CFS group and 
the average duration of these intense activity periods were significantly shorter for CFS 
patients. It is possible that the intensity of peaks reflects to a larger extent physical or 
motor capacity, while the length of the peaks reflects the endurance capacity for 
physical exertion and is as such more closely related to fatigue. In future research one 
could test this assumption by comparing physical condition data of endurance tests 
with the actometer parameters.
Since CFS patients often indicate that they need lengthy and excessive rest periods 
after physical exertion, the periods after peak activity were inspected. The results 
showed that CFS patients indeed had longer rest periods following their activity peaks 
and patients were characterised by a larger drop in activity during the hour after a peak. 
These overall (group) findings seem to fit the general statements patients give about 
changes in their activity. Compared to healthy controls, no indication was found that 
the CFS patients as a group were characterised by a high number of large day-to-day 
fluctuations in activity. However, this finding does not exclude that there are 
individuals who have such a pattern. The fluctuation measures used were limited to 
day-to-day changes and did not control whether some patients were active for some 
days, and then inactive for a prolonged period of time. The day-to-day fluctuation 
measures were based on somewhat arbitrary criteria (one standard deviation and 33% 
activity change). However, when we post-hoc tested alternative criteria (50 or 66% 
activity change) again no significant group differences between controls and CFS 
patients emerged. One could argue that large day-to-day differences are rare in a group 
of patients that is overall inactive. Additional testing revealed that when the pervasively 
passive patients were omitted from the analyses again no differences on day-to-day 
fluctuations occurred between the remaining more active CFS patients and controls. 
Previous research of our group has shown that self-report measures of activity and 
behavioural data often correlate poorly [6]. One reason for these low correlations could
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be that self-report of complaints and behaviour may be biased by illness- and disability- 
related cognitions.
In earlier studies we observed that CFS patients differed considerably in their physical 
activity levels, but that a subgroup of CFS patients seemed to be physically inactive all 
the time. However, with self-ratings of activity it was rather difficult to isolate this 
group, since the majority of CFS patients reported to be rather inactive. With a simple 
procedure we tried to identify these patients. The validity of this procedure was backed 
up by the fact that none of the healthy controls fell into the category of pervasively 
passive and by the fact that pervasively passive had significantly lower daily reported 
activity scores. In the current sample ambulant patients who volunteered and were able 
to participate in an intervention study were studied. Therefore, it is possible that the 
obtained results underestimate the prevalence of pervasively passive CFS patients in 
the total population of CFS patients.
The results of this study showed no relation between type of activity pattern and levels 
of depressive symptoms. As such, psychological distress or levels of experienced 
fatigue were unlikely to be the major determinants of differences in physical activity 
levels. One possible explanation could be that pervasively passive patients are more 
inclined to avoid physical exertion in order to prevent fatigue, or that those pervasively 
passive patients are characterised by more physical dysfunction. Higher incidence of 
physical dysfunction could be in line with the fact that pervasively passive patients 
reported more disability. In future studies it would be worthwhile to compare 
physiological and psychological parameters of patients according to their physical 
activity patterns.
Attempts have been made to associate levels of physical activity with other behavioural 
and psychological measures. A recent study reported a relation between neuro­
psychological impairment and functional disability in patients with CFS [11]. Patients 
who failed a higher number of neuropsychological tests reported significantly more 
days of general inactivity. The authors suggested that this association was not merely a 
result of psychiatric factors but perhaps indicated a failure in a common physiological 
mechanism. However, these findings could have been biased by the fact that physical 
activity, in contrast to neuropsychological functioning, was measured by self-report.
The obtained results confirmed that the CFS patients were as a group less active and 
took more rest after physical exertion, and that it was possible to identify pervasively 
passive patients. However, the results also showed that a proportion of CFS patients 
had activity patterns and parameters comparable to those of controls. One can 
hypothesise that pervasively passive CFS patients do need quite a different approach 
compared to relatively active CFS patients. Perhaps that passive patients benefit more 
from increasing physical activity, while activity regulation is more important for the 
more active CFS group. Preliminary findings of our research group indeed indicated 
that baseline classification of physical activity patterns could significantly improve the 
prediction of success of cognitive behaviour therapy. Although the current findings 
need further exploration, they offer several perspectives for individualising treatment 
protocols according to the type of activity pattern, and a further refining of CFS 
classification.
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CHAPTER VI
DAILY FATIGUE PATTERNS AND PHYSICAL ACTIVITY IN 
PATIENTS WITH CHRONIC FATIGUE SYNDROME0
ABSTRACT
Patients with chronic fatigue syndrome (CFS) experience a close 
relation between everyday physical activity and changes in daily 
fatigue. It has been hypothesised that physical inactivity might 
cause deconditioning and might facilitate exertion related fatigue. 
CFS related research has primarily assessed this fatigue-activity 
association by correlating overall estimates of fatigue and activity. 
The goals of this study were to describe the course of fatigue and 
physical activity during the day, and to test their interrelation. The 
data pertained to samples of 164 ambulant female CFS patients 
and seventy-three healthy female controls. During 12 subsequent 
days, a complaint diary and an actometer were used to measure 
levels of fatigue four times a day (wake-up, morning, afternoon, 
and evening) and mean physical activity during four equal 6- 
hourly time periods (0.00-6.00, 6.00-12.00, etc). Avoidance of 
activity coping was measured with a questionnaire. Correlations 
between daytime fatigue and daytime physical activity were 
calculated for all 164 CFS patients individually. CFS patients 
reported more fatigue than controls at each time point of the day. 
The control sample and the CFS sample did not differ with respect 
to their evening and night time physical activity scores. The 
pervasively passive, moderately active and pervasively active 
CFS samples did not differ with respect to their mean wake up, 
morning, afternoon and evening fatigue scores. Pervasively active 
CFS patients reported more often an increase in fatigue during the 
day compared to less active CFS patients. Pronounced 
correlations between daytime fatigue and physical activity were 
found in only 12% of the total CFS sample. The data provided 
little support for exertion related fatigue and a strong linear 
relation between daytime activity and daytime fatigue was found 
in only a small part of the CFS sample. The results of this study 
therefore contrasted with the frequently and profoundly perceived 
activity-fatigue association of many CFS patients.
° S van der W erf, J Prins, P Servaes, J van der Meer, G Bleijenberg 
The relation between daily fatigue patterns and physical activity in chronic fatigue
syndrome.
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INTRODUCTION
It has been suggested that in Chronic Fatigue Syndrome (CFS) the cause of initial 
fatigue complaints might be either a somatic or psychological stressor, but that the 
persistence of fatigue is a consequence of psychological factors [1-3]. Pervasive 
avoidance of physical activity, causing a decreased tolerance for physical exertion, is 
thought to be one of those possible perpetuating factors [3]. An empirically tested 
model for persistence of fatigue indeed showed that a stronger conviction of the patient 
that the complaints had a physical cause was related to greater physical inactivity, 
while inactivity was related to more fatigue [2]. Recently, it has also been proposed that 
prolonged inactivity and low physical fitness are possible risk factors for and not 
merely consequences of CFS [4,5].
The reports of CFS patients that even ordinary physical exertion causes tiredness or 
exhaustion could be considered as a sign of deconditioning. Exertion-related fatigue is 
a common complaint in for example cardiovascular and neuromuscular diseases. In 
these conditions, normal daily physical activity levels can cause abnormal fatigue 
because of physiological limitations (e.g. VO2max reduction or muscle weakness) and 
increases in physical activity result in more fatigue. However, several physical exercise 
studies in CFS found neuromuscular mechanisms intact [6-9]. A recent study, that 
compared exercise test results of 20 ambulant CFS patients with that of 20 well 
matched neighbourhood controls, found no significant differences in various indices of 
physical fitness [10]. This study questioned whether physical deconditioning was a 
perpetuating factor in CFS and whether the efficacy of some gradual exercise programs 
could be attributed to increases in physical fitness. This notion was also touched upon 
in a study that monitored physical activity during a two-week period among 277 CFS 
patients [11]. One fourth of the CFS patients and none of the controls were 
characterised by persistent low physical activity level and were labelled as pervasively 
passive. Pervasively passives and more active CFS patients did not differ with respect 
to their overall fatigue estimates. Subsequently, it was suggested that the fatigue- 
activity association might differ among subgroups of CFS patients or that physical 
activity patterns might not be associated with fatigue but merely reflect the differences 
in coping style [11]. The fact that these baseline activity patterns predicted success of 
cognitive behaviour therapy advocated the use of activity classification among CFS 
patients to study possible relations between daily physical activity, daily fatigue and 
copingstyle [11-12].
More detailed information about the course of fatigue during the day might be helpful 
to clarify possible activity-fatigue mechanisms in CFS. Patients with mood 
disturbances, for example, frequently suffer serious wake-up fatigue, which may 
disappear in the evening. In contrast, patients with muscle weakness report that they 
feel rested after a night sleep, but that their fatigue rapidly increases during the day. 
Both complaint diaries and actigraphic assessment provide the means to describe the 
course of fatigue and physical activity during the day and to assess possible individual 
differences in daytime fatigue-activity associations. Until now we have aggregated 
these type of time-series data into one mean fatigue and one mean activity score, which 
might have obscured the daytime variation of fatigue and physical activity. With these
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types of data it was for example not possible to test whether CFS patients suffered 
more wake-up fatigue or were physically more active during the night, than controls. 
This study, therefore, will use both group and intra-individual analyses to assess the 
course of fatigue and activity during the day and their interrelations. Controls and CFS 
patients will first be compared with respect to their mean wake-up, morning, afternoon 
and evening fatigue scores, and with respect to their mean night, morning, afternoon 
and evening physical activity scores. In addition, it will be tested whether in the CFS 
sample the previously defined physical activity patterns were related to differences in: 
(1) wake-up, morning, afternoon, or evening fatigue scores, (2) number of days with an 
increasing fatigue pattern, and (3) levels of avoidance coping. Finally, the correlations 
between daytime fatigue and daytime activity levels will be computed for each 
individual separately. It is hypothesised that exertion-related fatigue is especially 
associated with an increase of fatigue during the day and a positive correlation between 
daytime activity and daytime fatigue levels. Wake-up fatigue, avoidance coping, non­
significant or negative correlations between daytime physical activity and daytime 
fatigue, are considered signs of avoidance of physical activity or activity levels being 
independent of fatigue.
METHOD
-Subjects
Out of a sample of 203 consecutively referred female CFS patients complete 
actigraphic and complaint diary data were obtained of 164 female CFS patients (mean 
age: 35.9 years, sd=10.2, range: 18-59). All patients participated in a recently published 
randomised control study assessing the effects of cognitive behaviour therapy on 
fatigue and functional disability. Patients fulfilled the CDC criteria of CFS, were aged 
between 18 and 60 years, had a mean illness duration of 5.5 years (SD=5.9, range 0.5­
32). The detailed in- and exclusion criteria of this sample have been described 
elsewhere [12]. The comparison group consisted of 73 females (mean age: 46.2 years, 
SD=9.0, range: 19-60) who either served as controls for a study assessing fatigue after 
treatment for cancer or as controls for our previous activity study in CFS [11,13]. 
Subjects with an acute or chronic medical condition, possibly or known to be 
associated with fatigue were excluded. Written informed consent was obtained for all 
participating patients and controls.
-Daily fatigue
Patients and healthy subjects kept a complaint diary for twelve consecutive days. They 
had to rate their fatigue levels four times a day on a five point (0-4) scale: 0=no fatigue, 
1=mild fatigue, 2=moderate fatigue, 3=severe fatigue, and 4=very severe fatigue. 
Patients had to rate their levels of fatigue at waking up, at noon, at approximately six ‘o 
clock in the afternoon and at bedtime [12]. The 12 wake up, morning, afternoon and 
evening scores were each averaged into a mean wake up, morning, afternoon and 
evening fatigue score.
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The number of days (range 0-12) that patients reported more fatigue in the afternoon 
and evening (afternoon + evening score), compared to wake up and morning (wake up 
+ morning score) was taken as measure of an increasing fatigue pattern.
-Physical activity
Parallel to the 12-day self-registration period, physical activity levels were measured 
with an actometer. The actometer (Actilog V3.0) is a motion-sensing device that can 
register and quantify human physical activity [11]. The actometer is small (55*25 
*15mm), weighs 26gr, and has to be worn at the ankle. Accelerations are continuously 
sampled and summed into 5-minute intervals. Hence physical activity levels are 
expressed in number of accelerations per five minutes. These CFS patients were 
already classified in our previous study as pervasively passive, moderately active or 
pervasively active [11]. This classification was based on daytime physical activity 
levels. New in the present study was the fact that the physical activity data of the total 
24-hour (day and night) period were analysed. These daily 24-hours registrations were 
divided into four succeeding 6-hour periods. The time between 0.00-6.00 is pertaining 
to the night, 6.00-12.00 to the morning, 12.00-18.00 to the afternoon and 18.00-24.00 
to the evening. These time-periods were chosen to precede the four daily self­
observation fatigue moments: night activity directly preceding the wake-up fatigue 
score, morning activity period directly preceding the morning fatigue rating, etc. The 
mean physical activity level for each of the four time periods was expressed as the 
mean number of accelerations per 5-minute interval.
-Avoidance coping
Avoidance coping was assessed with five questions regarding the avoidance of physical 
activity as a way of coping with fatigue complaint [14]. Examples of items are: ‘I try to 
avoid fatigue by not exerting’, ‘I take rest a soon as I feel fatigued’). These five items 
were scored on a 4-point scale and summed into one total score (range 5 to 20).
A subsequent factor analysis yielded a single factor solution that explained fifty-seven 
percent of the variance. All five of the factor loadings exceeded 0.73 and the internal 
consistency (Cronbach’s alpha) of this scale was 0.80.
-Statistics
Comparing the CFS and control sample with respect to wake up fatigue and course o f  
fatigue during the day
A univariate ANCOVA with age as covariate was used to test whether the mean wake 
up fatigue score of CFS patients and controls differed. A multivariate analysis of 
variance with the mean wake up, morning, afternoon and evening fatigue scores as 
repeated measures and group membership as between subject factor was carried out to 
test whether the course of fatigue during the day differed for both samples. In case of a 
significant interaction effect (group x time) three paired t-tests were used to assess in 
each sample separately, possible differences between adjacent fatigue scores (e.g. 
wake up fatigue v.s. morning fatigue). Alpha was set at 0.008 (0.05/6) to control for 
inflated type I error due to the number of comparisons.
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-Comparing night-time, morning, afternoon and evening physical activity levels 
The mean physical activity levels during the night, morning, afternoon and evening of 
the CFS and control sample were compared with four univariate ANCOVAS with age 
as a covariate. A Bonferroni adjustment was made (alpha=0.012) to control for type I 
error inflation due to family-wise comparisons.
-Physical activity patterns in relation to daily fatigue patterns and avoidance coping 
One-way analyses of variance were used to test within the CFS sample, whether the 
pervasively passive, moderately active and pervasively active groups differed with 
respect to: (1) wake-up, morning, afternoon and evening fatigue scores; (2) the mean 
number of days with an increasing fatigue pattern; (3) the degree of avoidance coping 
behaviour. Significant F-tests were followed up by post-hoc testing (Tukey HSD).
-Intra-individual correlations between daily fatigue and daily activity and their 
relation with activity patterns
For each individual, the 12 morning (6.00-12.00) and 12 midday (12.00-18.00) activity 
scores were correlated with their 24 time-corresponding (morning and afternoon) 
fatigue scores. Correlations exceeding 0.45 or smaller than -0.45, were considered 
indicative for a significant relationship. Additionally, a one-way analysis of variance 
was used to test whether the three physical activity patterns might differ for their mean 
fatigue-activity correlations. A significant F-tests will be followed by post-hoc testing 
(Tukey HSD).
RESULTS
-Comparison o f  the CFS and control sample with respect to wake-up fatigue and 
course o f  fatigue during the day
The ANCOVA showed a significant group (F=135.7, df(1,234), p<0.01) and covariate 
effect (F=6.1, df(1,234), p=0.014. The mean wake-up fatigue score (range:0-4) of the 
CFS sample (mean=1.6, Sd=0.8) exceeded that of the control sample (mean=0.1, 
Sd=0.2). Figure 1 shows the course of fatigue during the day for both the CFS and 
control group. There was a significant interaction effect (group x time F= 59.1 df(3, 
233), p<0.01). Subsequent post hoc testing showed that in the CFS sample morning 
fatigue exceeded wake up fatigue (t=7.0, p<0.01); afternoon fatigue exceeded morning 
fatigue(t=12.1, p<0.01) but the evening fatigue score did not differ significantly from 
the afternoon score (t=0.5, p=0.64). In the control sample the wake-up fatigue score did 
not differ significantly from the morning fatigue score (t=1.5, p=0.132), but compared 
the morning the afternoon and evening fatigue scores showed a gradual significant 
increase (afternoon fatigue>morning fatigue, t=5.7, p<0.01; evening fatigue>afternoon 
fatigue, t=-4.4, p<0.01) (Figure 1).
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-Comparison o f  the nighttime, morning, afternoon and evening physical activity levels 
The four univariate ANCOVA showed that the CFS and control sample did not differ 
significantly with respect to their nighttime physical activity score (F=2.12, df(1,234), 
p=0.15). The control sample had significantly higher morning activity (F=17.8, 
df(1,234), p<0.01) and afternoon activity (F=11.6, df(1,234), p=0.001) scores. There 
was a trend for the mean evening activity scores being higher in the control group 
(F=3.9, df(1,234), p=0.049). Only in this last analysis the effect of the covariate age 
reached significance (Figure 2).
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Figure 1. Mean daytime fatigue scores during the four subsequent 6-hour time periods
- - -i - - 'CFS n=164 — ■— Controls n=73 
Figure 2. Mean physical activity levels during the four subsequent 6-hour time periods
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-Physical activity patterns in relation to daily fatigue patterns and avoidance coping 
None of the analyses (Tab1e 1) showed a significant effect for the four mean daytime 
fatigue scores (wake-up fatigue F=1.38, df(2,161), p=0.25; morning fatigue F=1.33, 
df(2,161), p=0.27; afternoon fatigue F=1.00, df(2,161), p=0.37; evening fatigue F= 
1.01, df(2,161), p=0.37). Physical activity patterns were however associated with the 
number of days patients reported an increase in fatigue during the day (F=3.66, 
df(2,161), p<0.05). Post-hoc testing indicated that pervasively active patients reported 
more often an increasing fatigue pattern, than the moderately active sample. There was 
only a trend that the activity patterns were associated with avoidance coping (F=2.92, 
df(2,161), p=0.06).
Table 1. Relation between physical activity pattern and daily fatigue patterns and avoidance 
coping
Pervasively 
passive CFS 
sample (n=46)
Moderately active 
CFS sample (n=97)
Pervasively active 
CFS sample (n=21)
Mean (SD) wake-up fatigue 
score
1.6 (0.9) 1.7 (0.8) 1.4 (0.8)
Mean(SD) morning fatigue score 
Mean (SD) afternoon fatigue
2.0 (0.7) 1.9 (0.6) 1.8 (0.4)
score 2.4 (0.6) 2.2(0.5) 2.3 (0.4)
Mean (SD) evening fatigue score 2.3(0.6) 2.2(0.6) 2.4(0.6)
Mean (SD) number of days with 
an increasing fatigue pattern
7.3 (3.1) 7.0 (2.9) 8.9 (2.2)*
Mean (SD) avoidance coping 
score
13.9 (3.1) 12.7 (3.0) 12.3 (2.5)
Mean (SD) intra-individual 
correlations between the daytime 
fatigue and physical activity 
scores
-0.07 (0.30) 0.03 (0.25) 0.10 (0.27)#
*significant difference between pervasively active and moderately active CFS samples 
# significant difference between pervasively passive and pervasively active samples
-Intra-individual correlations between daily fatigue and daily activity scores and their 
relation with activity patterns
In 3% of the total CFS sample the correlations exceeded 0.45 while in 9% the rho was 
smaller than -0.45. The analysis of variance with the individual correlations as 
dependent measure was significant (F=3.4, df(2,161), p<0.05). The mean intra­
individual correlation in pervasively passive sample had a negative direction and post 
hoc testing showed it to be different from the mean intra-individual correlation in the 
pervasively active sample.
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DISCUSSION
This study provides a detailed assessment of the course of daytime fatigue and 
combines this information with a classification according to physical activity pattern. 
Furthermore, it is the first study that assessed in a large group of CFS patients intra­
individual correlations of daytime fatigue and physical activity, both measured over a 
prolonged period of time. The initial comparison showed that the CFS sample reported 
more wake-up fatigue compared to the controls. In the CFS group, fatigue increased 
during the day and reached its peak in the afternoon. In contrast, the controls showed 
no increase in fatigue throughout the morning but their fatigue subsequently increased 
during the afternoon and evening. The fact that the CFS sample indicated that abnormal 
fatigue was already present before they became physically active suggests that their 
fatigue exists independent of physical activity. However, the finding that CFS patients 
showed an increase in daytime fatigue and reached their highest fatigue levels before 
controls, could indicate that CFS patients got more easily fatigued during the daytime. 
Inspection of the 24-hour actometer registration showed that the CFS sample did not 
differ with respect to their nighttime and evening activity score, making abnormal 
physical activity at night a less likely explanation for abnormal wake-up fatigue in 
CFS.
Since it was hypothesised that different CFS subgroups are characterised by different 
fatigue-activity associations, fatigue patterns were compared for pervasively passive, 
moderately active and pervasively active CFS patients. None of the four mean daytime 
fatigue scores differed among these subgroups but pervasively active patients reported 
more days an increasing fatigue pattern. Therefore, this sample seemed somehow to 
resemble more closely the hypothesised characteristics of exertion-related fatigue, 
which is intriguing, since this is also the group being the least likely to be 
‘deconditioned’. Although avoidance coping was thought to be another variable 
explaining the differences in activity pattern, only a trend was observed for the 
pervasively passives reporting more avoidance coping. The intra-individual daytime 
fatigue-activity correlations reached significance only in a small proportion of the total 
sample, providing little support for daily activity to be associated with daily fatigue in 
CFS. The data showed that in the pervasively passive group there was a trend towards 
a negative activity-fatigue correlation, suggesting that in this group changes in fatigue 
levels more readily lead to avoidance of activity.
These interpretations deserve, however, some caution. First of all, the data pertain only 
to female CFS patients. Although the majority of CFS patients are female, our previous 
physical activity study showed that there were significant gender differences 
concerning overall physical activity levels and peak activity [11]. Secondly, the intra­
individual correlations were exploratory in nature and would gain validity when they 
could be compared to similar correlations in patient groups that, based on their physical 
limitations, would be expected to suffer exertion related fatigue. Nevertheless, our data 
indicate that in most of the participating CFS patients there was no strong linear 
relation between physical activity levels and experienced fatigue. The overall findings 
of this study therefore indicate, that the relation between physical activity levels and 
daytime experienced fatigue is small in most of the participating CFS patients.
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Physically active CFS patients seem somewhat more likely to suffer exertion-related 
fatigue, while in pervasively passive patients variation in daily activity might better be 
viewed as a consequence of fatigue and avoidance. As such, the data gave some 
support to the previously suggested differentiated therapeutic approach of activating 
pervasively passives and balancing activity in physically more active patients [12]. 
Additional analyses in the previous exercise study of our research group also indicated 
a dissociation between daily experienced fatigue and daily activity. Although CFS 
patients reported a considerable increase of fatigue in the two days following the 
exercise test, their physical activity levels were unaffected and tended even to be higher 
than before the exercise test [10]. The disparity between these findings and the strong 
activity-fatigue association perceived by most CFS patients could partly reflect strong 
expectations of patients about the harmfulness of physical activity. Previous research 
also showed that perceived physical activity levels were not strongly associated with 
actigraphic measures, and that CFS patients indeed expected to get more fatigued from 
specific physical activities compared to equally physical active patients with multiple 
sclerosis [15].
It is also possible that other types of activity are associated with fatigue, such as mental 
or social activities. A study that assessed the day-to-day variation of fatigue over a 10- 
day period, did find that daily fatigue covaried with day-to-day stress and negative 
affect. It is a pity that this study did not include measures of physical activity [16]. 
Since mental and social activities were not addressed in our study, future activity 
studies could focus on the impact of these type of daily activities upon daily fatigue.
The findings of this study help to explain CFS patients that daily physical activity is not 
necessarily related to the experience of fatigue, that avoidance of physical activity does 
not prevent fatigue, and that equally fatigued CFS patients might differ considerably in 
their physical activity levels. This knowledge, could alter the perception and 
expectations of CFS patients concerning the harmfulness of physical activity. Perhaps, 
activity regulation in CFS should focus more on mental and social activities, while 
exposure to physical activity, like in gradual exercise programs, may facilitate the 
change of activity related beliefs and also promote self-efficacy expectations of patients 
concerning the possibilities to change behaviour despite being fatigued.
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CHAPTER VII
NEUROPSYCHOLOGICAL TESTPERFORMANCE IN PATIENTS WITH 
CHRONIC FATIGUE SYNDROME0
ABSTRACT
The aim of this study was to assess the potential impact of effort 
on comparative studies assessing neurocognitive dysfunction 
among patients with and without a neurological diagnosis. It was 
hypothesised that in a group of patients with prominent 
neurocognitive complaints but without a neurological diagnosis, a 
subgroup of patients would have impaired performance on a task 
originally designed to detect malingering. Neuropsychological 
performance of a group of forty patients with a definite diagnosis 
of Multiple Scleroses (MS) was compared to that of 67 patients 
with Chronic Fatigue Syndrome (CFS). The Amsterdam Short 
Term Memory Test (ASTMT), a forced-choice memory task, 
served as measure to detect submaximal effort. In addition, we 
administered a regular neuropsychological task generally 
considered to be sensitive for cognitive deterioration. A larger 
proportion of the matched CFS group (30%), as compared to the 
MS group (13%), obtained scores indicative of reduced effort. In 
contrast, the proportions of patients scoring below the cut-off of a 
conventional neuropsychological test did not differ significantly 
(MS=17% and CFS=16%). The obtained results raised the 
question to what extent abnormal test findings, in the absence of 
documented neurological impairment, should be interpreted as a 
sign for cerebral impairment. The suggestion has been made to 
screen more often for biased results in comparative research 
studies in order to enhance valid interpretation of 
neuropsychological findings.
° S van der W erf, J Prins, P Jongen, J van der Meer, G Bleijenberg 
Abnormal neuropsychological psychological findings are not necessarily a sign of 
cerebral impairment: a matched comparison between 
chronic fatigue syndrome and multiple sclerosis 
Neuropsychiatry, Neuropsychology, and Behavioral Neurology
2000;13(3):199-203
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INTRODUCTION
Chronic Fatigue Syndrome (CFS) is a medically unexplained clinically defined 
condition, characterised by long lasting ( 6 months) severely disabling fatigue and a 
combination of at least four out of eight symptoms [1]. One of these eight symptoms is 
self-reported impairment in concentration and short-term memory. Despite the fact that 
many patients with CFS report problems with concentration and memory, 
neuropsychological findings are not consistent [2-9]. Recent reviews suggested that 
these varying results were caused by differences in diagnostic criteria for CFS, the 
heterogeneity of the CFS population, small sample sizes or methodological diversity 
[10-11]. Imaging studies in CFS yielded also heterogeneous results and until now no 
common pattern of cerebral abnormalities has been found [12].
Although several studies have reported relations between psychological factors and the 
severity and persistence of fatigue in CFS [13-16], little is known about the possible 
influence of psychological or behavioural factors upon neuropsychological 
performance in CFS. During past clinical and research neuropsychological assessments 
of CFS patients, we sometimes had the impression that the behaviour of a small 
proportion of CFS patients was indicative of psychological distress or poor motivation. 
However, we were not able to quantify such behaviour or to reliably distinguish 
between normal and abnormal test behaviour.
Therefore, the aim of this study was to compare and evaluate performance of patients 
with CFS and patients with Multiple Sclerosis (MS) on a test developed to detect 
feigned memory deficits. Abnormal results on this task, in absence of a history of 
neurological impairment, were interpreted as a sign of sub maximal effort or unreliable 
test performance. Since relations have been found between psychosocial factors and the 
persistence of fatigue, we hypothesised that psychological factors were likely to 
influence test performance in a subgroup of CFS patients. Therefore we expected that a 
subgroup of CFS patients would have abnormal scores on such a task. With respect to a 
conventional neuropsychological task, sensitive to neurological impairment and 
requiring effort, we hypothesised that an equal proportion of both the MS and CFS 
group would score below normal expectation. Some MS patients would do so because 
of neurological impairment and some CFS patients because of a submaximal effort. 
Hence, we expected that a conventional task would be less likely to differentiate 
between both patient groups. Furthermore, we tested whether there was a relation 
between depressive symptoms and performance on the detection task and conventional 
test.
METHODS
-Subjects
This study was conducted at the department of Medical Psychology of the University 
Hospital Nijmegen in the Netherlands. Forty non-hospitalised patients with clinically 
definite MS according to the revised Poser criteria [17], and 144 CFS patients who were 
medically screened and fulfilled the most recent Centre of Disease Control (CDC)
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criteria for CFS [1], received the combination of a detection task, and a standard 
neuropsychological test. We were able to match 67 patients on basis of gender, 
educational level and age. Educational levels were scored on a 5-point scale: 1=only 
primary school, 3=high school (about eleven years education) and 5=university degree 
(about seventeen years of education). Subject characteristics of the total CFS sample 
and both matched patient samples are shown in Table 1. Both patient groups 
participated in ongoing longitudinal fatigue studies. The assessment of CFS patients 
was made at baseline, while the MS patients underwent the combination of tests two 
years after baseline of a placebo controlled treatment study with Interferon Beta 1a. In 
the MS group the Expanded Disability Status Scale (EDSS) of Kurtzke was used to rate 
the degree of neurological impairment [18]. An experienced neurologist performed the 
EDSS ratings.
Table 1. Demographic data o f the patient groups
CFS total 
(n=144)
MS (n=40) Matched CFS 
(n=67)
Matched-CFS vs. 
MS
Gender M/F 26/110 15/25 25/42 1.00*
% Male 19.1 37.5 37.2
Mean age (range) 36.7 38.5 37.2 0.53#
(18-60) (22-53) (18-54)
Mean education§ 3.2 3.1 3.2 0.62#
(Range) (1-5) (1-5) (2-5)
Mean EDSS 4.1
(Range) (1 -  6.5
*Fisher’s exact test, # Mann-Whitney,
§1=primary school, 3=approximately 12 years of education, and 5=university degree
-Amsterdam Short Term Memory Test (ASTMT)
The ASTMT is a forced choice verbal recognition task. The test consists of 30 items, 
each item covering three separate pages [19]. On the first page of each item, patients are 
asked to read aloud five stimulus words from a common semantic category (e.g., 
clothes, countries, and drinks) and memorise them. Subsequently, this page is turned 
over and on the second page the subject is distracted with a simple arithmetic task (e.g. 
23+6, 43+5, 18+7) and one has to give an oral answer. On the next third page the 
subject is presented with five words of the same semantic category as on the first page. 
Three words are equal to those on the first page and two words are new. Subjects are 
asked to indicate which three words they recognise from the previous trial. The number 
of words recognised correctly is the total score. The maximum score is 90 points (3 x 
30 items). The validation study showed high average scores (>89) for healthy subjects 
and mild Cerebral Head Injury (CHI) patients [18]. The test discriminated perfectly 
between CHI patients (all scores above 86) and subjects who were instructed to feign 
cognitive impairment (score range 75-85). The authors subsequently used the cut-off
68 Chapter VII
value of 86 points in a study investigating post-whiplash complaints in the context of 
litigation [20]. None of the healthy controls and none of the patients with closed head 
injury and well-documented cognitive impairment, scored below the cut-off. In 
contrast, a significant proportion of post-whiplash patients had ASTMT scores 
indicative of submaximal performance, while between the closed head injury group and 
the post-whiplash group no differences were found on the regular neuropsychological 
tests. Furthermore, comparing post-whiplash patients, who were assessed for litigation 
procedure, and patients who were not, revealed 61% abnormal test-scores in the 
litigation group and 29% in the non-litigation group.
-Symbol Digit Test (SDT)
The SDT of the Dutch version of the Wechsler Adult Intelligence Scale was 
administered to all subjects [21]. The SDT is considered to be one of the most sensitive 
sub-tests of the WAIS for ageing and cognitive deterioration [22]. Raw SDT scores 
were converted to T-scores according to the most recently published norms (n=595) in 
the Netherlands [23]. Scores corrected for age and gender were compared to the average 
SDT T-scores of five different educational levels. A SDT T-score of two standard 
deviations below the average SDT-score of the appropriate educational group was 
chosen as a sign of cognitive impairment.
-Beck Depression Inventory
The Beck Depression Inventory (BDI) served as self-report measure of psychological 
distress. An indication or depression was defined as a BDI-score of more than 16[24].
-Statistics
The validation studies showed that the data of the ASTM were considerably skewed 
towards the maximal score of 90; therefore, non-parametric testing was conducted. 
Fisher’s exact tests for dichotomous variables were used to test for proportional 
differences between groups. Since we hypothesised that the proportion of abnormal 
ASTMT scores of the matched CFS group would be higher compared to the MS group, 
and normal performance would indicate 0% below the cut-off, this difference was 
tested one-sided (p=0.05). Since no specific directional group differences between the 
proportions of patients with abnormal SDT and BDI scores were assumed, differences 
were tested two-sided. The relationships between levels of depression and the SDT and 
ASTMT were expressed by Spearman Rank correlation coefficients.
RESULTS
-ASTMT
A cumulative percentage plot of the ASTMT scores of both matched patients’ samples 
is displayed in Figure 1. Table 2 shows that compared to the CFS sample a significant 
smaller proportion of the MS sample obtained scores below the cut-off of 86 points 
(13% vs. 30%, +2=4.2, p=0.03).
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-Symbol Digit Test
Table 2 shows also that there were no significant differences between the proportions 
of patients scoring under the proposed cut-off of the SDT (CFS-total 18%, and CFS 
matched 16% vs. MS 18%, +2=0.2, p=0.89).
-Depression
Compared to the MS-sample, a significant larger proportion of the matched CFS group 
had elevated BDI scores (3% vs. 25%, +2=9.4, p=0.02). In the CFS group the 
correlations between BDI scores and ASTMT scores (-0.12, p=0.31), and between BDI 
scores and SDT scores (-.16, p=0.20) were low and non-significant. Similar results 
were obtained for the MS-group (-0.09, p=0.58 and -0.07, p=0.68).
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Figure 1. Cumulative percentage plot o f ASTMT scores o f the CFS and MS samples
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Table 2. Proportions o f MS and CFS patients scoring below or above cut-off values o f the 
three outcome measures
CFS total 
(n=144)
MS
(n=40)
Matched CFS 
(n=67)
Matched CFS versus MS 
p-values
ASTMT < 86 29% 13% 30% 0.03*
SDT < cut-off 18% 18% 16% 0.89#
BDI >16 26% 3% 25% 0.02#
ASTMT=Amsterdam Short Term Memory Test, SDT= Symbol Digit Modalities Test, BDI=Beck’s 
Depression Inventory, *Fisher’s exact test, one-sided, #Fisher’s exact test, two-sided
70 Chapter VII
DISCUSSION
Closed head injury patients, who were purposely selected because of well-documented 
brain damage, had no difficulties with the ASTMT, while their performance on a 
conventional auditory verbal learning task was significantly below that of healthy 
controls [19]. Nevertheless, five of our MS patients scored below the proposed cut-off. 
These five patients had significantly higher EDSS scores (5.5 vs. 3.9; z=2.29, p=0.02) 
compared to MS patients with normal ASTMT performance and their ratings (range 
3.5-6.5) indicated moderate to more severe neurological impairment. The percentage of 
CFS patients that scored below the cut-off was more than twice the size of that of the 
MS group. Four CFS patients scored even below the worst performing MS patient. 
Since the ASTMT should be considered as relatively insensitive to mild brain damage 
or mild cognitive impairment, it would be unlikely that a subtle cognitive dysfunction 
would cause such discrepancies between MS and CFS patients.
Inspecting the cumulative frequencies of the ASTMT scores showed that a cut-off 
value of 87 maximised the group differences. Forty percent of the CFS patients and 
18% of the MS patients scored below 87 points (+2=6.0, p=0.01). In their previous 
research the authors of the ASTMT did suggest that the proposed cut-off of 86 points 
was perhaps too stringent and that a cut-off value of 87 would be more effective. 
Nevertheless, in order to minimise the chance that patients would be classified falsely 
as malingerers they maintained the proposed cut-off [20]. Although equal proportions of 
the MS sample had abnormal ASTMT and abnormal SDT scores, abnormal ASTMT 
performance not always coincided with an abnormal SDT score. One would expect that 
impaired performance on a relatively easy task would also lead to abnormal results in a 
more sensitive task. However, 5% of the MS patients had an abnormal ASTMT score 
combined with a normal SDT score. This finding could suggest that the SDT cut-off 
value of two standard deviations below expectation was too stringent. A cut-off value 
of 1.5 standard deviation did indeed result in none of the MS patients having an 
abnormal ASTMT score in combination with a normal SDT score.
When a similar comparison was made for CFS patients, nineteen percent of the CFS 
patients had an abnormal ASTMT and a SDT score better than two standard deviations 
below expectation. Still 13% of the CFS patients had an abnormal ASTMT score in the 
presence of a SDT score better than 1 ‘V standard deviation below expectation (0% MS 
vs. 13% CFS, two-sided p=0.02). This finding demonstrated that in the CFS group the 
disparity between performance on a relatively easy task and on a more sensitive 
measure, could not merely be resolved by choosing an appropriate cut-off. This 
disparity in the CFS sample could indicate that the ASTMT is sensitive to a specific 
cognitive ability. Perhaps that some CFS patients are characterised by a specific verbal 
recognition deficit. However, two previous studies that used the Californian Verbal 
Learning Test and compared performance of a group of CFS patients with that of a 
group of healthy controls showed no differences in first trial performance or between 
the average delayed recognition scores [2,25]. Two review articles about neurocognitive 
function in CFS did not mention evidence for a specific verbal recognition deficit, and 
one of these reviews even stated that memory deficits have not been found for word 
learning lists [10,11].
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The discrepancy between findings in the current study and the absence of verbal 
recognition deficits in other research, could stem from the fact that patients who 
complain about memory deficit experience excessive stress when confronted with a 
memory task, or assume beforehand that they will fail on such a task. Alternatively, it 
is possible that some of the CFS patients fear that their problems go unnoticed on a 
relatively easy task and therefore adjust their effort to the difficulty or type of task 
involved. Because subjective neuropsychological complaints are one of the eight key 
symptoms of the CDC criteria of CFS, some patients may adapt their behaviour to their 
disease expectations. The unknown aetiology of CFS, the ‘difficult’ disease status and 
subsequent fear of complaints not taken seriously, could enhance such a process. 
Although the proportion of elevated depression ratings was significantly higher for the 
CFS group, there was no significant relation between levels of self-reported depression 
and the ASTMT and SDT scores. DeLuca et al. also found no significant relationship 
between neuropsychological performance and psychological ratings on questionnaires 
for somatisation, depression and distress [6]. However, Ray et al. reported significant 
correlations between levels of emotional distress and word- and colournaming on the 
Stroop interference task [26]. A previous CFS study of our group showed a relation 
between the extent of physical causal attributions and physical activity reduction. 
Future research could assess whether performance on neuropsychological tasks is also 
related to those types of attributions.
Since a low ASTMT score does not provide any information about the motivational 
basis of that finding, it is not suggested that abnormal neuropsychological test findings 
in CFS can exclusively be attributed to psychological factors. However, extremely low 
ASTMT scores indicated that such factors almost certainly played a role in some cases. 
To warrant valid neuropsychological comparisons between neurological disorders and 
disorders of unknown aetiology, one should screen for biased results. Comparative 
group studies can be especially confounded by invalid performance of subgroups. To 
attribute abnormal neuropsychological findings to cerebral impairment could be just as 
harmful as too readily interpreting those results as a consequence of psychological 
processes. Implying cerebral deficits can perhaps confirm or strengthen the patient 
beliefs that a possible neurological disease is the cause of their experienced cognitive 
problems. Although most instruments and methods for detecting submaximal 
performance are still far from perfect, application of these methods for research 
purposes might at least reduce the heterogeneity of neuropsychological test results to 
some extent.
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CHAPTER VIII
THE RELATIONS BETWEEN BODY CONSCIOUSNESS, SOMATIC 
SYMPTOM REPORT AND INFORMATION PROCESSING SPEED 
IN CHRONIC FATIGUE SYNDROME0
ABSTRACT
The aim of this study was to assess the potential influence of body 
consciousness and levels of somatic symptom report upon 
information processing speed among patients with chronic fatigue 
syndrome. According to a model of a fixed information 
processing capacity, it was predicted that in a group of CFS 
patients, high body consciousness in combination with a high 
report of somatic symptoms would affect information-processing 
speed negatively. Information- and motor-processing speed were 
measured simultaneously with a simple- and choice-reaction time 
task. Cognitive complaints were rated with two questionnaires. 
The hypothesised influence of private body consciousness and 
somatic symptom report upon information processing speed was 
tested in a model. A symptom-validity test was used to screen for 
possible illness behaviour. Private body consciousness was 
directly related to information processing speed and somatic 
symptom report. Somatic symptom report was related to both test 
performance and memory and concentration complaints. Levels of 
private body consciousness directly affected somatic symptom 
report and information-processing speed. This finding supports 
the role of attentive processes in CFS, and offers, besides possible 
cerebral dysfunction, an alternative explanation for slowing of 
information processing in CFS.
° S van der W erf, B de Vree, J van der Meer,G Bleijenberg 
The relations between body consciousness, somatic symptom report and 
information processing speed in chronic fatigue syndrome 
Neuropsychiatry, Neuropsychology, and Behavioral Neurology
2002;12: 12-15
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INTRODUCTION
Chronic Fatigue Syndrome (CFS) is a medically unexplained clinically defined 
condition, characterised by long lasting (at least 6 months) severe disabling fatigue, and 
a combination of at least four out of eight symptoms [1]. One of these eight major 
symptoms is self-reported impairment in concentration and short-term memory. 
Despite the fact that many patients with CFS report problems with concentration and 
memory, neuropsychological findings are not consistent [2-10]. Recent reviews 
suggested that these varying results were caused by differences in diagnostic criteria 
for CFS, the heterogeneity of the CFS population, small sample sizes or 
methodological diversity [11,12]. In a recently published study we also found evidence 
that the neuropsychological test performance in comparative studies could have been 
biased by illness behaviour [13]. Despite these possible confounders, a possible 
reduction in information processing speed has been reported most consistently [11,12]. 
In a tested model for CFS, focusing on bodily symptoms, as measured by high somatic 
symptom report, turned out to be strongly related to both fatigue severity and 
experienced disability [14]. Several studies showed that a wide variety and high 
frequency of somatic symptoms characterised CFS patients. Compared to patients with 
multiple sclerosis or depression, CFS patients reported significantly more somatic 
symptoms on the somatisation subscale of the Symptom Checklist-90 (SCL90) [14-16]. 
These findings suggested a heightened bodily self-awareness in CFS.
In the literature the following two constructs of self-focused attention have been 
distinguished: private self-consciousness and private body consciousness [17,18]. 
Private self-consciousness relates to the tendency to attend to inner psychological or 
emotional processes, while private body consciousness reflects the individual’s 
sensitivity to perceive internal bodily sensations. Several studies showed that private 
body consciousness was related to symptom report and symptom severity, problem 
solving and attentional processing [19-21].
A recent study, pertaining to 57 non-clinical subjects, demonstrated that a heightened 
selective attentional focus on the body and the degree of symptom report predicted 
levels of illness anxiety [19]. A small, though significant relationship was found 
between the performance on a continuous performance test that measured visual 
sustained attention, and the extent subjects reported private body consciousness. Higher 
levels of private body consciousness were associated with a lower sensitivity index of 
the continuous performance test. Based on their findings the authors hypothesised that 
bodily preoccupation seemed to interfere with external task demands, making less 
attentional resources available for processing of external information.
Martin et al. [20] studied the relation between private body consciousness and state 
anxiety in the report of somatic symptoms during a clinical magnetic resonance 
imaging investigation. They found that state anxiety and private body consciousness 
interacted to predict the report of symptoms during the MRI procedure. These findings 
were explained using the information-processing model of Ahles et al. [22]. According 
to this model, anxiety interacts with the predisposition to focus on bodily sensations by 
increasing the likelihood that these sensations will be processed affectively. This type
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of affective processing amplifies the somatic sensations, which are then experienced 
and reported as symptoms.
Klein et al [23] assessed in 45 students whether a fixed-capacity information­
processing model could be used to explain the relationship between problem-solving 
errors and life stress as moderated by anxiety and private body consciousness [23]. The 
data showed that especially in subjects with high levels of private body consciousness, 
high state anxiety in combination with high life stress affected the performance on an 
analogical reasoning task negatively. It was concluded that stressful life events, and the 
task-irrelevant thinking that characterises state anxiety, occupied some portion of a 
finite processing capacity. Furthermore, the authors reasoned that anxiety is often 
accompanied with somatic sensations and that subjects who have high levels of private 
body consciousness will be more attentive to these sensations, leaving them with even 
less recourse for cognitive demanding tasks.
The aforementioned studies suggested that private body consciousness was associated 
with increased focusing on bodily sensations and higher somatic symptom report, and 
might affect decision-making and information processing capacity negatively. 
Therefore, the objective of the current study was to test a model that incorporated both 
body consciousness and the extent patients report somatic symptoms. Body 
consciousness was considered an independent predisposing factor for the detection and 
subsequent report of somatic symptoms, while it was assumed that the report of 
somatic symptoms could also represent underlying psychosocial processes. According 
to the reports in the literature, body consciousness was hypothesised to directly 
influence information-processing speed, especially in subjects that are characterised by 
high somatic symptom report. Since the somatic symptom report could involve 
different causal processes like active focusing on bodily sensations, anxiety or perhaps 
even some form of illness behaviour, the influence of somatic symptom report upon 
neuropsychological test-performance was expected to be less specific and not only to 
be limited to information processing speed. Therefore, the model was also tested with 
motor speed measures and measures of self reported cognitive complaints. To control 
for the possibility of response bias influencing both neuropsychological performance 
and interrelations between variables, the proposed models were tested for the sample 
that showed valid performance on a symptom validity task.
METHODS
-Subjects
This study was conducted at the Department of Medical Psychology of the University 
Medical Centre Nijmegen, the Netherlands. Complete data were collected in 57 (44 
females and 13 males) patients with a CDC diagnosis of CFS, aged between 16 and 56 
years, and fulfilling operational criteria for fatigue severity and disability. Informed 
consent was obtained prior to the start of the study [1]. The mean age of this group was 
34.7 years and the mean illness duration was 1.9 years (range: 1 to 4 years).
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-Private body consciousness
The subscale private body consciousness of the Body Consciousness Questionnaire 
was used to measure this concept [18]. This subscale has five items that can be 
answered on a scale that ranged from 0 (extremely uncharacteristic) to 4 (extremely 
characteristic). The private body consciousness scale had the following five items: (1) I 
am sensitive to internal bodily tensions; (2) I know immediately when my mouth or 
throat gets dry; (3) I can often feel my heart beating; (4) I am quick to sense the hunger 
contractions of my stomach; (5) I ’m very aware of changes in my body temperature. 
The validation study showed that patients who scored higher on the private body 
consciousness scale were stimulated by caffeine [18]. The instrument has been 
translated and psychometric-ally evaluated in the Dutch population. The evaluation of 
he translation resulted also in a three-factor structure and the Cronbach’s alphas were 
comparable to the original test (ranging between 0.63 and 0.64) [24].
-Degree o f  somatic symptoms
The subscale somatisation (SCL90-somatization) of the SCL90 was used [25]. This 
subscale rated the burden patients experienced from a number of psychosomatic 
symptoms.
-Information processing speed and motor speed
Both, a simple- and a choice-reaction time task were administered to measure motor 
and mental speed under two conditions. This test has been used in an ageing study of a 
normal population and a previous neuropsychological CFS study [2]. The ageing study 
showed an age effect for both the motor speed en information processing speed 
measures [26]. On a response board five target buttons were situated at equal distance 
around a start button. Each target button contains a stimulus light. During the two tasks 
the subject keeps the start button pressed, until a stimulus lights up. In the first task 
only one stimulus button (the middle) can light up. In the second task, three different 
target buttons can light up in random order. In both tasks subjects are asked to respond 
as fast as possible to the button that lights up by releasing the start button and moving 
to and subsequently pressing the target button. In both conditions a distinction can be 
made between speed of information processing (stimulus selection, choice selection 
and response initiation) and motor speed (movement time between releasing start 
button and pressing the target button). The neuropsychological test resulted in two 
movement times (MT1 and MT2) and three reaction times (RT1 and RT2).
-Subjective memory and concentration problems
The subscale alertness behaviour of the Sickness Impact Scale (SIP alertness 
behaviour) and the subscale CIS-concentration were used to measure the degree of 
subjective memory and concentration problems [15,27].
-Validity test-performance
The Amsterdam Short Term Memory Test (ASTMT) is a forced choice verbal 
recognition task developed to detect underperformance during neuropsychological
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testing [28]. This test has been described in detail in a previous study. The maximum 
score is 90 points (3 x 30 items). Validation studies showed high average scores (>89) 
for healthy subjects and mild Closed Head Injury (CHI) patients. Based on different 
validation studies a cut-off value of 86 points has been proposed [29].
-Statistics
Structural equation modelling techniques were used to test the model [30]. Calculations 
were performed with the computer program AMOS 4.0 [31]. The maximum likelihood 
method of estimation was used to estimate unknown regression parameters. In the 
proposed model (Figure 1), information-processing speed was defined as a latent 
construct with the two reaction times being the measurement variables. Body 
consciousness was thought to directly influence information processing speed and 
somatic symptom report. It was also hypothesised that information processing speed 
dependent on the degree of somatic symptom report and the age of the patient. For 
cross-validation purposes this model was also tested with the motor speed measures 
and the self-report measures as separate latent constructs. The %2 statistic and the 
Adjusted Goodness of Fit Index (AGFI) were used to test data fit. According to 
guidelines for structural modelling, the data were considered to fit the model when c 2 
statistic was not significant and AGFI was high (preferably above .90). Furthermore, 
the population error of approximation (Root Mean Square Error of Approximation) was 
taken into account as measure of discrepancy per degree of freedom. Values up to 0.05 
indicate a close fit and value up to 0.08 represent reasonable errors of approximation in 
the population. Preferably the 90% confidence interval (90%CI) of the RMSEA index 
lies between 0.00 and 0.10 [32]. When the data did not fit the model well, the 
modification indices provided by the AMOS program were used to investigate whether 
the model could be adjusted according theoretically valid propositions
RESULTS
-Descriptives
Thirteen (23%) of the 57 patients had ASTMT scores possibly indicative of 
underperformance. Hence, model testing took place in a sample of 44 subjects (32 
females and 12 males). Information about the age and illness duration of this sample, 
and the means of the model variables are provided in Table 1while Table 2 shows the 
interrelations of the model variables in this sample of 44 subjects.
80 Chapter VIII
Table 1. Demographics and mean test scores o f model variables in sample (n=44) with valid 
(>85) ASTMT scores
Minimum Maximum Mean Standard Deviation
Age 16 56 34.1 12.0
Illness duration 1 4 1.9 0.7
Body Consciousness Scale 7.00 20.00 15.8 3.1
SCL-somatisation 16.00 52.00 29.0 8.6
RT1* 0.22 0.73 0.32 0.10
RT2 0.25 0.80 0.37 0.12
MT1 0.14 0.42 0.23 0.07
MT2 0.15 0.48 0.24 0.07
CIS-concentration 6 35 27.1 6.9
SIP-alertness behaviour 0 702 338.2 204.7
* Reaction (RT) and movement (MT) times in seconds
Table 2. Correlations between model variables in sample with valid ASTMT performance
Age Educ. SCL Body RT1 RT2 MT1 MT2 CIS- SIP-
somat. Cons. Conc. Alert
Education -.14 1.00
SCL Somatisation -.08 .02 1.00
Body Consciousness -.04 -.01 .32 1.00
Reaction time 1 .14 -.22 .43* .43* 1.00
Reaction time 2 .12 -.24 .52* .42* .86* 1.00
Motor time 1 .30* -.01 .34* .29 .54* .54* 1.00
Motor time 2 .31* -.03 .22 .13 .51* .57* .87* 1.00
CIS-concentration .27 .09 .30* .08 .04 .09 .08 .09 1.00
SIP-alertness .17 .16 .41* .35* .35* .40* .31* .27 .58* 1.00
*Correlations are significant at the 0.05 level (2-tailed),
-Model testing
Both the c 2 index and AGFI index indicated good fit (c2 =2.6, df=8, p=0.96; 
AGFI=0.94). The 90%CI of the Root Mean Square Error of Approximation also 
indicated a close fit of the model in relation to the degrees of freedom (RMSEA=0.00, 
90%CI: 0.00-0.00, p=0.97). The direct relation between Body Consciousness and 
Information Processing Speed did reach significance (b=0.32, p=0.01). Level of 
somatic symptom report had also a direct significant effect upon information 
processing speed (b=0.43, p<0.01), while Body Consciousness was significantly
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related to level of somatic symptoms report (P=0.30, p=0.04). Although education had 
significant relation with information processing speed (b= -0.25, p=0.04), age was not 
significantly related to information processing speed (b=0.19, p=0.12). The model 
explained in total 46% of the variance in information processing speed.
Figure 1. Model information processing speed. Error terms have been omitted in the figure. 
-Testing the model with motor speed
The c 2 and AGFI indices indicated good fit (c2 =4.2, df=8, p=0.54; AGFI=0.92). The 
90%CI of the Root Mean Square Error of Approximation indicated a less close fit of 
the model in relation to the degrees of freedom (RMSEA=0.00, 90%CI: 0.00-0.11, 
p=0.87). In this model, the direct relation between Body Consciousness and Motor 
speed did not reach significance (b=0.20, p=0.14), but level of somatic symptom report 
did have a significant effect upon Motor Speed (b=0.30, p=0.03). There was a direct 
effect of Body Consciousness upon level of somatic symptom report (b=0.30, p=0.04). 
Age was also significantly related to motor speed (b=0.33, p=0.01), but education was 
not (b=0.00, p=0.96). In total 27% of the variance in motor speed was explained by the 
model.
-Experienced memory and concentration problems
In this sample the model showed reasonable fit of the data (c2=6.2, df=8, p=0.77; 
AGFI=0.88) but the RMSEA 90%CI indicated a less close fit in relation to the degree
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of freedom (RMSEA=0.00, CI: 0.00-0.15, p=0.70). The direct relation between Body 
Consciousness and level of somatic symptom report did reach significance (b=0.32, 
p=0.03), and level of somatic symptom report had a significant direct effect upon 
experienced memory and concentration problems (b=0.43, p<0.01). However, there 
was no direct significant effect of Body Consciousness upon experienced memory and 
concentration problems (b=0.23, p=0.11). Age was significantly related to experienced 
memory and concentration problems (b=0.29, p=0.04), while education was not 
(b=0.18, p=0.20). In total 42% of the variance in experienced memory and 
concentration problems was explained by the model.
DISCUSSION
In the introduction, two studies were described that reported private body 
consciousness was associated with increased focusing on bodily sensations and higher 
somatic symptom report, and affected information processing negatively in non-clinical 
populations [19,21]. Similarly, Martin et al [20] reported that in a clinical population, 
body consciousness and state anxiety levels predicted the report of symptoms. In all 
three studies attentive processes were thought to play an important role in the report of 
symptoms and the processing of external information because patients with CFS report 
high levels of somatically unexplained (physical) symptoms, frequently show slowing 
of information processing during formal testing, generally believe that their illness has 
a physical cause [2,15,16]. We hypothesized that such in-formation processing models 
might be used to explain possible relations between somatic symptom report and 
processing of external information in CFS.
The findings of this study indeed lend some support to the proposition that in CFS 
attentive processes, such as private body consciousness, might affect somatic symptom 
report and either directly or indirectly interfere with external task demands. Therefore, 
similar mechanisms as described in the information-processing model of Ahles et al 
[23] could possibly be applied to CFS. Previous CFS research has stressed the 
importance of illness cognitions. Physical causal attributions and self-efficacy were 
found to predict persistence of symptoms in CFS. One could hypothesize that the 
conviction of the patient that there is physically something wrong, and that one cannot 
influence their complaints, does increase body consciousness and state anxiety 
concerning symptoms and exertion. Instead of labelling slowing of information 
processing as a direct result of cerebral impairment or deficit, it could also be 
interpreted as a consequence of affective processing of symptoms or a too strong 
attention for bodily sensations. Because motor output is independent of stimuli 
processing, one would expect that body consciousness or active focusing on bodily 
symptoms would to a less extent be associated with motor speed. The results of the 
model testing were in agreement with this proposition. A previous study of our 
research group , using similar tests and self-report measures, showed that there were no 
significant associations between neuropsychological test performance and experienced 
neuropsychological problems, but experienced neuropsychological problems were
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related to both fatigue severity and depression [2]. The findings of the present study 
also suggest that the expression of cognitive complaints is associated with somatic 
symptom report and not merely reflected in information-processing speed.
The motor planning task has been used in a cohort aging study of healthy subjects and 
subjects who had biological life event possibly affecting brain function. In contrast to 
this study, age was not associated with information processing speed. However, the 
aging study in which a relation between age and information processing speed was 
reported, pertained to a large sample of healthy controls who’s age ranged between 17 
and 48 years [26]. In comparison, our sample was relatively young and most patients 
had a short illness duration, as such there was less variation in age. Furthermore, it is 
possible that other factors than age dominated test performances in this clinical sample. 
Furthermore, the sample that provided data to test the hypothesized models was small, 
therefore the power to detect significant relationships (standardized regression 
coefficients) was restricted to medium effect sizes. Our results would gain validity 
when they could be replicated in other CFS samples with different age distributions. In 
addition one could verify whether similar mechanisms as found in the current study 
could apply to other somatically unexplained chronic conditions.
To what extent attentive processes play a role in CFS does need further research. It 
would be interesting to compare early and late components of somatosensory event 
related potentials during an experimental task in which attention will be manipulated 
by a distraction task. Similarly, one could test the effects of somatosensory stimulation 
upon a continuous performance task. The clinical implications could be a therapeutic 
focus upon: (1) relabelling bodily sensations, (2) diverting attention to bodily 
sensations by distracting tasks, or (3) exposing to physical exertion in order to increase 
bodily sensations and, as such, possibly blunt the affective response to less intense 
bodily stimuli. These treatment strategies could be part of either a cognitive behaviour 
therapy or a graded exercise protocol, both of which have been proven effective in CFS 
[33,34].
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CHAPTER IX
RELATIONS BETWEEN FATIGUE COMPLAINTS, CEREBRAL MRI 
ABNORMALITIES AND NEUROLOGICAL DISABILITY IN 
MULTIPLE SCLEROSIS °
ABSTRACT
Although fatigue is a frequent complaint of patients with multiple 
sclerosis (MS), little is known about the origins of MS-associated 
fatigue. Our primary focus was to study whether the extent of 
cerebral abnormalities, as shown on magnetic resonance imaging 
(MRI), had any relation with the frequency and intensity of 
fatigue complaints of patients with a definite diagnosis of MS. 
Fatigue severity was rated by the patients with the use of a 2-week 
diary and a fatigue questionnaire, while conventional T1- and T2- 
weighted MRI provided several measures for cerebral 
abnormalities. In total, 72% of 45 patients reported to be seriously 
fatigued at least several times a week over the preceding 3-month 
period. Fatigue severity was not related to the total extent of 
cerebral abnormalities, or to MRI based atrophy measures. 
Regional lesion load did not differ between fatigued and non­
fatigued subjects. Although neurological disability, as measured 
by the Expanded Disability Status Scale (EDSS) and Neurological 
Rating Scale (NRS), did correlate significantly with most MRI 
measures, it showed no relation with fatigue severity. 
Neurological progression rates and number of exacerbations in the 
2-year period prior to assessment were not significantly associated 
with the fatigue measures. Therefore, our findings suggest that 
differences in levels of self-reported fatigue in patients with MS 
cannot merely be explained by the degree of clinical disease 
activity, neurological disability or the extent of MRI 
abnormalities. These results are compared to other research 
findings and the possible role of alternative factors influencing 
fatigue in multiple sclerosis are discussed.
°  S van der W erf, P Jongen, G Lycklama à Nijeholt, F Barkhof,
O Hommes, G Bleijenberg
Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral
abnormalities and neurological disability 
Journal of Neurological Sciences 1998;160:164-170
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INTRODUCTION
Fatigue is recognised as a major symptom in many neurological illnesses. At the same 
time it is generally considered to be a non0specific and highly subjective complaint, 
difficult to measure or explain. For that reason most standard evaluations of 
neurological impairment do not include ratings of fatigue. As such, the use of 
subjective feelings of fatigue as a research variable has been hampered by the lack of 
reliable and valid assessment methods. Recently there has been increasing interest in 
fatigue research, offering insight in prevalence and impact of fatigue, and providing 
new measurement methods. Some of these studies address the clinically well-known 
fact that a large proportion of patients with MS experience disabling fatigue. This 
research confirms that there is a high incidence of persistent fatigue in MS, and that 
many patients rate fatigue as one of their most troublesome symptoms [1-5]. The cause 
of fatigue in MS is a topic of considerable speculation. Most studies report weak or 
absent relations between neurological disability and fatigue experience [6-8], and 
between physical muscular fatigue and self-reported fatigue [6,9]. In contrast to these 
findings, psychosocial factors were found to play a more prominent and consistent role 
in explaining levels of fatigue [8,10].
Despite the distinct cerebral histopathology of MS, such as widespread areas of 
inflammation, demyelinisation and axonal loss, none of the above-mentioned studies 
include measures of cerebral abnormalities. For that reason it is unclear if 
morphological brain abnormalities have a causal relation with self-reported fatigue. 
MRI is regarded as one of the most sensitive techniques for detecting and quantifying 
cerebral abnormalities in multiple sclerosis. Conventional brain T2-weighted MRI is 
currently the standard assessment method to support an early diagnosis of MS. It is also 
increasingly used to monitor the disease process or to evaluate the efficacy of 
pharmacological treatment [11,12] although conventional MRI has found to correlate 
poorly with neurological symptoms in MS, new MRI parameters, such as measures of 
cerebral atrophy, enhance the specificity and validity of MRI [13-19]. Indeed, 
significant correlations are increasingly found between these MRI measures and 
neurological functioning.
While pharmacological treatment with amantadine and pemoline has been shown to 
relieve fatigue in some patients, the working mechanisms of these types of treatment 
are still poorly understood [20-23]. Many patients report adverse effects, so 
administering these drugs does not provide a satisfactory solution for many patients 
with MS-associated fatigue. With respect to therapeutic development it is important to 
know to what degree cerebral abnormalities influence MS-associated fatigue. In this 
study we used a variety of brain MRI-parameters and related them with different 
measures of perceived fatigue. In addition, we tested whether clinical disease activity 
or the neurological progression rate could predict fatigue scores at time of assessment
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METHOD
-Subjects
Baseline MRI and fatigue data were collected from 45 outpatients with clinically 
definite MS according to the revised Poser criteria [24]. The total group involved 26 
relapsing remitting (RR) and 19 secondary progressive patients (SP) consisting of 28 
females and 17 males (RR: 18/8 and SP: 10 /9 ). The mean age in years for the total 
group was 37.6 ± 8.4 (range 20 - 53). The participants took part in a double blind 
placebo controlled treatment (Interferon-beta 1a) study and all patients gave informed 
consent to the study protocol. The inclusion criteria for relapsing-remitting patients 
were: (1) a history of two or more acute exacerbations in the previous two years; (2) 
have been in a stable neurological state for at least four weeks at time of pre-entry 
evaluation; (3) have an EDSS of 0-5.0. The inclusion criteria for secondary-progressive 
patients were: (1) have clinically definite secondary progressive multiple sclerosis 
defined as progressive deterioration of disability for at least six months and a 
deterioration in the EDSS of at least one point during the last two years, with or 
without superimposed acute exacerbations following an initial relapsing remitting 
course; (2) have an EDSS of 3-6.5. Patients who had an exacerbation in the 3-month 
period prior to assessment or received any treatment with corticosteroids or ACTH in 
the 2 months preceding study entry were excluded. None of the patients received any 
form of immunosuppressive treatment in the 12 months preceding study entry.
-Fatigue
Fatigue was assessed by three measures, all of which were used in previous studies of 
our research group [8,25]. The fatigue subscale fatigue of the Checklist Individual 
Strength (CIS-Fatigue) was used to measure levels of fatigue. Throughout a 2-week 
period patients were asked to rate their fatigue four times a day on a 4-point scale. 
These daily ratings were averaged into a daily fatigue score (range 0-16). Finally 
patients were asked how often they experienced severe fatigue during the 3 months 
prior to assessment (fatigue frequency). Patients who reported to be fatigued at least 
several times a week over the last 3-month period were classified as fatigued, while 
patients who experienced only occasionally fatigue or no fatigue over this period where 
classified as non-fatigued.
Table 1. Characteristics o f  patients group
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Total group 
Mean (SD)
Relapsing Remitting 
Mean (SD)
Secondary progressive 
Mean (SD)
Number o f patients 45
Male/Female 17/28
Age in years 37.6 (8.4) 34.3 (8.0) 42.0 (6.7)*
Range (20-53) (20-51) (28-53)
Mean disease duration in years 7.9 (4.2) 6.4 (4.4) 9.9 (4.8)
NRS 68.7 (13.3) 73.8 (12.3) 61.7 (11.5)#
EDSS 3.5 (1.5) 2.9 (1.0) 4.1 (1.2)
CIS-fatigue 37.9 (12.7) 34.5 (12.6) 42.6 (11.5)
Daily fatigue 4.5 (3.1) 4.3 (3.5) 4.7 (2.9)
*RR vs. SP, p<0.05; #RR vs. SP, p<0.01.
-Magnetic Resonance Imaging
During the same period as the fatigue assessment all patients underwent MRI at 1 T. 
MR imaging consisted of proton density (PD) and T2-weighted spin-echo (SE) 
(2000/20,90/1 [TR/TE/excitations]). In addition, for the RR group, both non-enhanced 
and gadolinium-enhanced (0.1 mmol/kg) T1-weighted SE (600/10/2) images were 
made. Slice thickness was 5mm, and pixel size was 1x1 mm. Lesion load on the T2- 
weighted MR images was analysed by one reader (GL), blinded to the clinical findings, 
using a semi-quantitative scoring method. Lesions were scored on a four-point scale for 
maximal diameter: 1: 0-5mm, 2: 6-10mm, 3: >10mm; while four points were scored for 
large confluent lesions, typically located periventricular. Lesion load was assessed for 
twenty-four anatomically defined locations in both hemispheres. Distinctions were 
made between cortical, subcortical, central, periventricular and additional subtentorial 
areas, such as medulla, pons, thalamus etc. The supra tentorial areas were subsequently 
divided according to their anatomical region: frontal, parietal, temporal and occipital. 
All different areas are shown in figure 1. Brain atrophy was assessed using T2- 
weighted images. The following atrophy indexes were measured: frontal horn index, 
biparietal index, third ventricle index, and bicaudatus index [26].
-Clinical assessment
Disability was graded by an experienced neurologist (ORH) according to the expanded 
disability status scale (EDSS) of Kurtzke and the Scripps neurological rating scale 
(NRS) [27,28].
-Clinical disease activity and neurological progression rate
In both the RR- and SP-group neurological progression rates were defined as the EDSS 
score at assessment divided by the disease duration. In the RR-group the total number 
of exacerbations in the 2-year period prior to assessment was taken as a measure for 
clinical disease activity.
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-Treatment variables
The following treatment data concerning the 2-year period prior to assessment were 
available: (1) type and number of treatments, (2) total dose of methylprednisolone the 
individual patient received in that period.
-Statistics
In case of approximately normally distributed data (skewness between 1 and -1), the 
relations between variables and differences between groups were evaluated by means 
of Pearson correlation coefficients and by Student’s t-test. Otherwise data were 
analysed by Spearman's rank correlation coefficients and Mann-Whitney test. The a 
was set at 0.05 two-tailed. Since this study was aimed to study whether there were 
significant relationships, no corrections for multiple comparisons were made. In this 
way the power to detect modest relationships remained sufficient. Multiple regression 
analyses were only performed on non-skewed data available for all 45 subjects. Cross­
tabulation provided information on nominal data (fatigued/non-fatigued and MS-type).
RESULTS
-Patient characteristics
Patient characteristics of the total group and the different subgroups are displayed in 
Table 1. Mean age, EDSS, NRS and disease duration for the RR-group were 
significantly (p<0.01) lower as compared to the SP-subjects.
-Fatigue
In total, 71% of the patients reported to be seriously fatigued at least several times a 
week over the last 3-month period. Fifty-two percent of the patients had CIS-Fatigue 
scores of 40 points or more. Normative data out of a previous study showed that no 
healthy control had a score above 40 points [25]. The mean daily fatigue score was 4.5 
(std=3.1). The CIS-fatigue and daily fatigue measures were evenly distributed and 
correlated significantly with each other (0.70, p< 0.001). The SP and RR group did not 
differ in their Fatigue Frequency (SP=68% fatigued and RR=73% fatigued, +2=0.11, 
df=1, p=0.73). Although the mean CIS-Fatigue score was significantly higher for the 
SP-group (p=0.033), both groups did not differ (p=0.65) on their mean daily fatigue 
ratings (Table 1).
-MRI
All patients showed T2-weighted MRI abnormalities and 21 of the 26 RR-patients 
showed T1-weighted abnormalities in at least one of the cerebral areas. In the RR- 
group, only 3 patients showed enhancing lesions. The incidences of MRI abnormalities 
in the separate cerebral areas are depicted in figure 1. This graph clearly shows that 
lesions were unevenly distributed. Few patients displayed abnormalities in the 
brainstem en diencephalic areas. Lesion patterns for both hemispheres were quite 
similar and in concordance with other MRI studies, as most abnormalities were found 
periventricular and especially in the frontal and parietal regions. Except for the T2- and
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T1- weighted total lesion load measures, and the four atrophy indices, most of the other 
regional MRI measures were considerably skewed.
-Clinical disease activity, neurological progression rate and treatment variables 
The mean neurological progression rate (EDSS at time of assessment divided by 
disease duration) for the total group (RR+SP) was 0.63 (std=0.47). The mean 
neurological progression rate for the RR group did not significantly differ from the SP 
group (0.73 vs. 0.49; p=0.414). For the RR-group the number of exacerbation in the 2 
years prior to assessment ranged from 2 to 5 (mean 2.8). In total 84% of the patients 
received intravenous methylprednisolone treatment in the 2 years prior to assessment. 
The average total dose of methylprednisolone for the RR group was 18771 mg (range 
0-50000) and the average dose for the SP groups was 13155 mg (range 0-30000).
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Figure 1. Percentage o f  RR- and SP patients with T2-MRI abnormalities and percentage o f 
RR-patients with T1-MRI abnormalities in the different cerebral regions
Table 2. Pearson correlation coefficients between main variables
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T2-
MRI
Total
N=(45)
T1-
MRI
Total
(n=26)
Frontal
hom
index
Biparietal
Index
3rd ventricle 
index
Bicaudatus
Index
EDSS NRS
CIS 0.07 -0.27 0.11 0.10 0.05 0.18 0.26 -0.30*
fatigue
Daily -0.28 0.06 -0.26 -0.04 -0.02 -0.07 0.05 -0.05
fatigue
EDSS 0.31* 0.16 0.48# 0.37# 0.40# 0.52# 1.00
NRS -0.30* -0.13 -0.56# -0.42# -0.41# -0.63# -0.85#
*p<0.05, #p<.001
-Fatigue and M R!
No significant correlations occurred between T2- and T1-weighted total lesion load and 
fatigue measures. Similarly, in both patient groups (RR & SP) and in the total group, 
cerebral atrophy indices did not correlate with the CIS-Fatigue and daily fatigue scores 
(Table 2). Patients were classified as fatigued or non-fatigued according to their self­
reported fatigue frequency. Both, the fatigued and non-fatigued group did not differ on 
their average T2- or T1- weighted lesion load in any of the cerebral areas (Mann­
Whitney test). Since some areas displayed only few MRI abnormalities, statistical valid 
comparisons per area were not always possible. For that reason we collapsed certain 
areas, but again no significant group differences in the average T2- and T1-weighted 
lesion load of those regions were found (Figures 2 and 3).
-Fatigue and neurological disability
Both EDSS and NRS were normally distributed and no significant relation occurred 
between these two fatigue outcome measures and EDSS. Only a modest correlation 
was found between NRS and CIS-Fatigue (Table 2). Fatigued and non-fatigued (fatigue 
frequency) patients did not differ on their average EDSS or NRS.
-Fatigue compared to clinical disease activity, neurological progression rate and pre­
assessment treatment
Neurological progression rates were not significantly correlated with CIS-Fatigue 
(0.19, p=0.21) or Daily Fatigue (0.16, p=0.30) ratings. Similarly, in the RR-group no 
significant correlation was found between the number of exacerbations in the 2 years 
prior to assessment and CIS-Fatigue (-0.12, p=0.56) or Daily Fatigue (0.13, p=0.52) 
scores. In the RR and SP group the total dose of methylprednisolone had no significant 
correlations with CIS-Fatigue or daily fatigue. When we compared patients (SP and 
RR) who received treatment (n=38) in the 2 years prior to assessment with those who 
did not (n=7), no significant differences on the fatigue scores emerged (CIS-Fatigue: 
40.6 vs. 37.3; and daily fatigue 3.8 vs. 4.6).
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Figure 2. Comparison o f average T2-MRI lesion load between fatigued and non-fatigued SP 
and RR-patients
-MRI and neurological disability
All MRI-measures (T2-weighted total lesion load and atrophy indices), except for T1- 
weighted total lesion load, were significantly related to the EDSS and NRS scores 
(Table 2). Stepwise multiple regression analyses, using the atrophy indices and T2- 
weighted total lesion load as independent variables, revealed that the bicaudatus index 
was the main, and the frontal horn index the second best predictor for both EDSS and 
NRS. These two variables explained 30% (adj. R2 =0.30, F=10.65, df(2,42), p<0.001) 
of the variance of the EDSS score and 46% (adj. R2 =0.46, F=19.5, df(2,42), p<0.001) 
of the variance of the NRS score.
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Figure 3. Comparison o f average T1-MRI lesion load between fatigued and non-fatigued SP 
and RR-patients
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-Fatigue and M RI and neurological disability
Tentatively we entered EDSS, NRS, T2-weighted total lesion load and the atrophy 
indices as independent variables in a regression analyses. First the CIS-Fatigue score 
and subsequent the daily fatigue score served as dependent measure. While entering all 
independent variables none of these two equations reached significance. Subsequent 
stepwise analyses revealed that only the NRS showed a small though significant 
contribution to the regression equation with the CIS-Fatigue score as dependent 
variable (adj. R2= 0.07 , F=4.16, df(1,43), p=0.047) .
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DISCUSSION
Abnormal fatigue showed to be a frequent complaint in our group of patients with MS. 
This result is in agreement with other reported findings. Both the RR- group and the 
SP-group reported considerable fatigue. Equal proportions of both groups could be 
classified as fatigued and no significant differences were found between their mean 
Daily Fatigue scores. However, SP-patients had on average slightly higher CIS-Fatigue 
scores. We found that the level of experienced fatigue in patients with MS was not 
related to the total extent of cerebral abnormalities and also not to the extent of MRI- 
abnormalities in discrete cerebral areas. These results suggest that factors other than 
focal lesions or cerebral atrophy mediate levels of fatigue in multiple sclerosis.
Despite the relative stable clinical phase of our RR-patients at time of assessment, the 
majority of them reported to be seriously fatigued at least several times a week, and the 
group reported on average much higher levels of experienced fatigue as compared to 
healthy subjects. The limited number of patients who showed enhancing abnormalities 
on MRI confirmed the clinically stable phase of the RR-group. The fatigue scores of 
these three patients showed no consistent pattern with the total Gd-enhanced lesion 
load. In addition the number of exacerbations in the two years period prior to 
assessment was not related to the levels of fatigue. As such, we question if active 
inflammation is a major mechanism causing this type of fatigue.
No evidence was found that the extent of abnormalities in discrete cerebral areas 
differed between fatigued and non-fatigued patients. This is surprising since some 
functional systems, like the reticular activating system or the basomedial prefrontal 
cortex, are thought of to mediate motivation and arousal. A reported finding of 
brainstem abnormalities in MS patients being related to global fatigue could not be 
replicated in this study, although our patient population was nearly double in size (45 
vs. 25) and almost equal in their average EDSS (3.5 vs. 3.3) [29]. A recent 
electrophysiological study demonstrated that exercise-induced fatigue showed no 
relation with self-reported fatigue scores on Krupp’s Fatigue Severity Scale (FSS) [6]. 
Similar they found no association between EDSS and FSS scores, which is in 
agreement with our current results and previous reported data of our research group [8]. 
Kersten et al. (1996) also failed to demonstrate a relationship between physical muscle 
fatigue and perceived fatigue [9]. Since a recent large survey mentioned significant 
relations between some EDSS functional system scores and global fatigue, we 
additionally inspected the functional system scores [7]. There was indeed a trend 
towards a significant though small association between cerebellar functioning and one 
of the three fatigue measures (EDSS cerebellar and CIS-fatigue r=0.31 p=0.07).
Despite our semi-quantitative ratings, most of our MRI measures correlated 
significantly with measures of neurological disability, validating our procedure. 
Multiple regression analyses indicated that the atrophy measures proved to be the best 
predictors for clinical functioning. Self-report measures are perhaps no truly objective 
signs for muscle fatigue or mental fatigue (e.g. slowing mental speed). However, the 
experienced fatigue measured in this way, has shown to correlate and interfere
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significantly with self-reports of daily functioning [1,2,8]. We measure as such an 
important aspect of fatigue, which has for the patient a high impact on daily living.
In view of our findings the question remains unanswered which factors do contribute to 
the experience of fatigue. Since MRI cannot detect low-grade diffuse inflammations, 
endocrinological mechanisms in multiple sclerosis could account for fatigue. Treatment 
studies, using interferon, have shown that fatigue was a commonly reported side effect 
for some types of interferon-treatments, suggesting a possible role of cytokines 
mediating fatigue [30-32].
In contrast to the absence of significant correlations between our somatic parameters 
and fatigue experience in MS, moderate correlations between psychosocial factors and 
measures of this type of fatigue have been reported consistently. Especially self­
efficacy, 'the feeling you can influence or master your complaint or environment', has 
found to be an important explaining variable [8,10]. Similar to this study, these findings 
suggest, that the reported fatigue experience is not merely mediated by somatic or 
clinical aspects of the disease, but that psychosocial factors play an important role. In 
addition these researchers showed that self-reported limitations in daily living were 
accounted for by clinical disability, but also by the extent of experienced fatigue. 
Pharmacological intervention is primary aimed at reducing disease activity and delay of 
clinical deterioration. Since fatigue during a clinical stable phase in multiple sclerosis 
seems to be related minimally to clinical functioning, chronic feelings of fatigue most 
likely do not fully benefit from this approach. As such fatigue remains a limiting factor 
in daily functioning. Besides pharmacological treatment, psychological fatigue 
management can perhaps reduce limitations in daily functioning.
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CHAPTER X
HELPLESSNESS, NEUROLOGICAL DISABILITY, EXPERIENCED FATIGUE 
AND DEPRESSION IN PATIENTS WITH MULTIPLE SCLEROSIS0
ABSTRACT
The aim of this study was to test, in patients with multiple 
sclerosis, whether the concept of helplessness might improve the 
understanding of the relationship between disease severity 
(neurological impairment) and personality characteristics 
(emotional instability) on one hand, and depressive mood and 
fatigue severity on the other hand. Data pertain to 89 patients 
with a definite diagnosis of multiple sclerosis (Expanded 
Disability Status Scale [EDSS] ratings: 1-8). Helplessness, fatigue 
severity, depressive mood and motional instability were rated with 
validated questionnaires. Model testing revealed that more 
neurological impairment and more emotional instability were 
associated with more helplessness, while higher levels of 
helplessness were associated with more fatigue and depressive 
mood. The initially observed direct relationship between EDSS 
and fatigue disappeared. Emotional instability had also a direct 
significant relationship with depressive mood, and depressive 
mood had only a small relationship with fatigue severity. The 
results indicated that helplessness affected both depressive mood 
and fatigue severity and that fatigue was not merely a symptom of 
depressive mood. The correlation between neurological 
impairment and fatigue severity was largely explained by the 
mediating effect of helplessness. These findings suggest that 
multiple sclerosis patients troubled by disabling fatigue might 
benefit from a psychological intervention targeting unfavourable 
illness cognitions.
° S van der W erf, A Evers, P Jongen, G Bleijenberg 
The role of helplessness as mediator between neurological disability, emotional 
instability, experienced fatigue and depression in patients with multiple sclerosis.
Multiple Sclerosis, in press
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INTRODUCTION
Chronic severe fatigue is a frequent and disabling symptom that has received 
increasingly attention in multiple sclerosis related studies [1-8]. MS-related fatigue 
research has been focussed on determining whether experienced fatigue is a 
neurological-based symptom or can be seen as a psychosocial reaction to having a 
chronic disabling disease. In two of our previous studies (n=50 and n=45) the 
correlations between the Expanded Disability Status Scale (EDSS) ratings and fatigue 
severity were small (rho= 0.31 and rho=0.29), and we also failed to demonstrate a 
significant relation between cerebral magnetic resonance imaging (MRI) abnormalities 
and fatigue severity [1,3]. A large study with 207 patients with MS reported a strong 
relationship between depression scores and fatigue severity and a modest, though 
significant, relationship between EDSS and experienced fatigue (rho=0.33) [6]. In this 
study, the course of the disease was also associated to fatigue levels; a progressive 
course resulted in higher fatigue levels. However, an analysis of covariance showed 
that this difference was almost exclusively attributable to differences in disability. 
Another recent study reported fatigued patients to have significantly higher EDSS and 
Hamilton and Beck depression scale scores [8]. The correlation between EDSS and 
fatigue severity was significant (rho=0.43), but after controlling for depression, fatigue 
severity scores did not longer significantly correlate with the EDSS rating. The authors 
concluded that fatigue in MS was independent of physical disability but was associated 
with depression. They suggested that common mechanisms might play a role in MS- 
associated fatigue and depression and that these mechanisms could include 
psychological factors and/or brain lesions in specific neuroanatomical pathways.
Similar to MS-associated fatigue, depression in MS has received considerable 
attention. Patients with a chronic disease have a heightened risk for depressive 
symptoms and several studies found that depressive disturbances are more common in 
MS than in the general population [9,10]. The prevalence of significant depressive 
symptoms in these studies ranges from 14% to 54%. Comparable with MS-associated 
fatigue research, no single neurological or biological causal factor for depression in MS 
has emerged.
The development of depression and fatigue complaints not only depends on disease 
characteristics, but is also influenced by predisposing psychological factors. Emotional 
instability, for example, is known to facilitate the development of depressive disorder 
and physical complaints [11]. Similarly, illness cognitions, which reflect the way 
patients perceive and think about their disease, are considered to be important 
mediators between disease and the patient’s well-being [12,13]. Depressive patients are 
characterised by maladaptive illness cognitions, which are often targeted in 
psychological interventions. One particular illness cognition that has been repeatedly 
found to be unfavourable to chronic disease is helplessness [14]. In cases of high levels 
of helplessness, patients emphasise the negative aspects of their chronic condition as an 
uncontrollable, unpredictable and unchangeable consequence of their disease, and 
generalise these negative aspects to functioning in daily life.
Empirical evidence has indicated that helplessness is a risk factor for an unfavourable 
physical and psychological health status for patients with various chronic diseases
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including multiple sclerosis. For example, helplessness predicted depression in patients 
with multiple sclerosis and a comparative study, testing models of fatigue in multiple 
sclerosis and patients with chronic fatigue syndrome, showed that the lack of perceived 
control over symptoms, a construct closely related to helplessness, predicted 
persistence of fatigue in both samples [15,16]. Therefore, the objective of this study was 
to test whether the concept of helplessness may be the common mechanism that 
mediates the relationship between the clinical neurological signs, predisposing 
vulnerability, like emotional instability, and the experience of fatigue and depressive 
mood.
Structural equation modelling is a statistical technique that allows testing whether 
clinical data fit a theoretically model of relationships. The causal directions of the 
relationships are hypothesised by the investigator and can be based on both theoretical 
considerations and empirical findings already available. This technique makes it not 
only possible to test different relationships simultaneously but also to compare the data 
fit of two or more proposed models. Based on the previously described research 
findings, it is hypothesised that a simple theoretical medical model, supposing direct 
causal relations between psychological vulnerability and neurological impairment on 
one hand and fatigue and depression on the other, would benefit from adding 
helplessness as mediating variable.
METHOD
-Subjects
This study involved a consecutive survey among patients visiting our outpatient clinic 
and who had a definite diagnosis of MS according to the revised Poser criteria [17]. 
Eighty-nine MS patients (63 females and 26 males) received a neurological evaluation 
(clinician-rated EDSS) at time of assessment. The average EDSS score of these patients 
was 4.4 (range: 0-8). Fifty-two of these patients had a relapsing-remitting course and 
37 patients had a primary or secondary progressive course of the disease. The mean age 
of this sample was 41.9 years (range: 25-69) and the mean time between assessment 
and initial diagnosis (illness duration) was 10.1 years (range: 1-29).
Based on medical background information and his clinical observation, the clinician 
estimated cognitive dysfunction on a 4-point scale ( 0=absent, 1=mild, 2=moderate, 
3=severe). This was done to check whether the patients were cognitively able to fill out 
the questionnaires. None of the patients were judged to have severe cognitive 
impairment while in 83 (95%) patients cognitive dysfunction was estimated as either 
absent or mild.
-Helplessness
Helplessness cognitions were measured with the subscale Helplessness of a recently 
developed Illness Cognition Questionnaire. This scale showed adequate internal 
consistency in different samples (Cronbach’s alpha ranging from 0.84-0.91) [18,19]. 
The helplessness items reflect a general attitude towards having a chronic disease and, 
as such, do not refer to a specific time period. Respondents had to indicate on a 4-point
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scale the extent (1=not at all, 2=somewhat, 3=to a large extent, 4=completely) to which 
they agreed with the following six items:
1. My illness frequently makes me feel helpless.
2. My illness limits me in everything that is important to me.
3. My illness controls my life.
4. Because of my illness I miss the things I like to do most.
5. My illness prevents me from doing what I would really like.
6. My illness makes me feel useless at times.
-Fatigue severity
Fatigue severity was assessed with the subscale Subjective Fatigue of the Checklist 
Individual Strength (CIS-fatigue) [20,21]. The eight items of this scale pertained to the 
experienced fatigue in the previous two weeks. The subject had to indicate on a 7-point 
scale (1=yes, that is true -  7=no, that is not true) whether the statement was appropriate 
for their situation. The total fatigue severity score could range from no fatigue (8) to 
severely fatigued (56). CIS-fatigue scores above 39 are considered indicative of severe 
fatigue.
-Depressive mood
The subscale Depressed Mood of the IRGL (Impact of Rheumatic Diseases on General 
Health and Lifestyle) assesses various depressed mood states over the previous two 
weeks. The IRGL is derived from the Arthritis Impact Measurement Scale (AIMS), 
which was originally developed to assess various aspects of psychological, physical 
and social health. The AIMS has shown to be reliable and valid for use in MS patients, 
while the reliability of the IRGL scales were highly satisfactory in RA patients [20,23].
-Emotional Instability
Emotional instability was rated with the subscale Neuroticism of a Dutch version of the 
Eysenck Personality Questionnaire [24,25].
-Neurological impairment
An experienced neurologist rated the Expanded Disability Status Score (EDSS). The 
seven (pyramidal, cerebellar, sensory, bowel & bladder, brainstem, mental and visual) 
functional system scores (FSS) were available for 66 patients [26].
-Procedure
The models were tested only on patients (n=87) with complete data on all 
questionnaires. The first model was based on previous methods that had been used in 
studies assessing the relations between neurological impairment, depression and 
fatigue. In this model emotional stability and neurological impairment were thought to 
affect both independently depressive mood and fatigue severity. Since fatigue could be 
considered a symptom of depression, depressive mood was hypothes ised to affect 
fatigue severity in this model. The results of testing this model (Figure 1) were 
subsequently used to develop an extended model in which helplessness had a place. 
According to theories concerning the role of illness cognitions and the empirical
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findings described in the introduction, illness cognitions were thought to have a 
mediating effect between neurological impairment and emotional instability on one 
hand and mood and fatigue complaints on the other. In addition, the seven functional 
system scores were individually correlated with fatigue severity. In a final explorative 
model testing, those individual functional system scores that showed significant 
correlations with fatigue severity substituted the EDSS score.
-Statistics
The models were tested with help of structural equation modelling techniques and the 
computer program AMOS 4.0 was used to test and modify models [27]. We tested a 
measurement model with directly observed variables in which the error terms 
associated with the observed variables were left free to be estimated and also were 
assumed to be uncorrelated with each other. The c 2 statistic and the Adjusted Goodness 
of Fit Index were used to test data fit. According to guidelines for structural modelling, 
the data were considered to fit the model when c 2 statistic was not significant and the 
Adjusted Goodness of Fit Index was high (preferably above 0.90). Furthermore, the 
population error of approximation (Root Mean Square Error of Approximation) was 
taken into account as measure of discrepancy per degree of freedom. Values up to 0.05 
indicate a close fit and value up to 0.08 represent reasonable errors of approximation in 
the population. Preferably the ninety percent confidence interval (90%CI) of the 
RMSEA index would be between 0.00 and 0.10 [28,29].
RESULTS
Tables 1 and 2 display the average scores on the different measurement variables and 
the correlations between the model variables.
Table 1. Mean and standard deviations of the measurement variables
Measurement variables Mean (SD)
Helplessness 14.4 (4.6)
CIS-fatigue 37.3 (12.2)
Depressive mood 5.G (5.1)
Emotional instability 36.1 (1S.6)
EDSS [range] 4.4 (1.S) [1 to S]
FSS* Pyramidal 2.S (1.1)
FSS Cerebellar 1.5 (1.2)
FSS Sensory 2.6 (G.9)
FSS bladder and bowel 1.1 (1.G)
FSS mental G.S (G.9)
FSS visual G.9 (1.5)
FSS brainstem 1.4 (G.9)
* FSS=Functional system score
106 Chapter X
Table 2. Correlations between the model variables and between functional system scores
Helplessness Fatigue severity Depressive
mood
Emotional
instability
EDSS
Fatigue severity 0.49#
Depressive mood 0.57# 0.38#
Emotional instability 0.48# 0.30* 0.65#
EDSS§ 0.54# 0.35# 0.20 -0.01
FSS Pyramidal^ 0.55# 0.37** 0.16 -0.01 0.92#
FSS Cerebellar 0.34# 0.12 0.12 -0.08 0.65#
FSS Sensory 0.47# 0.36# 0.21 0.09 0.70#
FSS Bowel&bladder 0.31* 0.03 0.12 0.10 0.51#
FSS Brainstem 0.25* 0.26* 0.24* 0.13 0.55#
FSS Mental 0.30* 0.14 0.19 0.16 0.28*
FSS Visual 0.36# 0.15 0.14 0.05 0.41#
*p<0.05, #p<0.01; §correlations between model variables are based on 87 observations; c^orrelations with 
FSS=Functional System Scores are based on 67 observations
-Testing model 1
Figure 1 depicts the first model tested and the beta coefficients of the different paths 
involved. Emotional stability had only a direct significant relation with depressive 
mood, indicating that more emotional instability was associated with higher depressive 
mood ratings. Neurological impairment showed only a direct significant relation with 
fatigue severity. Higher EDSS scores being associated with higher fatigue severity 
ratings. The path coefficient between depressive mood and fatigue severity showed a 
trend (p=0.06) towards a significant relationship. Altogether, the fit measures indicated 
that the data did not fit this model very well (Table 3).
Figure 1. Model I  with emotional stability and neurological impairment affecting fatigue
severity and depressive mood, error terms have been omitted in the figure.*p<0.05, 
#p<0.001
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-Testing model 2
It was tested whether model fit could be improved by adding helplessness as mediator 
variable. Emotional stability was thought to affect both helplessness and depressive 
mood, while neurological impairment was thought to affect both helplessness and 
fatigue severity. In addition, helplessness was thought to affect both depressive mood 
and fatigue severity. The relation between depressive mood and fatigue severity was 
retained since there was a trend towards a significant relationship. When tested, all the 
fit indices indicated excellent model fit (table 3). As such, there was a significant 
improvement in model fit compared to the first model tested. The beta coefficients 
showed that both higher emotional stability scores and more neurological impairment 
were significantly related to more helplessness, while more helplessness led to higher 
fatigue severity and depressive mood scores. Emotional instability still had a direct 
significant positive relation with depressive mood, but its effect was markedly reduced. 
In addition the direct relation between neurological impairment and fatigue severity 
failed to reach significance. Similarly, in this model depressive mood had no 
significant relation with fatigue severity.
Figure 2. Adjusted model with helplessness as mediator, error term have been omitted in the 
figure *p<0.05, #p<0.001
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-Replacing EDSS in the second model by the individual functional system scores that 
were significantly correlated to fatigue severity
Table 2 shows that only pyramidal function, sensory function and brainstem function 
had a significant correlation with fatigue severity, while all seven functional system 
scores were significantly correlated with helplessness. In none of the three tested 
models, with either pyramidal, brainstem, or sensory function replacing EDSS, had the 
direct relationship between functional system score and fatigue severity reached 
significance.
Table 3. Fit indices o f  both models that have been tested
c 2 AGFI* RMSEA, lower and upper 
bound#
P test for close fit
Model 1 6.2, df=1, p=0.01 0.56 0.28, 0.10 - 0.51 0.02
Model 2 0.5, df=3, p=0.91 0.98 0.00, 0.00 - 0.08 0.93
*AGFI= Adjusted Goodness o f Fit Index, # Root Mean Square Error Approximation and its 95% 
confidence interval.
DISCUSSION
The aim of this study was to test whether in a sample of patients with MS the 
occurrence of depressive mood and disabling fatigue could partly be explained by one 
common psychosocial mechanism. Helplessness is known to predict depression and 
fatigue in chronic diseases and therefore was thought to mediate between a chronic 
biological stressor and the individual’s psychological vulnerability, and in turn 
affecting both experienced fatigue and depressive mood. Instead of testing relationships 
between neurological and psychological factors individually, as most of the previous 
studies did, the hypothesised relations were tested simultaneously in one model.
The first model indeed showed that depressive mood was related to emotional 
instability and fatigue to neurological impairment. Although neurological disability and 
experienced fatigue were significantly correlated, the mediating effect of helplessness 
explained this relation. Although three FSS had a significant correlation with fatigue 
severity, model testing suggested that these relationships were also mediated through 
helplessness. In fact, post hoc model testing with all the individual FSS substituting 
EDSS revealed that, when controlling for helplessness, in none of the seven tested 
models were found significant direct effects between the FSS rating and experienced 
fatigue. Especially, pyramidal, cerebellar and sensory symptoms affected helplessness 
directly and fatigue indirectly. The relationship between helplessness and bladder and 
bowel functioning also approached significance. In contrast, mental and brainstem
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functioning were hardly related to helplessness, and it seems therefore, that the directly 
observable symptoms of MS particularly affect feelings of helplessness and indirectly 
contribute to feelings of depression and fatigue. One could perhaps interpret fatigue as 
the physically felt impact of disease burden and depression as the emotional cognitive 
component.
The results suggested that helplessness was indeed related to fatigue and depressive 
mood, and that fatigue could not be seen as merely a direct consequence of depression. 
Therefore, the results agreed with the hypothesis of Kroencke et al [6], that both the 
experience of fatigue and the experience of depression are mediated by similar 
psychological factors. However, this does not mean that fatigue and depression are 
interchangeable concepts in MS, since emotional stability did relate to depressive 
symptoms while levels of fatigue were correlated with the EDSS.
We have argued in a previous study that the non-significant relationship between EDSS 
and CIS-fatigue score that was found might be due to the sample of relatively mild 
neurological impaired multiple sclerosis patients (mean EDSS: 3.5) [3]. However, the 
data of the current study were based on sample of multiple sclerosis patients with more 
severe neurological disability, making a bias towards a relatively mild sample less 
likely. Consequently, the disease process cannot purely explain MS-associated fatigue. 
The fact that the patient can hardly influence neurological impairment in MS might 
increase the risk of the development of more helplessness. This helplessness pertains 
not only to low self-efficacy concerning neurological symptoms, but also to the wider 
psychosocial consequences of the disease, and even to the patient’s self-image.
One should of course be cautious by interpreting the hypothesised causal directions of 
the model, since it is based on cross-sectional data. However, the first simple model 
resembled a common straightforward method that has been used in many studies, 
assessing the relations between disease factors and complaints. Although, the data 
fitted the model with helplessness much better, this does not mean that this model is the 
true or only one that can explain the relationships between neurological impairment, 
fatigue and depression in multiple sclerosis.
Nonetheless, the results do agree with our hypothesis that both MS as a chronic 
biological stressor and emotional instability as a psychological vulnerability might lead 
to more feelings of helplessness which in turn affect the MS-associated complaints, 
such as depression and fatigue. This interpretation of the findings could indicate that 
MS patients who suffer from depressive symptoms or fatigue might benefit from a 
psychological intervention targeting an unfavourable illness cognition like 
helplessness.
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CHAPTER XI
THE EXPERIENCE OF SEVERE FATIGUE LONG AFTER STROKE °
ABSTRACT
Although the experience of abnormal fatigue is recognised as a 
major disabling symptom in many chronic neurological diseases, 
little is known about the persistence of severe fatigue after an 
abrupt neurological incident like a stroke. Therefore, the 
objectives of this study were to test whether the experience of 
severe fatigue persists long after a stroke has occurred, and to 
assess the relation between experienced fatigue and levels of 
physical impairment and depression. Ninety stroke outpatients 
and 50 controls returned mailed questionnaires. Compared to age- 
matched controls, a significantly larger proportion (16% vs. 51%) 
of the stroke respondents experienced severe fatigue, while 20% 
of the patients and 16% of the controls had elevated depression 
symptom scores. The amount of time that has past since the stroke 
occurred could not explain levels of fatigue. In the control group, 
the number of depressive symptoms explained most of the 
variance in levels of fatigue, while impairment in locomotion 
explained most of the variance in the stroke group.
° S van der W erf , H van den Broek, H Anten, G Bleijenberg 
The experience of severe fatigue long after stroke and its relation with depressive
symptoms and disease characteristics 
European Neurology 2001;45:6-12
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INTRODUCTION
In clinical practice, fatigue complaints that develop directly after a stroke are often seen 
as temporary and as a direct result of the functional impairment, psychological distress 
and recovery process. Patients who suffer a stroke are confronted with an acute 
unforeseen change in physical and psychosocial functioning. As such, they have to 
cope with a sudden severe health threat, loss of functional ability and often difficult or 
demanding rehabilitation process.
Most studies assessing the direct and long-term psychosocial consequences of a stroke 
have focused on the prevalence of depression and the possible underlying 
pathophysiological mechanisms [1-4]. Although a lack of energy and high levels of 
experienced fatigue are frequent symptoms of a depressive disorder, previous studies of 
our research group in patients with multiple sclerosis (MS) did show that the 
expression of severe fatigue is not necessarily merely an expression of depression. 
More than half of the MS patients studied reported extreme fatigue on a rating scale, 
while a significantly smaller proportion of patients displayed moderate to severe 
depressive symptoms on the Beck Depression Inventory (BDI) [5,6].
A recent study focussing upon prevalence and severity of post-stroke fatigue problems 
also reported that a large proportion of these patients had fatigue problems [7]. Similar 
to MS patients, the presence of fatigue was independent of depression. In this study, 
patients were approached who had suffered a stroke between 3 to 13 months prior to 
assessment. Many stroke patients show clinical improvement during the first year of 
rehabilitation and one can question whether fatigue problems persist beyond this 1-year 
time period. Therefore, the first objective of this study was to assess whether 
experienced severe fatigue was still a frequent complaint in a group of non­
institutionalised outpatients who suffered a stroke at least 1 year before the beginning 
of this study. The findings were compared to data of an age-matched control group. In 
both the stroke and the control group, it was assessed what the influence of depressive 
symptoms and physical impairment was upon experienced fatigue.
METHODS
-Subjects
Questionnaires were mailed to 138 outpatients who had a clinical diagnosis of a stroke 
at least 1 year prior to the beginning of the study. These patients were registered in a 
stroke database of the regional Maasland Hospital Sittard in the Netherlands. All 
patients had to have been discharged out of hospital or a rehabilitation clinic and to live 
semi-independently at home. The patients were asked to find an age-matched 
individual who had not a stroke to fill out the same questionnaires as a control.
-General information
The patients received a questionnaire package and an introduction letter in which the 
goal of the study was explained. The patients or control subjects who suffered from 
reading and writing problems were informed that they could ask help from a relative or
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caretaker to fill out the questionnaires. The first part of the questionnaire package 
contained one page with general demographic, health and fatigue questions. We 
checked whether patients had filled out the questionnaires by themselves or had needed 
help. In the introduction letter, patients and controls were urged to fill out these general 
questions and return them, even if they did not want to participate in this study.
Table 1. Items Fatigue subscale Checklist Individual Strength
1. I feel tired Yes, that is true
No, that is 
not true
2. Physically I feel exhausted Yes, that
is true
No, that is 
not true
3. I feel fit Yes, that is true
No, that is 
not true
4. I feel weak Yes, that 
is true
No, that is 
not true
5. I feel rested Yes, that 
is true
No, that is 
not true
6. Physically I feel I am 
in a bad condition
Yes, that 
is true
No, that is 
not true
7. I am tired very quickly Yes, that 
is true
No, that is 
not true
8. Physically I feel in a Yes, that
good shape is true
No, that is 
not true
-Experienced Fatigue
Patients were asked whether fatigue was their main complaint (yes/no). Besides this 
general fatigue question, the Checklist Individual Strength (CIS) was used to quantify 
fatigue severity. This inventory was developed by the Nijmegen Fatigue Research 
Group and has been used in numerous fatigue studies [5,6,8]. The fatigue subscale 
(table 1) indicates the levels of experienced fatigue over the past 2-week period and 
consists of 8 items that have to be answered on a 7-point scale. The score can range 
from 8 (no fatigue) to 56 (severe fatigue). Previous normative studies showed that a 
score equal or above 40 indicated severe abnormal fatigue. This cut-off also has been 
used to identify patient with chronic fatigue syndrome [5,6].
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-Depressive symptoms
Previous studies in patients who had suffered a stroke or had MS have shown that the 
assessment of depressive symptoms could be biased by neurological symptoms [9-11]. 
For that reason, the relation between experienced fatigue and depressive symptoms was 
studied with the recently proposed Beck Depression Inventory for Primary Care (BDI- 
PC). The BDI-PC excludes somatic and performance items of the original BDI and the 
authors proposed a cut-off score of 4 points for maximum clinical efficiency with both 
82% sensitivity and specificity rates [10].
-Functional disability
Seven subscales of the Sickness Impact Scale (SIP) were used to assess functional 
disability in the following areas: home management, mobility, alertness behaviour, 
sleep/rest, ambulation, social interactions and recreation and pastimes [12]. These seven 
subscale-scores were added together to provide one total score of general disability 
(SIP7-total). Previous findings of our research group indicated that the SIP-ambulation 
scale, as a self-reporting measure, most closely related to the Expanded Disability 
Status Score of patients with MS. Furthermore, the SIP-ambulation score was 
significantly correlated to physical activity on a movement-sensing device [13]. Since 
the current study did not contain an objective measure of clinical neurological 
functioning, the SIP-ambulation score was designated as the SIP score most validly 
reflecting physical impairment. Patients and controls were divided into non-impaired 
(SIP-ambulation= 0) and physically impaired (SIP-ambulation >0) subjects.
Experienced neuropsychological problems
The SIP-alertness behaviour score was used as a measure for experienced 
neuropsychological problems. A SIP alertness behaviour score of 0 indicated that 
patients did not endorse any of the neuropsychological items.
-Disease parameters
Clinical diagnostic CT-scans of 101 stroke patients were available. In the case of 
clearly interpretable CT-scans, the following information was registered: 1) the lesion 
location (left, right, double sided); 2) the depth of the lesion (surface, deep, deep & 
surface); 3) type of lesion (infarction or haemorrhage).
Statistics
+2 tests were used to test for proportional differences in dichotomous variables. t-tests 
and analyses of variance were used to make comparisons between groups of continuous 
data. In both samples, stepwise regression analyses were used to test the strength of 
association between fatigue as outcome measure and physical impairment and 
psychological distress as independent measures. Two-tailed tests of probability were 
chosen, along with a minimum significance level of 0.05.
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RESULTS
-Response
In total, 138 patients were approached. A total of 90 (65%) patients and 50 (37%) 
controls filled out part of, or completed the questionnaires. In 74 of the 90 clinical 
stroke respondents, a CT scan was made. In 64 (71%) stroke respondents, the clinical 
diagnosis was supported by CT data. Table 2 shows the demographics of respondents 
and controls. There was no difference in average age, but the control group had 
proportionally more females.
Table 2. Demographics o f  stroke respondents and controls
Respondents (n=90) Controls (n=50) Statistics
Male/female 65/25 23/27
% males 72% 46% C2=8.4, p<0.01
Age 62.1 59.1 =1 9 p II © 0 Os
(range) (32-73) (30-72)
In table 3, stroke responders and stroke non-responders were compared with respect to 
demographics and neurological data. Both groups were comparable concerning lesion 
location, gender, and age. The non-responder group more recently had suffered a 
stroke. Twenty-four percent of the stroke responders and 6% of the controls (+2=6.1, 
p<0.01) indicated that they needed help to fill out the questionnaires. In total, 70% of 
the patients and 46% of the controls (+2=6.6, p<0.01) reported one or more health 
problems. In the control group, the health problems most frequently reported were high 
blood pressure, diabetes, arthritis and cardiac problems.
-Experienced Fatigue
Table 4 shows that 50% of the 90 patients and 16% of the 50 controls indicated that 
experienced fatigue was their main complaint. Compared to controls, significantly 
more patients (51% vs. 12%) had elevated CIS-fatigue scores.
-Depression
In total, 20% of the patients and 15% of the controls had elevated (>=4) BDI-PC 
scores; this difference was not significant (table 4).
-Functional disability
Table 4 shows that, compared to the age-matched controls, a significantly larger 
proportion of patients reported some degree of impairment in walking (SIP- 
ambulation>0).
Table 3. Lesion characteristics o f  stroke respondents and stroke non-respondents
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Non-respondents
(n=48)
Respondents
(n=90)
Significance testing
Male/female (% males) 32/16 (67%) 65/25 (72%) -= 6 .6 , p<0.01
Age in years (range) 61.3 (14-73) 62.1 (32-73) t=0.89, p=0.38
Mean years since last stroke (SD) 2.3 (0.6) 3.8(2.9) t=3.3, p<0.01
No. o f patients with a bleeding 0 (0%) 4 (4%)
No. o f patients with an infarction 27 (56%) 60 (67%)
No. bleeding or infarction not clear 6 (13%) 10 (11%) - 2=5.25, p=0.15
No. without CT-info 15 (31%) 16 (18%)
No. o f patients with left lesion 12 (43%) 28 (44%)
No. right lesion 11 (39%) 24 (37%) - 2=0.03, p=0.99
No. double-sided lesion 5 (18%) 12 (19%)
No. o f patients with superficial lesion 8 (30%) 16 (29%)
No. with deep lesion 12 (55%) 30 (56%) - 2=0.49, p=0.78
No. with deep & superficial lesion 5 (15%) 8 (15%)
No. o f patients with a single stroke 27 (82%) 64 (81%)
No. who had two strokes 6 (18%) 14 (18%) - 2=0.42, p=0.81
No. with more than two strokes 0 (0%) 1 (1%)
-Neuropsychological complaints
Table 4 shows that, compared to the age matched controls, a significantly larger 
proportion of patients reported some degree of impairment in neuropsychological 
functioning (SIP-alertness behaviour>0).
-Age, gender and post-stroke time compared to fatigue, depression, neuropsychological 
complaints and functional disability
Based on the median age score in the control group, subjects were divided into a 
younger (<60 years) and older (>=60 years) age group. Group membership 
(controls/stroke patients), gender (male/female) and age group served as between- 
subject factors in five separate univariate (2x2x2) analyses of variance. CIS-fatigue, 
BDI-PC, SIP-ambulation, SIP-alertness behaviour and SIP7-total were the five 
dependent measures. Stroke respondents scored higher on CIS-fatigue (F(1,108)=30.7, 
p<0.01); SIP-ambulation (F(1,109)=21.8, p<0.01), SIP-alertness behaviour (F(1,109)= 
10.9, p<0.01); and SIP7-total F(1,109)=18.0, p<0.01. There was no main group effect 
for BDI-PC (F(1,102)=1.5, p=0.22). Besides the main effects for group-membership, 
there were no interaction or main effects in all of the five analyses. Table 4 depicts the 
average scores for these outcome variables according to group membership. The 
median time that had passed since the stroke occurred was 2 years. The amount of time 
elapsed since the stroke occurred was not significantly correlated to CIS-fatigue 
(r=0.06, ns), BDI-PC (rho=0.11, ns), SIP-ambulation (rho=0.18, ns), SIP-alertness 
behaviour (rho= -0.08, ns) or SIP7-total (rho=0.11, ns) scores.
Table 4. Comparisons between outcome measures o f the stroke respondents and the controls
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Stroke respondents Controls Significance testing
% o f subjects with health problems 70% 46% - 2=6.6, p<0.01
% o f subjects who reported fatigue to 
be their main complaints
50% 16% - 2=15.6, p<0.01
Mean CIS-fatigue (SD) 
% CIS-fatigue >=40
35.4 (14.6) 
51%
21.2(13.1)
12%
p<0.01* 
- 2=15.8, p<0.01
Mean BDI-PC (SD) 
% BDI-PC>=4
2.1 (3.1) 
20%
1.2 (2.2) 
15%
p= 0.22* 
- 2=0.63, p=0.35
Mean SIP7-total (SD) 998 (888) 333 (554) p<0.01*
Mean SIP-ambulation (SD) 
% SIP-ambulation>0
125 (148) 
61%
26 (73) 
20%
p<0.01*
- 2=19.0, p<0.01
Mean SIP-alertness behaviour (SD) 
% SIP-alertness behaviour>0
190 (223) 
66%
43 (98) 
26%
p<0.01*
- 2=16.4, p<0.01
* significance levels of main effect (group membership) of the analyses of variance
-Relationships between fatigue, total disability, depression and neuropsychological and 
physical impairment in the stroke and age-matched control samples 
In both samples, the total perceived disability score (SIP7-total) was significantly and 
highly correlated with the CIS-fatigue score (Patients: r=0.65, p<0.001 and Controls: 
r=0.78, p<0.001). Stepwise regression analyses were carried out with CIS-fatigue as 
dependent measure and BDI-PC, SIP-ambulation, SIP-alertness behaviour as 
independent variables. In the stroke group the SIP-ambulation score explained 34% of 
the variance in CIS-fatigue, while the BDI-PC score added another 11%, and the SIP- 
alertness behaviour another 3% (total adj. R2 =0.48). In the control group, the BDI-PC 
score explained most of the variance (56%) in CIS-fatigue, while the SIP-ambulation 
and SIP-alertness behaviour scores explained an additional 14 and 4%, respectively 
(total adj. R2 =0.74).
DISCUSSION
The findings of this study showed that the experience of severe fatigue remains a 
frequent and persistent symptom long after the stroke had occurred. Half of our patients 
rated fatigue as their main complaint. Although the expression of extreme fatigue is 
often interpreted as a sign of depression, only 38% of the extremely fatigued stroke 
patients in this study had elevated depression scores. When the results are compared 
with the study of Ingles et al [7], it seems that fatigue problems arise shortly after 
stroke, and can independent of depression persist for a long period of time. In fact, in
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the current study fatigue, physical impairment, neuropsychological impairment and 
depressive symptom scores were not related to the amount of time that passed since the 
stroke occurred. One can hypothesise that at time of assessment, most patients of our 
sample reached their maximum physical capability already and subsequently have 
adapted their life-style to their disability.
The proportion of patients with elevated BDI-PC scores (20%) contrasts with findings 
of large population-based study of first-stroke patients and their caregivers [4]. In this 
study depressive symptom severity was assessed with the BDI at 3 and 12 months post­
stroke. A comparison was made between districts with and without intervention 
programs subsequent to discharge from hospital. At three months, 41% percent of the 
stroke patients in the districts with active programs were depressed and 54% of the 
patients in the control districts were depressed. At twelve months, the proportions of 
depressed patients stayed virtually the same (42% versus 55%). However, that study 
used a BDI cut-off of 10 points in order to label patients and caregivers as depressive. 
The use of this cut-off value is rather liberal, especially when is taken into account that 
no corrections were made for items that easily can be biased by disease specific 
somatic symptoms. By using a similar cut-off of 10 points in our sample, 39% of our 
patients and 15% of the controls would be classified as depressed. The proportion of 
'depressed' patients in our sample approached that of the Finnstroke study. Studies that 
reported results in line with our findings seemed to use also more strict criteria to rate 
elevated depressive symptoms. MacHale et al. [1] reported that 26% of a group of 
stroke patients who suffered a stroke at least six months prior to assessment, did meet 
the DSM-IV criteria of an anxiety or depressive disorder, with depression being the 
most common (20%) diagnosis.
In contrast to the fatigue study of Ingles et al. [7], no significance difference between 
the proportions of controls and stroke patients with elevated depressive symptoms was 
found in this study. Although different measurement methods were used, the selection 
of controls and patients were comparable. The fact that in our study a smaller 
proportion of stroke patients had elevated depression scores could indicate that 
depressive symptoms decrease within the first year following stroke, although the 
comparison with the Finnstroke study makes such a decrease unlikely. The data should 
be interpreted with some caution, however. The assessment through mail 
questionnaires may have biased the sample towards patients with milder impairments 
and less severe depression. Some patients may have had anosognosia and subsequently 
may have minimised their deficits, whereas other anosognosic patients may have 
avoided this problem through adequate informants. It is likely that some of these 
informants were close relatives instead of neutral observers, which could have 
influenced their responses. The fact that the nonstroke comparator group was identified 
by asking the patients to nominate suitable people, and the fact that the majority of 
controls were females, suggests that the majority of the controls are partners of the 
stroke patients. This could introduce a bias toward controls that have had to take care 
for another handicapped person. Therefore, it is possible that the fatigue and depression 
rates could be inflated in this control group and as such, the problem of fatigue in 
stroke victims and the difference with age-matched controls could even be greater. It 
can be argued that experienced fatigue as measured by self-reporting is perhaps not a
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truly objective indication for muscle fatigue or mental fatigue, and possibly reflects 
merely the extra effort needed to compensate for disability. The measure of 
experienced fatigue, however, has shown to correlate and interfere significantly with 
self-reporting of disability. As such, experienced fatigue is an important aspect of 
fatigue that has a great impact on daily functioning of the patient. Nevertheless, 
additional research is needed to assess the precise relation between experienced, 
peripheral (muscular) and central fatigue. The lesion location data in the current study 
pertained to a relatively small selection of the total sample studied and could have 
introduced response bias by the potential exclusion of aphasic patients. Therefore, no 
comparisons were made between responders with single left and right-sided lesions. 
Regression analyses indicated that in the patient and control sample, depression, as 
well as physical impairment and neuropsychological complaints, was related to levels 
of experienced fatigue. Controls without physical impairment did not report extreme 
fatigue and hardly ever had elevated depression scores. One could therefore 
hypothesise that in the control group, the health problems that result in physical 
impairment lead to reactive depression and subsequent fatigue. It is possible that in part 
of our patient sample, similar causal mechanisms played a role. Nevertheless, the 
occurrence of extreme fatigue in non-depressed, physically non-impaired and 
neuropsychological problem-free stroke patients indicated that other factors or 
processes also mediated fatigue. Besides walking and neuropsychological difficulties 
(SIP-ambulation and alertness behaviour), other stroke-related impairment such as 
pareses of the upper extremities or speech impairment could have limited social 
interaction and subsequently produced depression. The fact that stroke patients may 
have to compensate for these other types of physical or cognitive impairment could 
also have resulted in severe fatigue. Furthermore, the exact relationship between 
neuropsychological sequellae and experienced fatigue remains unclear, since the 
quantification of neuropsychological problems was based on self-reporting rather than 
formal neuropsychological test scores.
A recent prospective study [14] showed that in a group of 116 stroke victims, about two 
thirds of the stroke patients suffered sleep-related breathing disorders in the acute 
phase. Three months later, during the stable phase 62% of the patients had still signs 
breathing disorder as measured by the apnoea-hypopnoea index. The incidence of 
Cheyne-Stokes breathing dropped from 62% in the acute phase to 8% at follow-up. The 
authors concluded that certain sleep-related breathing problems could be a risk factor 
for stroke, while other sleep related-breathing disorders could possibly be seen as a 
consequence of stroke. Another study [15] found a similar high incidence of sleep 
apnoea syndrome in elderly individuals with a stroke history. The findings of these 
studies warrant further exploration, both prior to and after stroke, of a possible relation 
between experienced daytime fatigue, daytime physical activity levels and sleep-related 
breathing problems. Future assessment could benefit from a longitudinal approach that 
includes behavioural measures for physical and cognitive functioning. Better 
understanding of which factors influence the course of fatigue after a stroke could be 
helpful in deciding which combination of behavioural, psychological or medical 
treatment strategies is most adequate to handle severe fatigue in individual stroke 
patients.
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CHAPTER XII
FATIGUE IN NEUROMUSCULAR DISEASES: A COMPARISON 
WITH MULTIPLE SCLEROSIS0
ABSTRACT
Little is known about the experience of fatigue among patients 
with neuromuscular diseases. Therefore, both the prevalence of 
severe fatigue and its relation with psychological distress and 
physical disability were assessed in a group of neuromuscular 
patients and compared to findings in multiple sclerosis, a 
neurological disease known to be associated with serious fatigue 
complaints. In this study 68 consecutive neuromuscular 
outpatients were compared with 94 outpatients with multiple 
sclerosis. Fatigue severity was rated while using the subscale 
fatigue severity of the Checklist Individual Strength (CIS-fatigue). 
Functional limitations were measured with the Sickness Impact 
Profile (SIP), while psychological distress was assessed with the 
Symptom Checklist-90 (SCL90) and the Beck Depression 
Inventory Primary Care (BDI-PC). In total 64% of the patients 
with a neuromuscular disease and 57% of the patients with MS 
experienced severe fatigue, while respectively 23% and 27% of 
the two samples had elevated depression scores. Both patient 
groups were comparable with respect to the degree of their 
functional limitations and psychological distress. Fatigued 
neuromuscular patients reported significantly greater reduction in 
motivation compared to the fatigued MS patients, while the 
patients with MS reported significantly more concentration 
problems. The frequency of abnormal fatigue seemed particularly 
high among patients with myotonic dystrophy. It was concluded 
that the experience of severe fatigue might be equally frequent in 
patients with neuromuscular diseases as in patients with multiple 
sclerosis. Fatigued neuromuscular patients seemed to be 
characterised by more reduced motivation, which was not related 
to levels of depression. It was also concluded that the various 
systems affected by distinct neuromuscular diseases might 
provide opportunities to detail physiological aspects of 
experienced fatigue.
° S van der W erf, B van Engelen, J Kalkman, M Schillings, 
P Jongen, M Zwarts , G Bleijenberg 
Fatigue in neurom uscular diseases: a comparison with multiple sclerosis
Submitted
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INTRODUCTION
In previous studies we have demonstrated in various neurological patients groups that 
the experience of severe fatigue can be a major determinant of disability [1,2]. Since 
most neuromuscular diseases are chronic disorders, characterised mainly by muscle 
weakness, it is surprising that fatigue as a clinical symptom has received little research 
attention [3]. Clinical studies pertaining to neuromuscular patients increasingly 
incorporate quality of life or general disability questionnaires but not often 
questionnaires assessing experienced fatigue specifically [4-6].
A recent fatigue study in patients with myasthenia gravis used validated fatigue 
questionnaires and found that the patients had significantly higher mental and physical 
fatigue scores compared to controls, and that 81% of this sample (n=28) reported 
fatigue to be one of their disease related symptoms [7]. Another study measured the 
response of patients with chronic fatigue, muscular dystrophy and psychiatric illness to 
experimental stress. The muscular dystrophy patients (n=20) reported that their fatigue 
was mainly exacerbated by physical exertion. They had significantly lower mental 
fatigue inventory scores compared to the chronic fatigue patients and psychiatric 
controls [8].
In contrast to neuromuscular disorders, the experience of fatigue in multiple sclerosis 
(MS) has received considerably more research attention. Disabling fatigue is even 
considered a specific clinical symptom of MS, and assessments with validated 
questionnaires in various MS samples consistently revealed the experience of severe 
fatigue to be a frequent problem with a serious impact upon daily life [1,9,10]. 
However, there is less agreement about which disease and psychosocial factors might 
constitute this fatigue. Relations between neurological disability or cerebral lesion load 
and experienced fatigue were found to be small, while MS associated fatigue could also 
not be seen as merely an expression of depression [1,11-13].
The primary objectives of this study were: (1) to assess the prevalence of severe fatigue 
and its relation with psychological distress, physical and social disability in a sample of 
patients with various neuromuscular diseases, and (2) to compare these findings to a 
sample of patients with a definite diagnosis of multiple sclerosis.
METHOD
-Subjects
This study was conducted at the outpatient clinic of the Neuromuscular Centre, based 
at the Institute of Neurology of the University Medical Centre Nijmegen in the 
Netherlands. Consecutive patients with a definite diagnosis of a neuromuscular disease 
and who could be classified into one of following four diagnostic categories were asked 
to participate: (1) myotonic dystrophy, (2) other myopathies (e.g. FSHD= fascioscapulo 
humeral dystrophy and limbgirdle dystrophy), (2) metabolic disorders (e.g. mitochon­
drial myopathies) or (3) neuropathies (e.g. HMSN=hereditary motor sensory 
neuropathy). Out of the group of 84 consecutive patients who agreed to fill out the 
questionnaires, 68 patients fitted the inclusion criteria.
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This group consisted of 32 patients with myotonic dystrophy, 20 patients with other 
myopathies, 8 patients with metabolic muscle disease and 8 patients with a neuropathy. 
The mean age of this sample (32 female/32 male) was 46 years (range: 18-80) and the 
mean complaint duration 9 years (range 1 to 40).
The MS comparison group consisted of 94 patients (61 female/33 male). At the time of 
assessment 55 patients had a relapsing remitting course of the disease and 39 patients a 
secondary progressive course. All patients had a definite diagnosis according to the 
Poser criteria and participated in fatigue related studies [14]. The in- and exclusion 
criteria of these patients have been described in detail elsewhere [1,15]. The mean age 
of this sample was 37 years (range 18 to 56) and their mean complaint duration 7 years 
(range 0.5 to 24). All patients had a neurological impairment rating and the Kurtzke 
Extended Disability Status Scale (EDSS) scores ranged between 1.0 and 7.0 with a 
mean of 3.7 [16]. Written information about the purpose of the study was provided to 
all patients and written informed consent was obtained from the patients who indicated 
that they wanted to participate.
-Fatigue severity
The CIS is a 20-item questionnaire and measures the following four aspects of fatigue 
during the previous two weeks: fatigue severity (8 items), concentration problems (5 
items), reduced motivation (4 items) and activity levels (3 items) [1]. Each item is 
scored on a 7-point Likert scale. Higher scores indicate higher levels of fatigue, more 
concentration problems, a greater decrease in motivation and lower levels of activity. A 
CIS fatigue score equal or above 40 was used to identify abnormal fatigue [17,18].
-Functional impairment
Eight subscales of the Sickness Impact Scale were used to assess functional disability 
in the following areas: ambulation, home management , mobility, alertness behaviour, 
sleep/rest, social interactions, work limitations and recreation and pastimes. These eight 
subscale-scores were added to provide one score of general disability (SIP8-total) 
[17,19].
-Psychological distress
Signs of psychological distress such as anxiety, depression, sleeping problems, and 
somatisation were assessed with the SCL-90. The added subscales provide a general 
measure for psychological distress (score range 90 to 450) and higher SCL90-total 
scores indicate more distress [20]. The BDI-PC was used to identify patients who 
suffered depressive symptoms. Previous studies among patients who suffered from a 
stroke or who had MS showed that the assessment of some depressive symptoms (e.g. 
concentration problems, moving slowly, loss of energy) could be biased by 
neurological symptoms. The BDI-PC excludes these somatic and performance items a 
cut-off score of four points has been proposed for maximum clinical efficiency with 
both 82% sensitivity and specificity rates [21].
126 Chapter XII
-Statistics
The distribution of males and females did not differ significantly in both groups 
(neuromuscular 50% females, MS 65% females). However, there was a significant age 
difference between the two patient groups. Therefore, age was correlated to all 
outcome variables. All analyses that pertained to variables that were significantly 
correlated to age were carried out both with and without age as covariate.
Independent t-test and cross-tabulation were used to compare both patient samples with 
respect to demographics and the complaint severity measures. Then, two by two (MS 
vs. neuromuscular and severely fatigued vs. less fatigued) analyses of variance were 
conducted to test whether group membership or being severely fatigued were 
associated with fatigue related complaints. Significance testing was 2-sided with alpha 
set at 0.05. For explorative purposes only, the mean values of the main outcome 
measures were calculated for each of the four distinct neuromuscular diagnostic 
categories.
RESULTS
-Age correlates
In the neuromuscular group age correlated only significantly with SIP mobility 
(rho=0.26, p<0.05) and in the MS group age correlated only significantly with SIP 
ambulance (rho=0.22, p<0.05).
-Fatigue related problems
Being severely fatigued was associated with more problems in all areas (Table 2). A 
significant interaction effect (group x fatigued) was only found for the CIS subscale 
reduced motivation. The less fatigued MS patients and the less fatigued neuromuscular 
patients had comparable scores, while the severely fatigued neuromuscular group 
reported more problems with initiating activities than the severely fatigued MS group. 
Independent of fatigue severity, MS patients reported more concentration problems 
than the neuromuscular patients did.
-The experience o f  severe fatigue and other complaints in both patient samples 
Both groups experienced equal levels of fatigue (CIS-fatigue) and similar proportions 
(neuromuscular 64% vs. MS 57%) of patients were classified as severely fatigued 
(Table 1). Both groups were also comparable concerning their psychological distress, 
physical activity levels, and physical functional limitations. However, neuromuscular 
patients reported to have significantly more difficulties with initiating or planning 
activities (CIS-reduced motivation), while MS patients reported significantly more 
concentration problems on the CIS concentration and SIP alertness subscales, and also 
indicated to have more work related problems.
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Table 1. Complaint and symptom characteristics o f  both patient samples
Neuromuscular 
patients Mean (SD)
Multiple Sclerosis 
patients Mean (SD)
t- or -  - values and 
significance levels
CIS-fatigue 40.2(12.4) 40.6(11.7) t= -0.2, p=0.85
% CIS-fatigue>=40 64% 57% - 2= 1.3, p=0.34
CIS-concentration 17.1 (9.1) 20.1 (9.5) t= -2.0, p=0.04
CIS-motivation 16.2 (6.4) 13.2 (5.6) t= 3.2, p<0.01
CIS-activity 12.5 (5.4) 12.5 (5.7) t= -0.02, p=0.98
BDI-PC 2.3 (2.2) 2.1 (2.6) t= 0.5, p=0.64
% BDI-PC>=4 27% 23% - 2= 1.1, p=0.32
SCL90-total 125 (33) 131 (35) t= -1.2, p=0.23
SIP8-total 1102 (641) 1198 (597) t= -1.0, p=0.32
SIP-ambulation 184(134) 155(135) t= 1.4, p=0.16
SIP-sleep and resting 88(72) 85(63) t= 0.3, p=0.79
SIP-social functioning 168(155) 164(162) t= 0.6, p=0.87
SIP-mobility 86(95) 71(100) t= 1.0, p=0.33
SIP-household 165(126) 138(101) t= 1.6, p=0.12
SIP-alertness 128(161) 203(196) t= -2.7, p<0.01
SIP-recreation 113(79) 121(73) t= -0.7, p=0.47
SIP-working 169(161) 260(166) t= -3.6, p<0.01
Table 2. Fatigue related problems: depression, distress, concentration, motivation, 
________ physical activity, physical and psychosocial functional impairment________
Less fatigued 
NM patients 
Mean (SD)
Severely 
fatigued 
NM patients 
Mean (SD)
Less fatigued 
MS patients 
Mean (SD)
Severely 
fatigued 
MS patients 
Mean (SD)
Sign.
testing
BDI-PC 1.5 (2.0) 2.6(2.0) 1.7(2.1) 2.4(2.8) 2
SCL-total 109 (26) 128(26) 122(28) 139(38) 1,2
CIS-concentration 14.0(8.7) 17.7(8.7) 17.3(8.8) 22.2(9.6) 1,2
CIS-motivation 11.7(4.4) 18.5(5.4) 11.6(4.7) 14.5(5.9) 1,2,3
CIS-activity 10.0(4.4) 14.3(4.8) 11.2(5.7) 13.6(5.5) 2
SIP8-total 817(535) 1272(613) 915(523) 1402(576) 2
SIP-ambulation 158(117) 196(139) 128(121) 180(141) 4
SIP-sleep problems 61(68) 95(60) 57(46) 107(67) 2
SIP-social functioning 133(166) 193(150) 130(141) 184(173) 2
SIP-mobility 48 (58) 124(103) 50(65) 90(118) 2,4
SIP-housemaking 145(130) 174(117) 96(73) 166(108) 2
SIP-alertness 86(130) 158(166) 147(179) 242(202) 1,2
SIP-recreation 80(79) 131(73) 86(56) 147(76) 2
SIP-work problems 105(143) 208(160) 220(154) 286(172) 1,2,3
Main effects: 1=group membership is significant, 2=fatigued vs. non-fatigued is significant. Interaction 
effect: 3=group x fatigue interaction is significant. Comparisons pertaining to SIP-mobility and SIP- 
ambulation were carried out with age as covariate. 4=covariate age is significant. The table displays 
uncorrected mean scores.
128 Chapter XII
-Incidence o f  severe fatigue and mean outcome measures o f  the different 
neuromuscular categories
The subsequent analysis of the four subgroups of neuromuscular disorders suggested 
that the incidence of severe fatigue differed considerably: DM (26/32= 81%), other 
dystrophies (8/20= 40%), metabolic muscle disorders (5/8= 63%) and neuropathies 
(2/8= 25%). Table 3 depicts for the four diagnostic categories the means of the main 
outcome variables.
Table 3. Four diagnostic categories and their mean values on the main outcome measures
Mytonic Dystrophy 
(n=32)
Mean (SD)
Other myopathies 
(n=20)
Mean (SD)
Metabolic 
disorders (n=8) 
Mean (SD)
Neuropathies
(n=8)
Mean (SD)
CIS-fatigue 42.1 (9.5) 33.9 (16.7) 43.8 (10.6) 33.8 (9.0)
CIS-concentr. 18.8 (7.4) 13.7(10.3) 17.4(9.8) 13.1(8.6)
CIS-motivation 17.4(5.6) 14.3(7.3) 14.9(6.1) 13.4(5.9)
CIS-activity 12.8(4.8) 10.8(6.3) 13.9(3.9) 13.1(4.7)
SIP8-total 1249(655) 816(630) 1086(667) 846(284)
BDI-PC 2.7(1 .9) 1.6 (2.1) 2.4 (2.7) 0.7(0.8)
SCL-total 126(29) 110(25) 129(24) 108(21)
DISCUSSION
This study shows that a considerable proportion of the neuromuscular patients that 
were investigated reported to suffer from severe fatigue. A finding that suggests that 
the experience of severe fatigue is not only characteristic of MS, but might be an 
equally frequent complaint in neuromuscular diseases. In both patient groups, being 
severely fatigued was associated with greater levels of psychological distress and more 
physical and psychosocial limitations. Although in both groups severe fatigue was 
related to higher levels of psychological distress, the majority of the severely fatigued 
patients did not fulfil the operational criteria of depression. Severe fatigue could 
therefore not be seen as merely a sign of depression.
The severely fatigued neuromuscular patients reported a stronger decrease in 
motivation than the severely fatigued MS patients did. This difference could not be 
explained by differences in depression scores. In fact, post hoc analyses revealed that 
the association between BDI-PC and CIS-motivation in the neuromuscular sample was 
non-significant (rho=0.13, p=0.28), while the same relation in the MS group did prove 
to be significant (rho=0.35, p<0.01).
Patients with MS experienced more concentration problems. The experience of 
concentration problems is a classical complaint associated with depression, but both
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patient groups did not differ with respect to their depression ratings. It might be that the 
differences in disease localisation between both patient groups underlie this 
discrepancy in concentration problems. Multiple sclerosis is a central nervous system 
disorder, which often affects brain structures. In contrast, some neuromuscular diseases 
(like myotonic dystrophy) do also affect brain structures, while others do not. It is 
therefore more likely that in the MS group the experienced concentration problems are 
related to cerebral dysfunction.
Although the results did confirm our clinical impression that many of the 
neuromuscular patients suffered from fatigue, they should be interpreted with some 
caution. Preliminary inspection suggested that the incidence of severe fatigue might 
vary considerably among the various neuromuscular subgroups, but larger groups of 
different neuromuscular diagnoses are needed to substantiate this finding.
The fact that in this study the experience of severe fatigue is as frequent in a group of 
patients with neuromuscular diseases as in MS is somewhat surprising, especially since 
fatigue is such an established and well researched symptom in MS, while it is hardly 
ever described in neuromuscular diseases. Assessing the experience of fatigue in 
various neuromuscular diseases gives the challenging opportunity to study the relation 
between distinct pathological aspects of peripheral (muscle), central (brain/spinal cord) 
function and the experience of abnormal fatigue.
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CHAPTER XIII
DAYTIME SLEEPINESS, FATIGUE AND REDUCED MOTIVATION IN 
PATIENTS WITH ADULT-ONSET MYOTONIC DYSTROPHY0
ABSTRACT
Daytime sleepiness is one of the symptoms of myotonic dystrophy 
but its relation with the experience of fatigue or reduced 
motivation has not been described yet. Thirty-two consecutive 
patients with adult-onset myotonic dystrophy were studied. The 
occurrence of excessive sleepiness was checked with items of the 
subscale sleep & rest of the Sickness Impact Profile (SIP), while 
subscales of the Checklist Individual Strength (CIS) were used to 
estimate fatigue severity and lack of motivation. Ten (31%) 
patients reported one or more symptoms of daytime sleepiness. 
Although the mean CIS fatigue score in this group was clearly 
elevated, the fatigue scores were not associated with the presence 
of daytime sleepiness. Daytime sleepiness was however 
associated with higher CIS-reduced motivation scale scores. 
These findings suggest that daytime sleepiness and fatigue are 
different clinical manifestations in myotonic dystrophy and that it 
is useful to use both daytime sleepiness and fatigue measures in 
clinical trials as well as in research of myotonic dystrophy.
° S van der W erf, B van Engelen, M Schillings, J Kalkman,
M Zwarts, G Bleijenberg
Daytime sleepiness, fatigue and reduced m otivation in myotonic dystrophy 
Journal of Neurology, Neurosurgery and Psychiatry, in press
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INTRODUCTION
Daytime sleepiness, apathy and lack of motivation are established clinical 
manifestations of myotonic dystrophy [1,2]. A recent study showed that Modafinil 
reduced daytime sleepiness and average sleep latency in a group of nine patients with 
DM [3]. This finding suggests that daytime sleepiness in DM patients and without 
obstructive sleep apnoea might be central in origin. A magnetic resonance imaging 
study indeed found evidence for a possible association between cerebral abnormalities 
in myotonic dystrophy and excessive daytime sleepiness [4]. Although several studies 
have measured levels of experienced fatigue with validated questionnaires in different 
neurological patient populations, fatigue questionnaires have not yet been related to the 
symptoms of daytime sleepiness in myotonic dystrophy [5,6]. With the results of the 
Modafinil study mentioned above in mind, our goal was to test the relation between 
excessive daytime sleepiness, experienced fatigue and reduced motivation.
METHOD
-Subjects
This study was conducted at the outpatient clinic of the Neuromuscular Centre 
Nijmegen, based at the Institute of Neurology of the University Medical Centre 
Nijmegen in the Netherlands. Consecutive ambulant patients with a genetically 
confirmed diagnosis of (adult-onset) myotonic dystrophy and an expanded CTG repeat 
on chromosome 19q13.3 (DM1) were invited to take part. Fatigue was not a criterion, 
for inclusion and the patients came to the hospital for their regular visits. Those willing 
to participate were asked to complete the questionnaires at home and then send them 
back to the hospital. Data were collected on 32 patients (16 female/16 male), mean age 
43.8 years (range 22 to 73), and mean complaint duration 10.1 years (range 1 to 35). 
Both myotonia and muscle weakness were rated using the 5-point Muscular Disability 
Rating Scale (MDRS) [7]. The scores in this group ranged from 0 (absent myotonia and 
no muscle weakness) to 4 (severe proximal muscle weakness and wheelchair 
dependence) and the mean MDRS score for this group was 2.3 (range 0 to 4).
-Daytime sleepiness
Three items (Nos. 2, 5 and 7) of the subscale sleep/rest of the Sickness Impact Profile 
refer specifically to an increased daytime sleepiness [8]. These three items (‘I feel 
continuously like dozing off’; ‘I am often hanging around half asleep’ and ‘I sleep 
more during the day’) were summed, and a score >0 was taken as an indication of 
increased sleepiness.
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-Fatigue severity
The subscale fatigue severity of the CIS measures the experience of fatigue-associated 
problems during the previous two weeks. The CIS-fatigue severity scale contains eight 
items that can be scored on a 7-point Likert scale. Scores can range between 8 and 56; 
higher scores indicate higher levels of fatigue and scores of 40 points or more are 
considered to indicate of severe fatigue [5,6,9].
-Reduced Motivation
The CIS subscale "reduced motivation" contains four items that are also scored on a 
seven point Likert scale (range 4 to 28). Higher scores are indicative of taking less 
initiative and a decreased motivation [9].
-Statistics
Independent t-tests were used to compare the groups of patients with and without 
sleepiness symptoms with respect to their mean CIS-fatigue, CIS-lack of motivation, 
and MDRS scores. A Spearman correlation coefficient was calculated to test the 
association between CIS-fatigue on the one hand and MDRS on the other. Significance 
testing was two-sided, with alpha set at 0.05.
RESULTS
Ten (31%) of the 32 patients answered positively on one or more of the three sleepiness 
items. The patients were then divided into a group that reported at least one of the 
three sleepiness symptoms (sleepiness; n=10) and a group that reported no sleepiness 
symptoms (non-sleepiness; n=22). Independent t-test showed no significant differences 
between the mean CIS-fatigue scores of the two groups (sleepiness, 44.6 (7.5); non­
sleepiness, 41.0 (10.2); t=0.98, p=0.33), but there was a significant difference for the 
CIS-reduced motivation score. The sleepiness group reported a significantly greater 
reduction in motivation than the non-sleepiness group (sleepiness, 22.5 (3.5); non­
sleepiness 15.1 (4.8); t=4.35, p<0.01). The groups did not differ with respect to their 
MDRS scores (mean MDRS in the sleepiness group, 2.2 (1.5); in the non-sleepiness 
group, 2.4 (1.0); t=-0.4, p=0.69). The MDRS score was also not significantly correlated 
with the CIS-fatigue score (Spearman rho=0.19, p=0.32).
DISCUSSION
Almost one third of this group of consecutive, ambulatory, adult onset myotonic 
dystrophy patients reported daytime sleepiness. This proportion is comparable with that 
in the study of Rubinsztein et al, in which 39% of 36 adults with non-congenital 
myotonic dystrophy were identified as hypersomnulent [2]. Another study also found 
that both myotonic dystrophy patients and patients with Charcot-Marie-Tooth had 
greater daytime sleepiness than healthy controls, but that the majority of myotonic 
dystrophy patients had daytime sleepiness scores below the proposed cut-off of the
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Epworth sleepiness scale [10]. In the two daytime sleepiness studies mention in our 
introduction, only small samples of patients (9 and 11) were studied, so comparisons of 
the incidence of daytime sleepiness are rather difficult [3,4]. However, the fact that we 
studied consecutive patients makes a bias towards those with fewer symptoms of 
daytime sleepiness unlikely.
The mean fatigue scores in both the sleepiness and non-sleepiness group exceeded the 
cut-off for abnormal fatigue and thus warrant a more extensive study of possible 
determinants of abnormal fatigue in this multisystemic disorder. The finding that the 
fatigue scores were increased independently of sleepiness suggests, and the fact that 
neither symptom was associated with the MDRS, suggests that different 
pathophysiological mechanisms underlie these clinical manifestations. Further 
assessment of the relation between these independent symptoms, and, for example the 
endocrinological and neurological status of the patients is required. Post hoc 
assessment of 22 patients of our group, showed that none of them suffered from thyroid 
dysfunction, while the prevalence of abnormal sleepiness (38%) and the mean fatigue 
score of these twenty-one patients resembled those of the eleven other patients on 
whom no thyroid function data were available. These findings suggest that abnormal 
sleepiness or fatigue may occur in myotonic dystrophy despite normal thyroid function. 
In the light of these results we would like to advocate the simultaneous use of both 
daytime sleepiness and fatigue outcome measures in future treatment and fatigue 
studies.
Daytime sleepiness and fatigue in myotonia dystrophy 137
REFERENCES
1. Harper PS. Myotonic Dystrophy. London: Saunders, 2001.
2. Rubinsztein JS, Rubinsztein DC, Goodburn S, Holland AJ. Apathy and hypersomnia
are common features of myotonic dystrophy. J  Neurol Neurosurg Psychiatry 
1998; 64:510-515
3. Damian MS, Gerlach A, Schmidt F, Lehman E, Reichmann H. Modafinil for
excessive daytime sleepiness in myotonic dystrophy. Neurology 
2001;56:794-796.
4. Giubilei F, Antonini G, Bastianello S, et al. Excessive daytime sleepiness in myotonic
dystrophy. J  Neurol Sci. 1999;164:60-63.
5. Werf SP van der, Jongen PJ, Lycklama, Barkhof F, Hommes OR, Bleijenberg G.
Fatigue in multiple sclerosis: interrelations between fatigue complaints, 
cerebral MRI abnormalities and neurological disability. J  Neurol Sci 
1998;160:164-170.
6. Werf SP van der, Broek HL van den, Anten HW, Bleijenberg G. Experience of severe
fatigue long after stroke and its relation to depressive symptoms and disease 
characteristics. European Neurology 2000;45:28-33.
7. Mathieu J, de Braekeleer M, Prevost C, Boily C. Myotonic dystrophy: clinical
assessment of muscular disability in an isolated population with presumed 
homogeneous mutation. Neurology 1992; 42:203-208.
8. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Scale:
development and final revision of a health status measure. Med Care 1981; 
19:787-805.
9. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, Meer JW van der, Bleijenberg G.
Dimensional assessment of chronic fatigue syndrome. J  Psychosom Res 
1994;38:383-392.
10. Phillips MF, Steer HM, Soldan JR, Wiles C.M., Harper P.S. Daytime somnolence in
myotonic dystrophy. J  Neurol. 1999;246:275-282.

CHAPTER XIV
SUMMARY AND GENERAL DISCUSSION
Summary of the findings
-Comparing the result ofprevious CFS studies to findings in members o f  the Dutch 
ME-association, CFS patients with short illness duration, and bedridden CFS patients 
It has been suggested that research participants do not reflect CFS patients in general. 
Therefore, the aim of the first study was to describe fatigue severity, physical disability 
status and other illness characteristics of a large sample of chronically fatigued 
members of a self-help organisation. The survey data of these members of the Dutch 
ME-association were also compared to a sample of 270 clinically referred patients who 
had participated in CFS research.
Of the nearly 2000 survey respondents 75% had an illness duration of more than six 
months and fulfilled similar operational criteria of severe fatigue and physical 
disability, as had been used in most of our previous studies. The survey results showed 
that the complaints had a high impact on work participation and use of medical 
facilities. Although the research participants were not less seriously fatigued or 
disabled than the survey respondents were, they were more optimistic about 
possibilities for recovery and the capability of CFS patients for physical exertion. The 
majority of patients in both samples believed that the social environment did not take 
CFS patients seriously and that it was important that other people would know how 
seriously CFS patients were incapacitated. It was concluded that research participants 
were not biased towards less serious fatigue or less physical disability but that they 
might differ in some of their illness cognitions and that illness cognitions might 
influence the way patients look for (medical) help and assistance.
The persistence of fatigue in CFS is reflected by the long illness duration of many of 
the research participants. It has been suggested that the factors that predict persistence 
of symptoms differ according to illness duration [1]. The goals of the second study 
(chapter 3) were to assess improvement and recovery rates in patients with a relatively 
short (maximum two years) illness duration and to test whether the predictors for self­
rated improvement differed from patients with a longer illness duration. The results 
confirmed that short illness duration was associated with higher spontaneous 
improvement and recovery rates and that the predictors for self reported improvement 
at follow-up were indeed different from our previous natural course study [2,3]. 
Improvement at follow-up was associated with less concentration problems, less 
dissatisfaction with the amount of social support, and more psychosocial causal 
attributions at baseline.
It was concluded that spontaneous recovery after 16 months was rare and assumed that 
especially in a relatively early stage of the illness, negative reactions of friends, 
relatives and co-workers might provoke psychological distress, which in turn could 
promote the persistence of symptoms. The finding that self-rated improvement
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occurred predominantly in an early phase of the illness makes it interesting to monitor 
whether the course of the illness of these patients continues to complete recovery or 
whether relapse occurs in the relatively few recovered patients.
Patients with severe disability might not visit the outpatient clinic and subsequently be 
missed in research. The third study (chapter IV) was aimed at describing patients who 
indicated that they were not able to participate in research because of their severe 
functional limitations. Eighteen of these patients were visited at home and their test 
results were compared to that of patients who participated in ongoing research.
This homebound group had a significantly higher mean age and illness duration 
compared to the group of research participants who visited our outpatient clinic. To 
control for differences in age and illness duration, a selection was made out of this 
clinically referred CFS sample. Compared to this matched group, homebound patients 
were physically far less active, had a stronger believe in a physical cause for their 
complaints, and reported significantly more daily fatigue and physical disability, but 
significantly less social disability. Compared to the non-matched CFS sample, both the 
homebound and the matched ambulant sample had a higher prevalence of lifetime 
depressive episodes. This finding indicates that CFS patients with a history of 
depressive episodes are more prone to persistence of symptoms. Despite their severe 
functional disability, homebound patients did not report more psychological distress 
than their more active counterparts. This study stresses that there are considerable 
differences in physical activity among CFS patients, and that the homebound patients 
represented a minority of extreme and persistently physically inactive patients. The 
finding that homebound patients reported significantly more daily fatigue indicated a 
possible relation between daily experienced fatigue and daily physical activity levels.
-Physical activity patterns in CFS and their relation to daily fatigue.
CFS patients report a distinct reduction in their physical activity levels compared to 
premorbid functioning, while measurements of actual physical activity showed 
considerable variation among patients and weak associations with self-report measures 
[4]. Since models of persistence of fatigue have suggested a vicious circle of inactivity, 
deconditioning and fatigue persistence the aims of the fourth study were to describe 
physical activity patterns in more detail [5-8].
A motion-sensing device that registered physical activity levels over a 12-day period 
was used to compare the physical activity patterns of CFS patients to that of healthy 
controls. The CFS group was less physically active than the control group. The 
duration and intensity of the ten largest activity peaks were similar for both samples, 
but the subsequent inactive periods after these activity peaks were longer for the CFS 
patients. No evidence was found that CFS patients were characterised by more 
pronounced day-to-day fluctuations in physical activity. However, major distinctions 
between the activity patterns of individual patients were observed. One quarter of the 
CFS patients were identified as being pervasively passive, while none of the controls 
displayed such a pattern. The findings of this study clearly suggested that pervasive 
inactivity does not apply to the majority of CFS patients and that there were 
considerable differences in physical activity levels among CFS patients. In contrast to 
the homebound patient study, activity patterns were not associated with differences in
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overall ratings of fatigue. Pervasively passive patients showed not more depressive 
signs than their more active counterparts. The findings raised questions concerning the 
exact relation between daily fatigue and daily fatigue in CFS and the possible role of 
physical inactivity as risk or perpetuating factor.
Since the activity study compared overall activity and fatigue levels the fifth study 
(chapter VI) looked into the course of fatigue during the day and its relation to physical 
activity. First, a comparison between controls and CFS patients was made between 
wake-up, morning, afternoon and evening fatigue levels. CFS patients appeared to be 
more fatigued throughout the day, indicating that their fatigue was already present at 
waking up. Since controls and CFS patients did not differ with respect to their 
nighttime physical activity score, wake up fatigue in CFS seemed unrelated to 
abnormal physical activity levels during the night. The controls showed a gradual 
increase of fatigue during the day with the highest fatigue in the evening, while the 
CFS patients reached their maximum fatigue already in the afternoon.
Between the pervasively passive, the moderately active, and the pervasively active CFS 
samples no differences on mean wake up, morning, afternoon or evening fatigue scores 
were found. The pervasively active patients, however, had more often an increasing 
fatigue pattern during the day. Finally, for each individual CFS patient the correlation 
between his or her subsequent daytime fatigue and physical activity scores was 
calculated. These intra-individual correlations turned out to be low and not significant 
for most of the patients. Pervasively active patients showed more often, that an increase 
in activity coincided with an increase in fatigue. There was a trend that pervasively 
passive patients were more inclined to prevent increases in fatigue by taking rest or 
avoid activity. Since the normal daily fluctuations in physical activity of CFS patients 
were hardly associated with fluctuations in daily experienced fatigue it is possible that 
the activity-fatigue association, that is so strongly perceived by CFS patients, reflects 
illness expectations or pertains to mental or social activities instead of physical activity.
-Assessment o f  mental ability in CFS and its relation to illness behaviour, body 
consciousness and somatic symptom report
Concentration and memory problems belong to the major symptoms of CFS and have 
been associated with fatigue severity but had no place in our model for persistence of 
fatigue [9,10,11]. Many of the CFS related neuropsychological studies report slowing of 
information processing speed, but none of these studies controlled for the possible role 
of illness behaviour, or tried to explain slowing of information processing strictly in 
behaviour terms [12]. Therefore, the goals of the sixth and seventh study of this thesis 
were to assess the possible influence of illness behaviour upon neuropsychological test­
performance and to try to explain the phenomena of slowing of information processing 
speed as a consequence of heightened bodily awareness in CFS.
First, MS and CFS patients were compared with respect to their performance on a task 
designed to detect feigned memory impairment and a standard neuropsychological task, 
considered being sensitive to mental slowing and memory. Both groups showed equal 
performance on the standard neuropsychological test, but a significant larger proportion 
of CFS patients had scores indicative of illness behaviour on the task developed to test 
for submaximal effort. Although one only could speculate about the underlying cause
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for this higher incidence of submaximal performance of CFS patients, the findings 
were taken as a warning against interpreting neuropsychological test to easily as a sign 
of cognitive dysfunction. It was concluded that high (test) anxiety, low motivation, or 
even symptom exaggeration, could bias test results also in research settings.
In several non-clinical studies, private body consciousness has been associated with 
increased focusing on bodily sensations, higher somatic symptom report, and reduced 
information-processing capacity [13-17]. Attentive processes were thought to play an 
important role in the report of symptoms and the processing of external information. 
While controlling for possible illness behaviour, the seventh study tested the relations 
between body consciousness, somatic symptom report and information processing 
speed.
The results showed that a higher body consciousness facilitated not only somatic 
symptom report, but was also directly related to a reduction of information processing 
speed. In contrast, slower motor responses and higher report of concentration problems 
were only related to more somatic symptom report. These findings provided an 
alternative explanation for possible mental slowing in CFS. It was suggested that 
illness beliefs such as physical causal attributions and low self-efficacy could not only 
raise body consciousness, but also facilitate symptom report and induce anxiety during 
situations that are perceived as demanding by the patient.
-Chronic fatigue in M S
In the modelling study of Vercoulen et al. it was found that the data of MS patients did 
not fit the CFS model for persistence of fatigue. Subsequent adaptations resulted in a 
MS model in which negative self-efficacy predicted fatigue severity and physical 
activity levels; neurological disability predicted also physical activity level but not 
fatigue severity; and fatigue severity turned out to be the only predictor for functional 
impairment. This model did not include MS specific parameters like the number of 
cerebral white matter lesions or measures of brain atrophy, and the data pertained to a 
sample of patients with relatively mild neurological impairment; this may have 
obscured an impairment-fatigue relation. Depression was not included since it played 
no role in the CFS model from which the CFS model was derived.
In the eighth study (chapter IX) it was first tested to what extent the experience of 
fatigue might be a direct expression of MS specific cerebral involvement. Magnetic 
Resonance Imaging (MRI) was used to identify white matter lesion load in different 
cerebral areas and to calculate several brain atrophy measures. Although the majority 
of the MS participants suffered from serious fatigue, this study failed to demonstrate a 
significant relationship between cerebral pathology and levels of experienced fatigue. 
Similarly, neurological disability, expressed in the expanded disability status score, 
explained only a small and non-significant proportion of the variance in fatigue. The 
conclusion was that there was not an obvious relation between the degree of 
experienced fatigue and the extent of white matter involvement and cerebral atrophy in 
MS. Similarly, neurological disability seemed to contribute only a small part to 
differences in experienced fatigue. Subsequent fatigue studies in MS have also failed to 
associate fatigue with cerebral pathology [18-20].
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In MS, fatigue has been associated with depression but similar to fatigue, no single 
neurological or biological causal factor for depression has emerged yet [21-24]. Illness 
cognitions are seen as a risk factor for an unfavourable physical and psychological 
health status for patients with various chronic diseases including MS [25-27]. The MS 
model indicated already that negative self-efficacy contributed to the experience of 
MS-associated fatigue, but the relation to depression or to neurological disability was 
not tested, and the data pertained mostly to patients with minor disability. The aim of 
the next MS study was to test whether an illness cognition, like self-efficacy indeed 
might act as mediator between neurological disability and personality characteristics on 
one hand, and depression and fatigue on the other.
First, neurological impairment and emotional instability were modelled to directly 
affect fatigue and depression. Emotional instability was seen as a vulnerability factor, 
while neurological impairment was viewed as a physical stressor [28,29]. In this model 
Expanded Disability Status Scale (EDSS) score showed a direct significant relation 
with fatigue but not to depression, and emotional instability was directly related to 
depression but not to fatigue. The data fit to the model was, however, poor. In the 
subsequent model, helplessness was introduced as a mediating variable between 
vulnerability and a somatic stressor on one hand, and fatigue and depression on the 
other [30]. Expanding the medical model with an illness cognition like helplessness, a 
concept closely related to the self-efficacy in the CFS model, resulted in a much better 
data fit and indicated that both emotional instability and neurological impairment 
indirectly affected levels of fatigue and depression by helplessness. Furthermore, it was 
found that neurological symptoms that were uncontrollable especially affected feelings 
of helplessness and as such increased the experience of fatigue. This study suggested 
that in chronic neurological diseases, just as in CFS, illness cognitions might influence 
the experience of fatigue.
-The experience o f  fatigue in other chronic neurological conditions 
In contrast to MS, fatigue complaints received little attention in other neurological 
conditions. The goal of the tenth study was to investigate the prevalence of fatigue in 
stroke victims. The results showed that relatively long after stroke more than 50% of 
the stroke victims experienced serious fatigue. Fatigue was associated with both 
depression and physical disability. Comparisons with an age matched control group 
showed that psychological distress was the most important explanatory factor for 
fatigue in controls, while physical disability contributed the most in the stroke sample. 
In this study, no measures of actual physical and cognitive dysfunction were taken and 
their exact role in the experience of fatigue needs further investigation. The fact that the 
experience of chronic fatigue was such a frequent symptom among stroke merited 
detailed also in other chronic neurological conditions.
Therefore, the next study compared a group of consecutive patients with a 
neuromuscular disease with a group of MS patients. Although muscle weakness is the 
key feature of neuromuscular diseases few systematic studies have been carried out to 
assess the experience of abnormal fatigue in these conditions [31]. The results indicated 
that abnormal fatigue was an equally frequent problem in both patient groups. The fact 
that both patient samples were similar with respect to overall disability and psycho­
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logical distress suggested that fatigue complaints might exist independently of specific 
disease factors. However, fatigued neuromuscular patients reported more reduced 
motivation and less concentration problems than MS patients did. The preliminary 
findings also indicated that there are considerable differences in prevalence of 
abnormal fatigue among the different neuromuscular diagnostic groups. The large 
variety of neuromuscular diseases with their distinct pathologies was thought to offer 
possibilities to study different somatic aspects that might contribute to the daily 
experience of fatigue.
The last study described in this dissertation stemmed from the observation that fatigued 
MS and fatigued neuromuscular patients differed only with respect to reduced 
motivation. Since daytime sleepiness and low initiative have been described as clinical 
features of myotonic dystrophy, it seemed necessary to test whether fatigue, reduced 
motivation and daytime sleepiness constituted one similar problem [31-34]. The results 
indicated that the experience of abnormal fatigue was a far more common complaint 
than daytime sleepiness. Since reduced motivation correlated highly with sleepiness, 
but far less with the experience of severe fatigue, it was suggested that daytime 
sleepiness, in combination with reduced motivation, might be characteristic of a 
subgroup of patients with myotonic dystrophy and is perhaps associated with the 
known neurological involvement of the disease.
DISCUSSION OF THE MAIN FINDINGS, CLINICAL IMPLICATIONS AND FUTURE 
RESEARCH
The main findings of this dissertation are first discussed against the background of the 
three variables (physical activity, illness beliefs, and focussing on bodily symptoms) 
that directly influenced fatigue in the CFS model. In addition, attention is paid to the 
importance of social factors in CFS. Embedded in this general discussion are the 
findings of the twelve studies that were presented, as well as the findings of other 
groups and ongoing research. Directions for future research and clinical implications 
will be presented in each section separately.
-Physical activity and the relation to chronic fatigue
In the CFS model of Vercoulen et al., physical activity has an important place and the 
persistence of fatigue is seen as a direct consequence of reduced physical activity [11]. 
The editorial that accompanied the publication of the physical activity pattern study 
stressed the importance of physical activity in CFS [35]. White (2000) hypothesised 
that low physical activity levels are a facilitating factor for the subsequent development 
of CFS [35,36]. Our investigations showed that physical activity levels differ 
considerably between different CFS patients. This was a finding that made physical 
inactivity as a key or single facilitating factor of CFS unlikely. In a recent study of our 
group, 20 CFS patients and 20 matched neighbourhood controls performed a maximal 
exercise test; no statistical significant difference in physical fitness was found between 
the two groups, and it was concluded that physical deconditioning was not likely to be 
perpetuating factor in CFS [37]. Only half of the CFS patients and eighty percent of the
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controls performed the test until they attained one of three criteria for a physiological 
limitation. The attained percentage of the predicted maximum workload correlated 
significantly with daily physical activity levels in the CFS group, but not in the control 
group. These findings do suggest that factors other than physical fitness, such as 
avoidance mechanisms, play an important role in regulating activity behaviour. These 
findings might also explain why in the fatigue pattern study no evidence was found for 
a strong daily activity-fatigue association.
It is interesting to compare these findings with activity and fatigue data in chronic 
neurological disorders. Many of the investigated stroke, MS and neuromuscular 
patients have physical impairments making them more prone to meet their physical 
limits in daily life. It is also possible that these patients continuously adapt their activity 
pattern in order to prevent excessive fatigue because of the chronic and often 
progressive nature of their disease. Ongoing research among neuromuscular patients 
might provide answers whether the absent relation between daily activity and perceived 
fatigue is only characteristic for CFS. In a group of 210 patients muscle strength, 
peripheral (muscle) central (nerve) and experienced fatigue are assessed 
simultaneously. These neuromuscular patients also carry the actometer and fill out a 
complaint questionnaire similar to the CFS fatigue activity study. These measurements 
will allow to test whether peripheral, central and experienced fatigue are interrelated, 
and whether these different types of fatigue predict associations between daily activity 
levels and daily fatigue. This type of information can provide important information 
how to cope with physical handicaps and environmental demands in order to prevent 
chronic fatigue.
It still remains to be answered why others have found that graded exercise alleviates 
fatigue in CFS, and why baseline activity patterns proved to be an important predictor 
for therapeutic success [38,39,40]. Regular exercise can promote health by reducing 
stress and depressive symptoms, but the exact mechanisms for these effects are still not 
known [41,42]. Perhaps that activity management in CFS resembles two frequently used 
cognitive methods of pain management, distraction and redefinition [43]. Physical 
activity could distract the patients from the normally felt fatigue and somatic symptoms 
or redefine the patients’ view concerning what are normal physical sensations and what 
are physical sensations related to more strenuous activity. Furthermore, the experience 
of being able to gradual increase activity despite being fatigued could enhance the self­
efficacy expectations of the patient. Providing knowledge that equally fatigued CFS 
patients differ considerably in their physical activity levels, and that daily physical 
activity is not necessarily related to daily fatigue, might alter in itself the perception 
and expectations of CFS patients concerning the harmfulness of physical activity. 
Exposure to physical activity could facilitate this change of cognitions and perception. 
This change is important since almost three-quarters of the survey respondents agreed 
that CFS patients are forced to do things very slowly, and almost half of the survey 
respondents thought that CFS patients were not capable of physical exertion.
A controlled study that assessed the impact of 15 weeks of aerobic training on fitness 
and quality of life in multiple sclerosis demonstrated that although the Expanded 
Disability Status Scale scores did not change, exercise training resulted in improved 
fitness (Vo2 max and muscle strength) and had a positive impact on factors related to
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quality of life (reduction in depression and anger scores and physical and social 
disability) [44]. These findings indicate that exposure to physical activity also change 
activity related beliefs about the possible harmfulness of exertion and promote self­
efficacy among patients with neurological diseases.
In contrast to physical activity, mental or social activities are not addressed in the CFS 
model of perpetuating factors or in the studies of this dissertation. The editorial that 
accompanied the stroke article that was presented in this dissertation commented on 
this and stressed the importance of mental activity, as opposed to physical activity, in 
inducing fatigue in neurological conditions mental activities might play an important 
role in the experience of fatigue [45]. Therefore, in ongoing studies of CFS, 
neuromuscular and neurotrauma patients, daily mental and social activities are rated. 
Furthermore, event related potentials and fMRI studies are conducted to find 
neurofunctional indices of mental exertion in fatigued patients.
-The role o f  illness cognitions in the experience offatigue
Illness cognitions reflect the way patients perceive and think about their disease and are 
Considered important mediators between disease and the patients’ well being. These 
illness beliefs can centre on various aspects of the illness, such as the cause of the 
disease, the consequences of the disease, and the sense of control over symptoms. 
Illness cognitions can affect illness-related behaviour such as the perception of 
symptoms, coping with complaints, seeking help and compliance to treatment [26,29]. 
According the social learning theory of Bandura, people’s behaviour is too strongly 
influenced by self-efficacy expectations [46]. Illness cognitions also play an important 
role in the CFS model for persistence of fatigue. Self-efficacy is as an independent 
variable, directly related to fatigue severity, while causal attributions indirectly 
influence fatigue severity by physical activity levels. One of the first studies of the 
Nijmegen Fatigue Research Group showed that only thirty-nine percent of 298 CFS 
patients believed that they could influence their complaints, while eighty-six percent 
reported a physical explanation for their complaints and only seven percent a 
psychological explanation [47]. A comparison between patients with CFS and patients 
with Addison’s disease also indicated that CFS believed in fewer possibilities to 
control or cure the disease, and were more convinced that external causes played a role 
in CFS related symptoms [48]. A comparison between MS and CFS patients showed 
that 30% of the MS patients and only 14% of the CFS patients named at least one 
psychosocial cause for their fatigue, while 88% of the MS and 78% of the CFS patients 
named at least one physical cause [49]. Moss-Morris showed that patients who viewed 
CFS as an uncontrollable and serious disease used a more passive and emotion-focused 
coping strategy which in turn was associated with less psychological well-being and 
more physical disability [50].
In this dissertation, however, the majority of the survey respondents and research 
participants believed that they (could learn) to influence their complaints. Comparable 
to our previous studies almost all survey respondents believed that CFS involved a viral 
cause, but a higher percentage (45%) of survey respondents mentioned also at least one 
possible psychosocial cause for their condition. These findings suggest a general shift 
towards more positive self-efficacy expectations and more openness to admitting that
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non-physical factors might affect the complaints. Possibly, that the vast amount of CFS 
publications has affected illness cognitions and expectations of patients. In the current 
treatment programs of the Nijmegen Fatigue Research Group it is emphasised that the 
goal of the treatment is to cure CFS [51]. This is a standpoint that differs fundamentally 
from a rehabilitation approach in which it is emphasised that CFS patients should learn 
how to live with their handicaps. In the survey study, 37% of the respondents believed 
that CFS could not be cured, while it was only 18% among research participants. It is 
possible that presenting cure as a therapeutic goal affects already the self-efficacy 
expectations of patients. In addition, publications or verbal reports of patients about 
successful therapy might, in it self, change illness beliefs in other CFS patients.
In contrast to CFS, MS patients suffer from a disease for which no cure is possible. 
Both, the diagnosis of having a progressive disease and the direct neurological 
consequences of MS can be seen as chronic stressors. It has repeatedly been found that 
in chronic diseases low self-efficacy expectations and increased helplessness are risk 
factors for an unfavourable physical and psychological health status [27,20]. The MS 
study in this dissertation showed that helplessness acted as a moderator between 
neurological disability and feelings of depression and fatigue. Previous research among 
patients with chronic rheumatic arthritis showed that patient education had a positive 
effect upon the self-efficacy expectations and helplessness of these patients [52]. 
Perhaps, that increasing self-efficacy expectations and diminishing helplessness could 
also be important targets for psychological intervention of MS associated fatigue. 
Disease characteristics such as the course and manageability of symptoms may also 
strongly affect illness beliefs. In our stroke study, walking problems were directly 
related to feelings of depression while in the MS study, the EDSS score which is 
strongly associated with walking problems, showed no direct association with 
depression. MS and most neuromuscular diseases have a chronic progressive character, 
while stroke victims often are confronted with a sudden change in their life situations. 
The discrepancy perceived between environmental demands and the patients’ resources 
might be greater for patients confronted with a sudden relapse in their condition, than 
for patients with a gradual course of the disease. These latter patients had perhaps more 
time to adapt their life both physically and psychologically to the daily hassles of their 
illness. Irrespective of the diagnosis, it seems important to pay attention to illness 
beliefs concerning the course and controllability of symptoms in chronically fatigued 
patients. Providing information about the role that illness cognitions play in the 
perception of fatigue in chronic diseases may diminish the risk of getting or remaining 
chronically fatigued.
-Fatigue perception, somatic symptom report, concentration problems, and attention 
Focussing on bodily symptoms was another important factor influencing fatigue 
severity in our CFS model. Previous studies already mentioned that CFS is not only 
characterised by abnormal fatigue but also by high somatic symptom report in CFS 
[49]. Post-hoc analyses on the data presented in this dissertation confirmed that the 
SCL90-somatization scores of both the homebound and CFS comparison samples were 
significantly higher than that of MS and neuromuscular patients fulfilling the CFS 
operational criteria of severe fatigue and profound disability. A previous study also
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found that the mean SCL90-somatization score of a sample of CFS patients was higher 
than that of seriously fatigued but cured cancer patients [53]. These findings confirm 
that high somatic symptom report, in absence of medical findings, is one of the 
characteristics of CFS. In the discussion of the body consciousness chapter of this 
dissertation it was suggested that heightened somatic symptom report in CFS might 
reflect neurophysiological disturbances such as an abnormally low threshold for 
somatosensory stimulation or increased bodily attention. Until now, no evidence has 
been found for primary somatosensory disturbance in CFS, while the aforementioned 
discussion of the role of illness beliefs, clearly indicated, that the report of and impact 
felt of fatigue could be influenced by illness cognitions like self-efficacy.
Just the fact of having a diagnosis may affect the perception and report of symptoms. 
Some of our neuromuscular patients, who after genetic counselling accidentally found 
out that they had a neuromuscular disease, told that this made it easier for them to 
recognise symptoms and attribute certain behaviours to the disease. Similarly, having a 
diagnosis could enhance the labelling of normal bodily sensation as harmful or as 
fitting to the illness. The belief that somatically something is wrong could not only 
increase attention to bodily sensations, but subsequently also facilitate labelling those 
sensations as being abnormal. In a biopsychosocial perspective, attentive processes 
almost necessarily play an important role in the perceptions and labelling of symptoms. 
In the CBT protocol used by the Nijmegen Fatigue Research Group, emphasis is put on 
stopping the patients labelling themselves or their behaviour as typical of CFS. As has 
been discussed before, exposure to physical activity may also change illness 
expectations and affect the perception and interpretation or labelling of bodily 
sensations.
-The role o f  social factors
Receiving higher levels of social reward such as avoidance of disliked social activities, 
getting help or attention from friends and family, has been associated to higher reports 
of pain, more disability and less activity in chronic pain patients [54,55]. Turk suggested 
that social processes in the family system of patients increase the dependency on others 
and decrease self-efficacy [56]. Although social factors had no place in our initial CFS 
model for perpetuating fatigue, the data of the different CFS studies in this thesis 
suggest that social factors and possibly solicitous behaviour of family members, are 
associated with symptom report, disability status and illness behaviour.
The survey showed that more than three quarters of the respondents agreed that their 
social environment does often not take CFS patients seriously and that CFS patients 
should show the severity of their complaints. These beliefs clearly show that many CFS 
patients experience little understanding for their illness and complaints. The 
discrepancy those patients experienced between wanted and received social support 
predicted persistence of fatigue among the CFS patients with short illness duration.
A post hoc investigation among the CFS patients with a short illness duration showed 
that not only the body consciousness but also the public consciousness scale (e.g. being 
aware what other people may think) was significantly (rho=0.46, n=57) associated with 
the degree of somatic symptom report. Patients, who felt that they were more aware 
about other people’s reactions and thoughts, reported more psychosomatic symptoms.
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The CBT study indicated that being involved in a legal procedure for work-disability 
interfered negatively with therapeutic success [57]. The severely disabled homebound 
CFS patients described in this dissertation judged their psychosocial limitations as less 
severe, and tended to experience fewer problems in social interactions than their less 
physically disabled and more active counterparts. These data could indicate that 
solicitous behaviour is one of the perpetuating factors in severely disabled patients. 
Besides the generally accepted beneficiary aspects of social support, the above­
mentioned findings are suggestive that social factors may aversively affect symptom 
report, motivation for change, and adherence to therapy. The role of solicitous 
behaviour of relatives, friends or colleagues, and the possible moderating effects of for 
example public consciousness and social anxiety upon symptom report are to be 
addressed in future studies.
-Concluding remarks
This dissertation is a continuation of work that already started in the early nineties and 
reflects the expansion of studies of the Nijmegen Fatigue Research Group, an 
expansion that parallels the increased interest in fatigue in both national and 
international research centres. It is perhaps surprising that the definition and 
investigation of an illness like CFS gave such a boost to assessment of fatigue in 
numerous other conditions. The results of this dissertation together with findings in 
other studies indicate that the experience of chronic fatigue is a frequent and prominent 
symptom in many diseases. Therefore, the long held view of many clinicians that 
fatigue is a non-specific symptom seems right, but at the same time, this long held 
belief has hampered the systematic investigation of this symptom. Just the fact that the 
persistent fatigue in CFS could not ‘automatically’ be attributed to an underlying 
somatic cause may have sparked the interest in fatigue research. The subsequent 
development of new assessment instruments and methods gave the opportunity to 
reliably identify abnormal fatigue in different conditions, to systematically study the 
effects of treatment upon fatigue, and to compare findings among different (patient) 
populations and between different research groups. The results of the studies described 
in this dissertation reinforce the importance of integrating psychosocial aspects not 
only into research but also into clinical care of chronic fatigue. A 'nonspecific' 
symptom such as the experience of chronic fatigue might be distinguished among 
individuals and different patient groups just by its behavioural, cognitive and social 
aspects.
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SAMENVATTING
DETERMINANTEN EN GEVOLGEN VAN ERVAREN VEMOEIDHEID BIJ HET CHRONISCH
VERMOEIDHEID SYNDROOM EN NEUROLOGISCHE AANDOENINGEN
In 1990 startte de Nijmeegse Onderzoeksgroep Chronische Vermoeidheid als een 
multidisciplinaire samenwerking tussen de afdelingen Algemene Interne Geneeskunde, 
Virologie en Medische Psychologie van het UMC St. Radboud. De eerste studies 
hadden betrekking op somatische en psychosociale determinanten en gevolgen van het 
chronisch vermoeidheidsyndroom (CVS) en er werd daarbij gewerkt vanuit het 
biopsychosociaal ziektemodel waarbij aandacht werd besteed aan zowel de identificatie 
van mogelijke biologische markers van CVS als ook aan gedragsfactoren. Deze 
vermoeidheidstudies vereiste de ontwikkeling van een meetmethode en 
instrumentarium voor het in kaart brengen van niet alleen de ernst van de ervaren 
vermoeidheid en beperkingen, maar ook van ziekteopvattingen, psychisch 
welbevinden, neuropsychologisch functioneren en lichamelijke activiteit. Vervolgens is 
op basis van in de literatuur veronderstelde theorieën en de resultaten uit de eerste 
prospectieve studies een verklaringsmodel ontwikkeld voor gedragsfactoren die CVS in 
stand kunnen houden. Dit model is vervolgens getoetst en aangepast. In het 
uiteindelijke model zijn een lage self-efficacy, lage fysieke activiteit, en een sterke 
gerichtheid op lichamelijke sensaties, directe voorpellers voor het aanblijven van 
vermoeidheid. Geringe lichamelijke activiteit en een sterke gerichtheid op lichamelijke 
sensaties bleken bij te dragen aan meer beperkingen in het dagelijks leven. Indien 
patiënten in sterke mate overtuigd waren dat hun klachten het gevolg waren van een 
lichamelijke afwijking resulteerde dit in een geringere lichamelijke activiteit. Dit model 
van instandhoudende factoren bij CVS en de nieuw ontwikkelde meetmethode dienden 
als uitgangspunt voor vervolg studies zowel bij CVS als bij andere aandoeningen.
De eerste drie onderzoekingen van deze dissertatie (hoofdstukken 2 t/m 4) hadden als 
doel om na te gaan in hoeverre voorafgaande onderzoeksbevindingen konden worden 
gegeneraliseerd naar andere CVS patiëntpopulaties. Een van de redenen hiervoor was 
dat sommige onderzoekers en patiënten twijfelden aan de representativiteit van 
patiënten in het onderzoek van gespecialiseerde CVS centra. Deze deelnemers aan 
onderzoek zouden volgens hen minder ernstig vermoeid en beperkt zijn dan CVS 
patiënten in het algemeen. Het eerste onderzoek (hoofdstuk 2) vergelijkt om die reden 
de resultaten van een enquête gehouden onder een grote steekproef van bijna 2000 
respondenten die donateur waren van de ME Stichting met gegevens van deelnemers 
aan onderzoek op het UMC St. Radboud. De demografische en ziektegebonden 
karakteristieken en de ernst van de vermoeidheid en beperkingen bleken voor beide 
groepen overeen te komen. Deelnemers aan het Nijmeegs onderzoek werden in ieder 
geval niet gekenmerkt door minder ernstige vermoeidheid of beperkingen. Wel hadden 
de deelnemers aan onderzoek positievere opvattingen ten aanzien van de mogelijkheid 
tot genezing, mogelijkheden tot lichamelijke inspanning en beïnvloedbaarheid van de 
klachten. Opvallend was verder dat een groot deel van de respondenten aangaf dat er 
vanuit hun directe sociale omgeving vaak te weinig begrip was voor de aan CVS 
gerelateerde klachten en beperkingen.
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Deelnemers aan voorafgaande Nijmeegse onderzoeken hadden een lange klachtenduur 
van gemiddeld 5 tot 8 jaar en lieten weinig spontaan herstel zien. Het doel van het 
tweede onderzoek (hoofdstuk 3) was dan ook om het beloop van vermoeidheid bij CVS 
patiënten met een relatief korte klachtenduur te beschrijven en na te gaan welke 
psychosociale factoren spontaan herstel na een jaar zouden voorspellen. Daarbij werd 
een vergelijking gemaakt met resultaten uit eerdere studies. Het bleek dat nagenoeg al 
het spontane herstel optrad vóór de vijftiende maand na het ontstaan van de klachten. In 
vergelijking met voorafgaande studies werden andere voorspellers gevonden voor het 
aanhouden van klachten. Patiënten met concentratie problemen en een ervaren tekort 
aan sociale steun hadden een grotere kans op het voortduren of een toename van de 
klachten, terwijl patiënten die in de uitgangssituatie aangaven dat psychosociale 
stressoren mogelijk een oorzakelijk verband hielden met de klachten een gunstigere 
prognose hadden. De gegevens suggereerden dat zich in een relatief vroeg stadium van 
de aandoening de grootste kans op spontaan herstel voordoet en dat interventies in die 
fase wellicht een grotere kans van slagen hebben. In deze vroege fase lijken sociale en 
stress factoren een belangrijke te rol spelen.
Het derde onderzoek (hoofdstuk 4) richtte zich op patiënten die normaliter niet aan 
onderzoek deelnemen. Met hulp van de patiëntenorganisatie voor CVS patiënten (de 
ME-Stichting) werden leden benaderd die aangaven wel aan CVS onderzoek mee te 
willen doen, maar vanwege de ernst van hun beperkingen niet in staat waren om naar 
het onderzoekscentrum te komen. Vervolgens werden achttien van deze ernstig 
geïnvalideerde patiënten door de onderzoekers thuis bezocht. De testresultaten van 
deze groep werden vervolgens vergeleken met data van een groep patiënten die had 
deelgenomen aan onderzoek op het UMC St. Radboud. De aan huis gebonden groep 
bleek in vergelijking met de ambulante groep gemiddeld ouder te zijn en een langere 
klachtenduur te hebben. Om die reden werd een deel van Nijmeegse vergelijkingsgroep 
geselecteerd op vergelijkbare leeftijd en klachtenduur. Ondanks deze matching werd de 
aan huis gebonden groep gekenmerkt door zeer lage lichamelijke activiteit, meer 
dagelijkse vermoeidheid en meer fysieke beperkingen, maar zij verschilden niet in 
psychisch welbevinden en sociale beperkingen van de vergelijkingsgroep. Bij een jaar 
follow-up bleken er nagenoeg geen veranderingen te zijn opgetreden in de gemiddelde 
activiteit, vermoeidheid en beperkingen. Een van de veronderstellingen was dat deze 
groep patiënten, vanwege de lange klachtenduur en het blijvend lage activiteitsniveau, 
een verhoogd risico had voor lichamelijk deconditioneren en wellicht een geheel 
andere behandeling nodig zou hebben in vergelijking met meer actieve CVS patiënten. 
In de onderzoeksliteratuur is verondersteld dat CVS patiënten activiteit vermijden 
waardoor hun lichamelijke conditie achteruit gaat, hetgeen dan weer gemakkelijker 
vermoeidheid oproept. Anderzijds is geopperd dat CVS patiënten worden gekenmerkt 
door een onregelmatig activiteitenpatroon waarbij activiteitspieken worden afgewisseld 
met langdurige rustperiodes. Ook in het CVS model neemt lichamelijke activiteit en de 
vermijding daarvan een belangrijke plaats in. Voorafgaande studies hebben aangetoond 
dat CVS patiënten minder actief zijn dan gezonde controles, maar dat de variatie in 
activiteit tussen CVS patiënten erg groot is. Ook bestaat de indruk dat patiënten sterk 
verschillen met betrekking tot hun dagelijkse fysieke activiteit en dat slechts een deel 
van hen als laag actief kan worden gekenschetst. Om die reden werd besloten
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(hoofdstuk 5) tot een nadere analyse van activiteitspatronen in CVS. Hiervoor werd een 
apparaatje gebruikt dat aan de enkel wordt bevestigd en bewegingen detecteert. Met 
behulp van deze actometer was het mogelijk om bij iedere CVS patiënt gedurende twee 
weken continu de bewegingactiviteit te registreren. De resultaten bevestigden dat de 
CVS groep minder actief is dan de gezonde controle groep, maar dat beide groepen niet 
verschilden in intensiteit en duur van de tien meeste actieve pieken in de 
observatieperiode. Wel waren de CVS patiënten gemiddeld langer inactief na een 
dergelijke piek. Ten opzichte van controles hadden CVS patiënten niet vaker 
fluctuaties in dagactiviteit. Wanneer CVS patiënten werden ingedeeld naar laag actief, 
gemiddeld actief en relatief actief bleek ongeveer 25% van hen een voortdurend laag 
activiteitenniveau te hebben terwijl dit bij niemand van de controlegroep van gezonden 
personen (controles) voorkwam. Met betrekking tot vermoeidheid en depressie werden 
geen verschillen gevonden tussen de passieve en de meer actieve CVS patiënten. Deze 
bevindingen geven aan dat slechts een deel van de CVS patiënten als passief kon 
worden geclassificeerd en suggereren dat de mate van activiteit wellicht los staat van 
de algemene ernst van ervaren vermoeidheid. Deze laatste bevinding is belangrijk 
aangezien de meeste CVS patiënten een sterke relatie tussen lichamelijke inspanning en 
vermoeidheid rapporteren en activiteitenregulatie vaak een belangrijk onderdeel vormt 
van therapeutische interventie.
Het zesde hoofdstuk gaat gedetailleerder in op de relatie tussen dagelijkse 
vermoeidheid en dagelijkse activiteit. Gelijktijdig met de actometer registratie werd 
met behulp van een dagboek het beloop van vermoeidheid gedurende de dag (opstaan, 
ochtend, middag en avond) bijgehouden. Een vergelijking met gezonde controles liet 
zien dat CVS patiënten op alle momenten van de dag, dus ook bij het opstaan, meer 
vermoeidheid rapporteerden. In beide groepen nam de vermoeidheid gedurende de dag 
geleidelijk toe, maar in de CVS groep bereikte zij haar maximum al in de middag. 
Passieve CVS patiënten, gemiddeld actieve en relatief actieve CVS patiënten 
verschilden niet van elkaar met betrekking tot hun gemiddelde vermoeidheidscores bij 
opstaan en gedurende ochtend, middag en avond. Bij individuele analyses bleek dat de 
relatief actieve CVS patiënten vaker (meer dagen) een toename in vermoeidheid 
(ochtendscore < middagscore) rapporteerden en minder vaak last hadden van ernstige 
vermoeidheid bij het opstaan dan de beide andere groepen. Voor iedere patiënt werd 
ook de correlatie berekend tussen de dagelijkse vermoeidheidscores en de 
actometergegevens. Slechts bij twaalf procent van de 164 CVS patiënten was er sprake 
een significant verband. Dit betekent dat bij de meeste onderzochte CVS patiënten de 
dagelijkse lichamelijke activiteit nauwelijks was gerelateerd aan de gerapporteerde 
vermoeidheid. Wel bleek dat de gemiddelde correlatie tussen actometerscores en 
vermoeidheidscores gemiddeld positief was bij de relatief actieve patiënten (meer 
actief meer vermoeidheid) en dat bij passieve patiënten dit verband gemiddeld negatief 
was. Passieve patiënten gaven ook aan meer geneigd te zijn activiteit te vermijden om 
vermoeidheid te voorkomen. De gegevens boden als zodanig weinig ondersteuning 
voor de door patiënten ervaren sterke relatie tussen de mate van dagelijkse activiteit en 
de mate van dagelijkse vermoeidheid. Op basis hiervan werd gesuggereerd dat ook de 
relatie tussen mentale en sociale activiteit enerzijds en ervaren vermoeidheid anderzijds 
zou moeten worden onderzocht.
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De volgende twee hoofdstukken (7 & 8) hebben één van de belangrijkste klachten van 
CVS patiënten als onderwerp. Deze patiënten ervaren vaak concentratieproblemen 
maar onderzoek met neuropsychologische testen rapporteren sterk uiteenlopende 
resultaten en verklaringen. Geen van deze onderzoeken houdt echter rekening met het 
feit dat gedragsfactoren, zoals faalangst of lage motivatie, de testresultaten beïnvloed 
kunnen hebben. In tegenstelling tot testonderzoek ten behoeve van bijvoorbeeld 
schadeclaims, wordt in wetenschappelijk onderzoek nauwelijks gecontroleerd voor 
gedragsfactoren die de interpretatie van neuropsychologisch testgegevens zouden 
kunnen bemoeilijken. Om die reden werden in hoofdstuk 8 de testprestaties van een 
CVS groep vergeleken met die van een groep patiënten met multiple sclerose (MS). 
Naast een gangbare neuropsychologische test werd een test afgenomen die is 
ontworpen om submaximale inspanning bij neuropsychologisch onderzoek te 
detecteren. Een afwijkend resultaat op een dergelijke test vormt een sterke aanwijzing 
dat gedragfactoren van invloed waren op de testprestatie. Met betrekking tot de 
prestaties op de gangbare neuropsychologische taak werd tussen beide groepen geen 
verschil gevonden, echter dertig procent van de CVS patiënten versus zestien procent 
van de patiënten met multiple sclerose hadden een afwijkende score op de detectie taak 
voor submaximaal presteren. Dit resultaat bevestigde de veronderstelling dat 
gedragsfactoren bij een deel van de CVS patiënten bijdragen aan afwijkingen 
gevonden bij neuropsychologisch onderzoek; een bevinding die de validiteit van de 
interpretatie van groepsgegevens fors kan beïnvloeden.
Rekening houdend met deze bevinding en het feit dat in de literatuur veelvuldig wordt 
gesproken over een afname in mentale snelheid bij CVS is in de volgende studie 
(hoofdstuk 9) getracht om vertraging van de informatieverwerking te verklaren met 
behulp van gedragsfactoren die typisch zijn voor CVS. In deze studie werd 
gecontroleerd voor afwijkende resultaten die het gevolg kunnen zijn van een 
suboptimale inzet. Vanuit een aandachtstheorie werd een model ontworpen waarbij 
getoetst werd in hoeverre verhoogde aandacht voor lichamelijke sensaties 
klachtrapportage bevordert en de informatieverwerking van externe prikkels vertraagt. 
Hiervoor werd een reactietijdparadigma gebruikt waarbij een onderscheid werd 
gemaakt tussen reactiesnelheid (informatieverwerking) en motorische snelheid (uitvoer 
respons). Het bleek dat patiënten die aangaven gevoelig te zijn voor de waarneming 
van lichamelijke prikkels, niet alleen meer klachten rapporteerden maar ook een tragere 
reactietijd hadden. De snelheid van de vereiste respons (motorische uitvoer) was ook 
geassocieerd met de hoeveelheid gerapporteerde klachten maar was niet gerelateerd aan 
de mate van aandacht voor lichamelijke sensaties. De resultaten van dit onderzoek 
toonden aan dat mentale vertraging ook verklaard kan worden vanuit CVS specifieke 
gedragsfactoren die nauw gerelateerd zijn aan aandacht voor lichamelijk sensaties.
De laatste onderzoekingen van deze dissertatie zijn gericht op vermoeidheid bij 
neurologische aandoeningen. In hoofdstuk 10 is getoetst of de ervaren vermoeidheid 
van patiënten met multipele sclerose is gerelateerd aan voor deze ziekte karakteristieke 
structurele afwijkingen in de hersenen die waren vastgesteld met behulp van Magnetic 
Resonance Imaging technieken. Bijna driekwart van de MS patiënten rapporteerde 
ernstige vermoeidheid maar er werd geen enkele relatie gevonden tussen de 
hoeveelheid witte stof laesies in de verschillende delen van de hersenen en de mate van
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vermoeidheid. Ook werd geen significant verband aangetoond tussen de ernst van 
neurologische beperkingen en de mate van vermoeidheid. Ervaren vermoeidheid bij 
patiënten met multipele sclerose kon dus niet eenduidig worden verklaard vanuit deze 
ziektespecifieke afwijkingen. In een voorafgaand onderzoek bleek, dat vergelijkbaar 
met de resultaten bij CVS patiënten, een geringere self-efficacy ook bij patiënten met 
multipele sclerose vermoeidheid voorspelde. In hoofdstuk 11 werd nagegaan of 
hulpeloosheid, een ziekteopvatting die sterk gerelateerd is aan een negatieve self­
efficacy, mogelijk een mediërende rol speelde tussen de ernst van de neurologische 
beperkingen enerzijds en de ernst van de ervaren vermoeidheid anderzijds. Er werd 
eerst volgens een klassiek ziektemodel getoetst of de mate van vermoeidheid en 
depressie rechtstreeks verklaard konden worden vanuit de mate van neurologische 
beperkingen. Vervolgens werd een model getoetst waaraan hulpeloosheid als een 
mediërende ziektecognitie was toegevoegd. De data van de MS patiënten bleken veel 
beter te passen bij het model dat deze ziektecognitie bevatte. Neurologische 
beperkingen droegen bij aan grotere gevoelens van hulpeloosheid, terwijl deze 
hulpeloosheid tot meer depressie en sterker ervaren vermoeidheid leidde. Deze studie 
toonde aan dat ziekteopvattingen ook bij een ziekte als multiple sclerose een rol kunnen 
spelen in de perceptie van vermoeidheid. Dit is een bevinding die aanknopingspunten 
biedt voor vormen van psychologische behandeling van vermoeidheid bij MS.
Patiënten die worden geconfronteerd met een herseninfarct of hersenbloeding 
(beroerte) krijgen plotseling te maken met lichamelijke en/of mentale uitvals- 
verschijnselen. Alhoewel veel van deze patiënten kort na de beroerte klagen over 
vermoeidheid, is weinig bekend in hoeverre vermoeidheid nog een probleem vormt, 
lang na het ontstaan van een dergelijke aandoening. In deze studie werd daarom een 
klachtinventarisatie gedaan bij patiënten die minstens twee jaar voor het onderzoek een 
beroerte hadden doorgemaakt. Bij een vergelijking bleek dat patiënten met een beroerte 
veel vaker ernstige vermoeidheid (51% versus 16%) rapporteerden dan controles van 
de dezelfde leeftijdsgroep. Bij patiënten met een beroerte was ernstige vermoeidheid in 
sterke mate gebonden aan beperkingen in het lopen, terwijl bij de controle groep de 
veel minder vaak voorkomende ernstige vermoeidheid het sterkst was gerelateerd aan 
depressie.
De laatste twee onderzoekingen hebben betrekking op patiënten met een spierziekte. 
Vergelijkbaar met multipele sclerose hebben spierziekten een chronisch karakter en 
vaak een progressief beloop. Spierzwakte is het algemene kenmerk van spierziekten 
maar er is weinig bekend over de vraag in hoeverre ernstige dagelijks ervaren 
vermoeidheid een probleem vormt. Om die reden werden aan patiënten met een 
spierziekte, die de polikliniek neurologie van het UMC St. Radboud bezochten, 
vragenlijsten meegegeven. Uit deze vragenlijsten kwam naar voren dat ernstige 
vermoeidheid net als bij multipele sclerose, veel voorkomt bij patiënten met een 
spierziekte. Bij nadere analyse bleek dat er grote overeenkomsten waren in 
beperkingen en psychisch welbevinden tussen ernstig vermoeide patiënten met een 
spierziekte en patiënten met multipele sclerose. Er waren ook verschillen, patiënten met 
een spierziekte hadden meer moeite met het initiëren van activiteiten terwijl patiënten 
met multipele sclerose vaker cognitieve klachten rapporteerden. Aangezien er een grote 
diversiteit aan spierziekten bestaat is een voorlopige analyse uitgevoerd waarbij
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onderscheid werd gemaakt tussen verschillende diagnostische categorieën. Er bleken 
tussen de diagnostische groepen aanzienlijke verschillen te bestaan in de frequentie 
waarin ernstige vermoeidheid voorkwam. Omdat er bij veel spierziekten een eenduidig 
onderscheid gemaakt kan worden tussen type uitval (bijvoorbeeld spier, zenuw), 
kunnen vermoeidheidstudies bij spierziekten goede aanknopingspunten bieden voor 
onderzoek naar somatische determinanten van dagelijks ervaren vermoeidheid.
Het laatste onderzoek heeft betrekking op patiënten met dystrofe myotonie, een 
chronisch progressieve multisysteem aandoening die zowel spieren als zenuwen 
aantast. Internationale publicaties hebben aangetoond dat een aantal van deze patiënten 
overdag last heeft van abnormale slaperigheid. Een deel van deze patiënten reageert op 
behandeling met Modafinil, een geneesmiddel dat net als amfetamines de alertheid en 
waakzaamheid verhoogt en onder andere de gevolgen van narcolepsie tegen gaat. Deze 
bevindingen vormden de reden om na te gaan of ervaren ernstige vermoeidheid en 
abnormale slaperigheid overdag uiting zijn van een zelfde symptoom. Ruim driekwart 
van de 32 patiënten rapporteerde ernstige vermoeidheid terwijl er slechts bij een derde 
van de patiënten met dystrofe myotonie aanwijzingen werden gevonden voor 
abnormale slaperigheid overdag. De mate van vermoeidheid was niet gerelateerd aan 
het wel of niet aanwezig zijn van abnormale slaperigheid. Ernstige vermoeidheid was 
bij deze groep patiënten een frequent probleem en stond los van een mogelijk 
ziektespecifiek verschijnsel als abnormale slaperigheid. De verkregen resultaten 
vormden voldoende aanleiding om onderzoek op te zetten naar mogelijke 
determinanten van aan dystrofe myotonie gerelateerde ernstige vermoeidheid.
Tot slot worden in de algemene samenvatting van deze dissertatie de belangrijkste 
bevindingen en mogelijke implicaties voor onderzoek en behandeling bediscussieerd. 
De gepresenteerde onderwerpen in deze dissertatie weerspiegelen de voortzetting en 
uitbreiding van het multidisciplinair onderzoek van de Nijmeegse Onderzoeksgroep 
Chronische Vermoeidheid. De definitie van CVS en het onderzoek naar de mogelijke 
determinanten daarvan hebben een impuls gegeven aan vermoeidheidsonderzoek bij tal 
van andere aandoeningen. Zowel uit deze dissertatie als uit (inter) nationaal onderzoek 
blijkt, dat bij patiënten met uiteenlopende ziektebeelden chronische vermoeidheid vaak 
een groot probleem vormt. Een bevinding die aansluit bij de opvatting van veel artsen 
dat vermoeidheid een a-specifiek symptoom is. Het feit dat de aanhoudende 
vermoeidheid bij CVS niet ‘automatisch’ kon worden toegeschreven aan een 
lichamelijke afwijking is wellicht juist de aanleiding geweest voor de toename in 
vermoeidheidstudies. De ontwikkeling van gestandaardiseerde meetinstrumenten 
maakte het mogelijk om de mate van ervaren vermoeidheid betrouwbaar te meten en 
daarbij vergelijkingen te maken tussen verschillende aandoeningen. Tevens werd het 
mogelijk om de effecten van behandeling op vermoeidheid te evalueren en resultaten 
van verschillende onderzoeksgroepen te vergelijken. De resultaten zoals beschreven in 
deze dissertatie benadrukken het belang om bij onderzoek naar en behandeling van 
chronische vermoeidheid psychosociale aspecten te betrekken. Verschillen in 
gedragingen, cognities en sociale interacties vormen de aanknopingspunten voor 
specifiekere diagnostiek en meer toegespitste gedrags- en/of medicamenteuze 
interventies bij patiënten die een ‘aspecifieke’ klacht zoals chronische vermoeidheid 
rapporteren.
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